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This thesis investigates the functional consequences of neutralising the negative charges on 
the bacteriophage T7 antirestriction protein ocr. The ocr molecule is a small highly 
negatively charged, protein homodimer that mimics a short DNA duplex upon binding to the 
Type I Restriction Modification (RM) system. Thus, ocr facilitates phage infection by 
binding to and inactivating the host RM system. 
The aim of this study was to analyse the effect of reducing the negative charge on the ocr 
molecule by mutating the acidic residues of the protein. The ocr molecule (117 residues) is 
replete with Asp and Glu residues; each monomer of the homodimer contains 34 acidic 
residues. Our strategy was to begin with a synthetic gene in which all the acidic residues of 
ocr had been neutralised. This so called ‘positive ocr’ (or pocr) was used as a template to 
gradually reintroduce codons for acidic residues by adapting the ISOR strategy proposed by 
D.S.Tawfik. After each round of mutagenesis an average of 4-6 acidic residues were 
incorporated into pocr. In this fashion a series of mutant libraries in which acidic residues 
were progressively introduced into pocr was generated. 
A high-throughput in vivo selection assay was developed and validated by assessing the 
antirestriction behaviour of a number of mutants of the DNA mimic proteins wtOcr and 
Orf18 ArdA. Further to this, selective screening of the libraries allowed us to select clones 
that displayed antirestriction activity. These mutants were purified and in vitro 
characterisation confirmed these mutants as displaying the minimum number of acidic 
residues deemed critical for the activity of ocr. This in vitro process effectively simulated the 
evolution of the charge mimicry of ocr.   
Moreover, we were able to tune the high-throughput assay to different selection criteria in 
order to elucidate various levels of functionality and unexpected changes in phenotype. This 
approach enables us to map the “in vitro” evolution of ocr to identify acidic residues that are 
required for protein expression, solubility and function proceeding to a fully functional 
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Chapter 1. Introduction 
 
1.1 Restriction Modification (RM) enzymes 
In 1962 Arber and Dussiox discovered a family of proteins that could provide host controlled 
restriction and modification of DNA. These enzymes were later named restriction 
modification systems. Since their early discovery, investigations have elucidated several key 
roles of Restriction Modification (RM) systems within a cell; a defensive role, the 
acquisition of beneficial sequence codes and/or propagation of selfish genetic elements.1 RM 
systems bind to DNA providing two different enzymatic processes; DNA cleavage and 
restriction or DNA modification. The RM restriction and modification complexes are able to 
recognise specifically modified sequences of DNA or “recognition sites”. In the event of an 
unmodified recognition site, the restriction process is initiated, resulting in the cleavage of 
the DNA duplex by the restriction endonuclease (REase). However, hemimethylated 
recognition sites initiate the modification process and so are methylated by the 
methyltransferase (MTase).  
As a defense mechanism RM systems have the ability to distinguish between the host cells 
genome and ‘foreign’ DNA. Each organism has its own signature DNA distinguishable by 
differential modification patterns (i.e. methylation sites) that are present on the DNA. In a 
bacterial cell the chromosomal (host) DNA is methylated at specified recognition sites which 
can contain methylated cytosine or adenine basepairs. During each round of replication 
newly synthesised DNA will lack this signature generating hemimethylated sites which are 
identified by RM enzymes and duly modified. However if the RM enzymes encounter 
unmodified DNA, it will trigger the restriction reaction of the REase. Figures 1.1 and 1.2 
demonstrate the general steps involved in the restriction and modification processes.1,2,3  
 
Figure 1.1: Hydrolysis of phosphodiester bonds and cleavage of dsDNA by a REase. The 





Figure 1.2: Reaction pathway for the methylation of adenine by a MTase. The reaction 
includes the use of the cofactor S-adenosyl-methionine (SAM) which is converted to S-
adenosylhomocysteine (SAH) upon donation of a methyl group to the DNA.4 44 
Several groups of RM systems have been identified over the years. These groups are 
distinguishable from each other by differences in enzyme composition, cofactor 
requirements, target site properties, the site of  DNA cleavage and are named Type I-IV, see 
table 1.1.1,3,5 
 Type I Type II Type III Type IV 
Example EcoKI EcoRI EcoP1I EcoMcrBC 
Genes hsd R,M,S ecorIR, ecorIM mod res mcrB, mcrC 
Subunits 
MTase: M2S1 MTase: M2 mod2res2 McrB 
REase: R2M2S1 REase: R2 mod2res1 McrC 
NTPase ATPase ATPase ATPase GTPase 
Co-factors for 
Restriction ATP, SAM, Mg2+ Mg2+ ATP, Mg2+, (SAM) GTP, Mg2+ 
Co-factors for 


















methylation sites at 
multiple sites 
DNA 
Translocation Y N Y Y 
Table 1.1: The different characteristics of Type I-IV RM Enzymes.2 
 
1.2 Type II, III and IV enzymes 
The Type II RM systems are the most well-known family of RM systems as they paved the 
way for bioengineering and experimental cloning. The Type II systems generally consist of 
two separate enzymes which perform the restriction (REase) and modification (MTase) 
processes, with both enzymes targeting the same recognition site on DNA. Upon binding to 
DNA, the MTase ensures that specific bases on both the sense and antisense strands of the 
target site are modified. If not, the MTase acts to modify the bases in the target site. Type II 
enzymes can modify the target site in various ways modifications include; N6-methyladenine 
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(m6A), N4- and N5-methylcytosine (m4C and m5C). A methyl group is donated to DNA from 
the cofactor S-adenosylmethionine (SAM). If the target site is unmodified then it is targeted 
by the restriction enzyme using an Mg2+ cofactor. The enzyme cleaves the DNA at specified 
sites that are either near or very close to the target site. The specific restriction sites of the 
Type II systems is a key feature that has been utilised within protein recombinant 
technology.2,3 
Type III systems consist of two subunits, the mod (recognition and modification) and res 
(restriction). The modification subunit can act independently from the restriction subunit and 
requires the cofactor SAM. To carry out restriction the enzyme can form one of two 
complexes either mod2res2 or mod2res1. The enzyme interacts with two copies of the 
recognition sequence in an inverse orientation, typically target sites are asymmetric and 5-
6bp long. For restriction activity the cofactor SAM is required in addition to Mg2+ and ATP. 
The restriction process is dependent on ATP hydrolysis which drives the translocation 
process of the DNA until the enzyme collides with another entity, usually a second RM 
enzyme, which then stimulates DNA cleavage. Translocation for Type III enzymes is a 
relatively short process and so cleavage by Type III enzymes occurs on the 3' side of the 
recognition sequence, not far from the original binding site.2,6,7  
Type IV enzymes are counterintuitive as they are methylation-dependent restriction systems. 
Therefore they require a methylated substrate to restrict the DNA. Due to this reason these 
systems act as REase enzymes only, seeking out foreign DNA methylated at a particular 
recognition site and subsequently cleaving the DNA. 2,7,8  
 
1.3 Type I RM Systems 
Type I RM systems produce multifunctional enzymes comprised of three different subunits; 
HsdS, HsdM and HsdR. These subunits assemble into two active forms which perform as an 
MTase or REase to provide methylation and restriction activity.1-5 The unique feature of 
Type I RM enzymes is the presence of the HsdS subunit also known as the specificity 
subunit. Upon binding the HsdS subunit recognises a specific recognition site on dsDNA9 
and is present in both the MTase and REase complexes. Whereas the MTase complex 
facilitates the methylation reaction using the cofactor SAM, the REase complex translocates 
and cleaves the DNA in an ATP-dependent process. The restriction reaction is facilitated by 
the presence of the cofactors Mg2+ and SAM. DNA cleavage is initiated by  an obstruction of 
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the translocation process, either by collision with another translocating complex or the 
‘topology’ of the DNA.3,7,10,11  
1.3.1 Subunit composition 
The molecular weight of the HsdS and HsdM subunits is 50-60kDa whereas the HsdR 
subunit is substantially larger with a molecular weight of ~140kDa.12,13 
The complete RM complex which is responsible for the restriction process is assembled with 
a stoichiometry of R2M2S1 producing a typical mass of 440kDa.7 However, the MTase 
complex which modifies the DNA consists of the trimeric core enzyme only; M2S1. This 
shows that the restriction subunits are not necessary for the methylation reaction of Type I 
enzymes. 14 Furthermore, the hsdM and hsdS genes have the same promoter but the hsdR 
gene is located with a separate promoter downstream.15 The resulting populations of both 
complexes in the cell show that there is a higher ratio of MTase to REase.1,16-17  
Differences between Type I RM systems are based on genetic complementation of the hsd 
genes, antibody cross-reactivity and DNA hybridisation from different systems producing 
five subfamilies of the Type I enzymes. These subfamilies are named Type IA-IE, however 
this thesis considers the Type IA RM enzyme, EcoKI in more detail.  
1.3.2 HsdS, the specificity subunit 
The role of the S subunit is to recognise specific DNA target sites. Typically these target 
sites are nonpalindromic bipartite sequences recognising two different regions of specificity 
separated by a number of non-specific DNA basepairs, for example, the recognition site of 
EcoKI is 5' AAC(N6)GTGC 3', where N signifies any nucleotide.17 A number of HsdS 
subunits have been crystallised and the solved structures show four distinct regions on the 
HsdS subunit, see figure 1.7.18,19,20 These include two globular domains designated target 
recognition domains (TRD) 1 and 2 which are separated by a highly conserved coiled coil 
region and a secondary conserved region located on the N-terminus. Sequence alignment 
studies show that the coiled coil region is the result of a highly conserved number of residues 
that are present among many HsdS subunits. The length of the coiled coil and alignment 
studies show that this coiled coil differs with the length of the non-specific region of the 
recognition site. Sequence analysis has shown that the HsdS coiled coil is very similar 
between Type IA RM systems.1,7,21 
As the name suggests the two globular TRD regions recognise and bind to the specific target 
sequence of the DNA recognition site. The overall folds of both TRD domains are near 
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identical not only with each other but also with HsdS subunits from other Type I enzymes, 
although sequence similarity is only ~40%. Any difference in sequence appears to be 
concentrated around the TRD domains which affects the local secondary structure and the 
binding interface of the HsdS subunits with DNA.22 The binding interface was identified by 
the presence of distinct DNA binding clefts present on each TRD.22 The clefts possess a 
number of polar residues which bind to the negatively charged phosphate backbone of 
DNA.7 However interestingly, a number of hydrophobic residues were also conserved within 
these clefts, which are thought to facilitate binding to DNA bases through van der Waals 
interactions.10, 21,23 
Models of the interaction between DNA and the HsdS subunit show that in order for the 
DNA target sites to align with the designated TRD sites of the HsdS subunit, the DNA needs 
to bend and kink and this has been shown to also partly unravel the DNA. This reveals the 
methylation target sites on the adenine nucleotide.19,24,25 
The HsdS subunit of the Type I RM enzyme from Thermoanaerobacter tengcongensis 
(TTE) was solved in 2011 by Gao et al.19 The structure identified differences in the 
orientation of the TRD domains relative to previously solved HsdS structures. The TRD 
domains exhibit a rotational motion as a result of the bending and twisting of the conserved 
coiled coil regions.19 Modeling of the HsdM subunits onto the structure of the HsdS revealed 
a potential open/close hinge mechanism for the MTase complex as a result of the domain 
motion, figure 1.3.  
A conserved region among all Type I TRD domains is an enriched proline hinge which has 
been identified as a linking region between the TRD domains with the coiled coils, allowing 
rotational freedom between the two domains. On the other hand the highly conserved coiled 
coil region which joins the two TRD domains together is held tightly together by a number 
of hydrophobic residues. These have been pinpointed by a number of mutagenesis studies 




Figure 1.3: The alignment of three HsdS subunits have been overlaid to show the effect of 
the twisting by the conserved coiled coil region and its contribution to the hinge mechanism 
of the MTase complex of Type I enzymes. TTE-HsdS (blue), Mja-HsdS (yellow) and Mge-
HsdS (red). This shows clear differences in the orientation of the three HsdS subunits.19 
1.3.3 HsdM subunit 
The C-terminal domain of HsdM subunit is highly conserved in Type IA enzymes, so much 
so that these HsdM subunits are interchangeable. As such it is thought that the C-terminal 
domain may act as an interface between the HsdS and the HsdM subunits.  
Several conserved regions have been identified from comparisons of HsdM subunits to Type 
II MTases. The regions concerned are located in the central part of the Type I HsdM subunit. 
Extensive studies have revealed that these motifs are important for the recognition of the 
methylation status, the docking of the SAM cofactor and the adenine target site which is 
situated in close proximity to the HsdS TRD sites.17,26 The partial unravelling of the DNA 
upon binding results in the insertion of the adenine target sites into the binding pocket of the 
HsdM subunit. This mechanism is a phenomenon termed nucleotide base flipping, figure 1.4. 
10,15,27 Co-crystal structures of a number of Type II MTases interacting with DNA have 
captured base flipping. The structures show that unmodified nucleotide target rotates out of 
the DNA helix, by the twisting of the sugar phosphate backbone, resulting in the capture of 




Figure 1.4: Model of DNA bound to MEcoKI, where the HsdM subunit is wheat coloured and 
the HsdS subunit is pale blue (pdb: 2Y2C). The DNA is highlighted in orange, an adenine 
base has flipped into the catalytic domain of the HsdM subunit (wheat colour). The catalytic 
domain contains a binding pocket for the cofactor SAM (green). Highlighted in red is a 
conserved region found on all MTase enzymes (NPPF).   
The HsdM subunit for EcoKI was successfully crystallised in 2005 by K M Rajashankar et 
al. (pdb: 2AR0) 
1.3.4 HsdR subunit 
HsdS and HsdM subunits that belong to the same family of Type I RM systems show high 
levels of sequence similarity and the HsdR subunit is no exception.  
In fact sequence alignments of HsdR subunits have revealed a conserved region located in 
Type I and Type II RM systems. This domain is located near the N-terminal region of Type I 
systems and studies have shown that this region is responsible for DNA cleavage and is an 
endonuclease domain. The central region of the HsdR subunit appears to be a domain that is 
unique to Type I and Type III enzymes. This region appears to be responsible for the 
translocation of DNA as it contains the conserved motifs of DEAD box helicases which are 
typically prevalent in many RNA and DNA helicases.15  
The first crystal structure of a near complete HsdR subunit was solved in 2008. Lapkouski et 
al revealed that the subunit consisted of four globular domains, see figure 1.5.29 These 
domains assemble to form a square planar arrangement with the formation of a groove 
through the middle, which is enriched with positive amino acid residues.10 The ATP and 
Mg2+ binding sites were identified in the centre of the structure by extensive mutagenesis. It 
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was found that the absence/inhibition of DNA translocation also prevents the DNA cleavage 
process by the HsdR subunit.29,30  
 
Figure 1.5: The crystal structure of HsdR subunit of the Type IC RM enzyme, EcoR124I in a 
planar domain arrangement. The domains have been highlighted in red for the endonuclease 
(aa13-260), blue and yellow for Helicase 1 and 2 (aa261-461 and 470-731) and a fourth 
helical domain in green (aa732-892) as interpreted by Lapkouski et al, 2008.29 
1.3.5 Translocation mechanism 
Upon binding to the recognition site of a DNA duplex, the HsdR subunit translocates the 
DNA, by “pulling” DNA towards the enzyme. This simultaneous movement both left and 
right is known as bidirectional translocation. If one HsdR subunit is inactive then dsDNA 
cannot be cleaved efficiently, although translocation is not affected, which implies that two 
proficient HsdR complexes are necessary to cleave double stranded breaks on a DNA 
duplex.11,31,32   
The first suggestion of translocation motion was by Shulman in 1974.33,34  Since then several 
models have been proposed in the literature. The current model is by Neaves et al, 2009, 
which was inspired from the previous model of Studier and Bandyopadhyay, 1988 and is 
outlined in Figure 1.6.35 In 1988 Studier and Bandyopadhyay had established that EcoKI 
enzymes individually bind to and translocate the target site on a DNA duplex. This is 
regardless of other RM enzymes binding to target sites located on the same piece of DNA. 
Cleavage occurs due to a collision between the two Type I enzymes.35 However, the AFM 
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results outlined in Neaves et al, 2009 have shown a cleavage mechanism similar to the Type 
II nuclease, FokI, which only cleaves DNA after dimerisation of the enzyme. They found 
that EcoKI can dimerise on the DNA and find the recognition site by linear diffusion up and 
down the DNA from a non-specific site.36 DNA cleavage in the presence of the dimer is 
caused by ‘DNA stalled translocation’, when the loops formed through translocation are 
fully contracted.37,38,11  
 
Figure 1.6: Diagram of EcoKI binding, translocation and restriction on DNA. Panel (a) shows 
the previous model (Studier and Bandyopadhyay, 1988). EcoKI monomers bind individually 
to each site and translocation occurs independently from both occupied sites. When the 
monomers meet, restriction occurs due to stalled translocation. Panel (b) shows a new 
model.34,37,38 EcoKI binds to one site and then a second “monomer” binds to form a 
dimerised complex. The EcoKI dimer then forms diffusive loops with non-specific regions of 
DNA until it is stabilised by contact with the secondary EcoKI site. Translocation is then 
initiated from both sides of both monomers and restriction occurs when the translocation 
process is stalled. For both panels DNA is represented as a line; specific EcoKI sites are 
represented by dots on the DNA molecules, and EcoKI monomers are represented as 
individual spherical objects.38 
 
Although evidence for dimerisation is strong, it is not an absolute requirement for 
translocation, as cleavage can occur in the presence of only one enzyme and one site.32,39 
Instead dimerisation seems to enhance restriction. The cooperation between two Type I 
complexes allows the enzymes to remain stationary, without having to pull another RM 
complex through a crowded solution of macromolecules. 
The translocation process has been recorded to distances of up to 50,000 basepairs. Various 
translocation rates have been recorded for different nucleases with the fastest translocation 
rate recorded at 1kb/s .40,31,41 The translocation rate of EcoKI was measured by introducing 
the enzyme into the genome of T7 phage. Translocation was monitored by the progressive 
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methylation of Sau3A1 restriction sites and estimated the translocation rate of EcoKI to be 
100bp/s.42 Further experimentation by Seidel and Szczelkun, 2008, showed that each 
translocation step is a movement of 1-2bp of DNA with an ATP expenditure of ~1ATP 
molecule per basepair.43 
 
1.4 EcoKI 
EcoKI was the first Type I RM system identified and purified (1968)44. However, attempts to 
successfully crystallise any Type I RM systems have as yet been futile. It is only recently 
that researchers have managed to crystallise each of the subunits.  
However, in 2009, Kennaway et al had resolved an 18Å resolution model of the MTase 
bound to a DNA mimic protein, wtOcr, using EM microscopy.45 Using the structure of 
recently crystallized HsdS, HsdM and HsdR alongside the extensive biochemical/biophysical 
data on M.EcoKI, Kennaway and colleagues managed to successfully produce a model of the 
M.EcoKI complex that fitted the EM structure. The subsequent models produced were of 
unbound M.EcoKI, DNA bound M.EcoKI and M.EcoKI bound with the DNA mimic Ocr. 
EcoKI appears to preferentially favour a closed state and the dimensions of the complex are 
~120Å by 100Å. The models show that upon binding to DNA or the DNA mimic Ocr the 
M.EcoKI enzyme produces a clamp-like structure which allows the enzyme to engulf 
Ocr/DNA. 14 The kink that is produced when Ocr dimerises and when DNA binds to 
M.EcoKI is accommodated by the enzyme by a kink that is formed in the coiled coil region 
of the HsdS subunit. 27  
1.4.1 Interactions of HsdM and HsdS 
Although the location of the C-terminal domains remains speculative and its structure 
ambiguous, the models designed by Kennaway et al have suggested that these domains are in 
close proximity to the HsdS subunit. Supposedly the C-terminal domain of the M subunit 
(aa470-529) interacts with the highly conserved coiled-coil region of the HsdS subunit. 
Previous biochemical data have shown that the removal of ~43 residues from the C-terminal 
region of the HsdM subunit still produced a folded and stable subunit but this was unable to 
bind to the complex M1S1. In addition the domains that are involved in this potential 
interface (C-terminal domain on the HsdM subunit and the coiled coil region of HsdS) are 
highly conserved in Type IA RM families, so much so that they are thought to be 
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interchangeable. Their high conservation among the enzyme family supports the suggestion 
that this domain on the HsdM subunits plays a role in subunit assembly. 
A secondary interface was also resolved which involved the two loop regions located on the 
catalytic domain of the HsdM subunit (aa430-433 and aa464-470) and an area close to the 
TRD domains of the HsdS subunit (N133-A144). However, the TRD domains are highly 
variable depending on the specific DNA site the HsdS subunit recognizes, therefore this 
interface is thought to be of secondary importance compared to the C-terminal interface. 45,24 
1.4.2 HsdS and DNA 
The TRD domains of the HsdS subunit on EcoKI are known to interact with the specified 
recognition site on dsDNA. The Kennaway M.EcoKI model confirmed the identity of two 
loop regions on the TRD 1 domain (located at the N-terminal region of the HsdS subunit) 
that were in contact with DNA; aa83-91 and aa96-118. Previous mutagenesis studies of these 
sites revealed that these amino acids bind to the complementary strand of the recognition site 
which contains the thymine basepair to the targeted adenine sites, upon substitution of these 
residues DNA was still able to bind to the enzyme but no activity was observed. Further 
mutagenesis studies identified further DNA-binding regions in the TRD domains; S149-
K148 in TRD 1 and T354-K363 in TRD 2 which bind to the major groove of dsDNA which 
is where the DNA recognition site is located, figure 1.7. Notably the model revealed that the 
amino acids that are in contact with the adenine nucleotides targeted for methylation were 






Figure 1.7: The structure of the HsdS subunit obtained from the M.EcoKI model by 
Kennaway (pdb:2Y7H). Each domain has been highlighted in red TRD1 and blue TRD2 
which bind to the EcoKI recognition site on DNA (5’-AAC-(N)6-GATC-3’). The residues 
thought to be directly involved are represented as spheres; for TRD 1 (S139-K148) and TRD 
2 (T354-K363). The grey spheres pinpoint the two residues N145 and Q357 which target the 
adenine basepairs for methylation. In green is the conserved coiled coil region that 
determines the length of the non-specific residues.45  
 
1.4.3  HsdM with DNA 
It is thought that the HsdM subunits play two roles in its interaction with DNA. Firstly the 
N-terminal domain acts as the interface for the hinge mechanism of M.EcoKI, which allows 
the flexing of the open and closed state of the enzyme that allows the DNA to bind. 
Mutations termed the m* mutations targeted residues within this N-terminal region (aa1-153) 
and on helix G64-L73 which is located at the HsdM:HsdM interface. The m* mutations are 
so called because the enzyme has lost its preference to bind to hemimethylated sites and so 
the enzyme is able to bind and modify both hemi-methylated and unmethylated DNA sites. 
Methylation and restriction processes are not affected therefore these mutations allow the 
enzyme to produce an r+m* phenotype (restriction proficient and methylation proficient 
enzymes for unmethylated and hemi-methylated sites). Additional mutations are located in 
the central catalytic domain of the HsdM subunit producing long distance conformation 
changes that alter the local N-terminal region. Mutations within the m* domain have been 
shown to induce an r-m* (restriction deficient and methylation proficient enzymes for 
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unmethylated and hemi-methylated sites) suggesting the possibility of an interaction between 
the HsdM N-terminal domain and the HsdR subunits, see figure 1.8.  
The DNA recognition site not only binds to the HsdS subunit but also the HsdM subunit 
where adenine base flipping is initiated.The adenine base is flipped into the catalytic domain 
of the HsdM subunit where it is modified with a methyl group donated by the cofactor SAM. 
The catalytic domain of the HsdM subunit consists of the AdoMet binding motif I for 
cofactor binding. However, mutations at N266 and F269 from catalytic domain IV reduce 
the methylation activity of the MTase, figure 1.4 shows that these residues are located next 
to the adenine target sites.45 
 
Figure 1.8: The m*mutations on the HsdM subunit taken from the Kennaway model of 
M.EcoKI (pdb:2Y7H) The central domain is highlighted in red and the N-terminal domains in 
orange the C-terminal domain has be omitted for clarity. Mutations that cause the r+m* are 
shown in blue (E48, L85, R124, L134 and R153) and r-m* are in cyan (S144, W115, L113). 
Loops that were disordered in the crystal structure are shown in green and yellow and the 
cofactor Adomet is in purple located in the catalytic domain of the HsdM subunit.25 
 
1.5 REase Complex 
After revealing the M.EcoKI structure, Kennaway et al (2012) resolved the structure of the 
REase complex for the EcoKI enzyme with and without DNA.25 The structure confirmed the 
location and assembly of the HsdS and HsdM subunits of the M.EcoKI enzyme revealed on 
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the M.EcoKI model by Kennaway et al (2009).on the earlier M.EcoKI model. However the 
2012 model also revealed the location of the HsdR subunits and the pathway of DNA 
through the complete enzyme. Although the EM models produced are low resolution in 
comparison to a crystal structure; extensive SAXS and SANS analysis, the known structures 
of crystallised subunits and the large amount of biophysical and biochemical data on the 
enzyme were used to produce a model which orientated the subunit structures to fit the EM 
model provided, figure 1.9.  
Although the HsdR subunits were well-defined, their orientation in the 2012 model remained 
ambiguous and the path of the DNA through the complex was obscured. However the crystal 
structure of the RecA-like motor domains of the chromatin remodeling translocase 
SW12/SNF2, which acts with a similar mechanism, was used to align the location and 
direction of the DNA path, by overlaying the crystal structure of the translocase with the 
HsdR subunits. The DNA path forms an S-like shape through the EcoKI complex with the 
M.EcoKI core flanked by the two HsdR subunits. DNA footprinting experiments and AFM 
studies on the translocation mechanism of EcoKI indicate that the pathway of the DNA 
through the enzyme is kinked.46,38,43 The orientation of the HsdR subunits allows for the 
formation of supercoiled DNA structures which occur as a result of HsdR subunits 








Figure 1.9: Extracted from Kennaway et al 2012.25 Atomic model of EcoKI+DNA DNA is 
coloured green (but is not shown bound to each HsdR for clarity), HsdM subunits are light 
and dark blue, the HsdS is yellow and the two HsdR subunits are shown in red, with the β 
sheets of the recA-like motor domains in orange and residues modelled de novo are shown 
in grey. The HsdS and HsdM have been modelled from the MTase structure (pdb: 2Y2C) 
and the HsdR modelled on those from EcoR124I (pdb: 2W00).25 
 
1.6 Mobile genetic elements 
Genetic diversity and evolution among the prokaryotic community is driven by a 
phenomenon known as horizontal gene transfer. Horizontal gene transfer (HGT) occurs due 
to the transmission and acquisition of genes from across different species as a result of 
mobile genetic elements. The acquisition of these genes occurs through the transfer of 




As a result HGT is responsible for the spread of pathogenic and environmentally hazardous 
genes and is a factor in the spread of antibiotic resistance. However, HGT is prevented, in 
part, by the presence of Type I RM systems. Type I RM systems are widespread among 
bacteria and archaea and thought to act as an innate immune response in bacteria against the 
introduction of foreign DNA in the host cell. Nevertheless HGT is rife and therefore the 
transmission of genes among bacteria is high, suggesting that RM systems do not appear to 
be efficient protectors of the cell. This is because mobile genetic elements have evolved to 
produce a number of antirestriction strategies which encourage the transmission of the genes 
across species.2 Most of the strategies adopted either modify the phage genome itself or 
produce accessory components which help the phage DNA to evade Type I RM systems.  
For instance, phage DNA can avoid having DNA recognition sites. Counter selection upon 
phage and plasmids has reduced the number of target sites on the phage genome. Phage can 
also modify basepairs. Examples of basepair substitutions include thymine to 5-
hydroxymethyluracil in B. subtilis phage, T-even phage substitutes hydroxylmethylcytosine 
for cytosine and the mom gene found in Mu phage modifies adenine to N6-(1-
acetamido)adenine.2   
In addition, a number of accessory proteins have been identified, which when co-injected 
upon conjugational infection, bind to the phage DNA to occlude the recognition sites from 
the endonuclease. This allows the subsequent modification of the phage DNA. Examples 
include the DarA and DarB proteins from phage P1.47 Other strategies include the hydrolysis 
of cofactors or interaction with the RM systems; phage lambda produces the Ral protein 
which stimulates the host MTase and suppresses the REase activity.48 lambda prophage 
found on the E. coli genome also encodes the Lar protein which has an equivalent role 
towards the Type IA RM system EcoKI.2,49  
There are also a number of antirestriction proteins that take a more direct approach; these 
proteins act as competitive inhibitors of Type I restriction enzymes by mimicking the size 
and shape of the B-form bent DNA. The most well studied antirestriction proteins include 
the Ocr protein from T7 bacteriophage and the Orf18 ArdA protein from the conjugative 
transposon Tn916. Both of these antirestriction proteins provide non-specific inhibition of 






In 1973, Studiers laboratory began publishing a series of investigations characterising the 
bacteriophage T7. By 1975, Studier had shown that phage T7 and T3 were susceptible to 
restriction from the RM systems upon mutations in gene 0.3.50,51 However it was 
investigations led by Kruger et al that showed that gene 0.3 protected phage T3 and T7 from 
a number of ‘classical’ restriction systems, namely E. coli Type I RM enzymes; O, B and K. 
The exact mechanism of antirestriction would not be known for a number of years, however; 
in 1977 gene 0.3 was labelled the ‘overcome classical restriction’ or Ocr gene function.52,53 A 
similar antirestriction function had been discovered previously which resides in gene 0.3 of 
T3 phage. For T3 phage, this gene also translated a SAMase protein to cleave SAM.54,55 
Gene 0.3 is located early in the viral genome and is one of the first phage related genes to be 
induced upon infection. By 1981 the Ocr protein expressed from gene 0.3 of T7 phage was 
successfully purified and its sequence determined.56 The Ocr protein consists of 117 amino 
acids of which ~30% are glutamic acids or aspartic acids conferring net negative charge on 
the protein.  
It was not until 2002 that the structure of the protein was solved, figure 1.10.46 The structure 
shows that the Ocr protein produces a stable homodimer in solution and this dimer mimics 
24bps of bent B-form DNA.  The structure is dominated by three helices; helix A (aa7-24), 
helix B (aa34-44) and helix D (aa78-106). A fourth helix, helix C (aa49-57) is located at the 
dimer interface.46 The structure confirmed much of the biochemical data that had been 
collected previously. DNA mimicry was produced by a constellation of acidic residues upon 
the surface of the protein that mimicked the placement of a DNA phosphate backbone as 
demonstrated in figure 1.11. A central kink at the point of the dimer interface was observed. 
This bend in the homodimer was substantial, producing an angle of ~34°.46 The kink is 
produced upon formation of the homodimer and provides the protein with a banana shape 
that is indicative of the shape that is induced by DNA upon binding to Type I RM 
systems.57,2 AFM has been used to determine that the bend induced by DNA upon its 
interaction to the Type IA enzyme EcoKI is on average 46°.57,46  
The antirestriction activity of Ocr inhibits all of the RM families, Type IA-D. This suggests 
that the binding of Ocr does not target the specific recognition domains but the electrostatic 




Figure 1.10: The structure of the Ocr homodimer. Each of the domains on the structure has 
been differentiated by a different colour and the N and C terminal residues are highlighted by 
black spheres.  
 
Figure 1.11: The DNA mimicry of the Ocr protein compared to the phosphate backbone of 
DNA bound to M. EcoKI, from the model by Kennaway et al, 2012. The acidic residues have 
been highlighted as red spheres on the structure of the Ocr homodimer (pdb:1S7Z) as 
determined by Putnam and Tainer in 2005.62,58 Dark red spheres indicate additional acidic 
residues that are present on the structure. The red spheres that mimic the phosphate 




Isothermal titration calorimetry (ITC) analysis of the interaction between the MTase of 
EcoKI and the wtOcr protein shows that the interaction is a highly favorable exothermic 
reaction with a ∆H of -85.8kJ/mol and a stoichiometry of 1:1 dimer: M.EcoKI. However, the 
entropy of the interaction was unfavorable, thought to be due to the loss of rotational 
freedom of the Ocr protein upon binding. The binding affinity of the interaction was too tight 
to be determined by ITC data, but fluorescent anisotropy experiments estimated that the 
binding affinity of the interaction was ≤100pM.57  
The same series of experiments showed that the Ocr protein also interacts with other 
derivatives of the EcoKI complex. Tryptophan fluorescence was used along with fluorescein 
tagging of the molecule to determine the binding of the Ocr towards the R.EcoKI nuclease. 
This interaction showed tight binding with a stoichiometry of 2Ocr2(dimer): EcoKI. In 
addition, the inactive M1S1 derivative of the MTase complex produced a tight interaction 
with Ocr, whereas the Ocr dimer with the M subunit alone exhibited a much weaker 
interaction.59,60,61 Fluorescein tags that were distributed across the whole surface of the Ocr 
protein were quenched upon binding of the Ocr protein to the M.EcoKI enzyme. This 
indicated that the binding interface covered a large surface area of Ocr.60.   
 
Figure 1.11: An equilibrium diagram for the in vitro assembly of the EcoKI and its interaction 
with the protein Ocr. Proposed binding affinities for the assembly of the EcoKI from its 
constituent subunits were a result of in vitro gel filtration measurements. Whereas, the 
interaction between Ocr and each of these complexes was measured by in vitro tryptophan 
fluorescence and fluorescent anisotropy. Although no quantitative measurement was 
measured for the binding affinity of M1S1 and Ocr they produce a tight interaction according 
to results from Atanasiu et al, 2002.59  
A total of 34 acidic residues are present on the Ocr protein, many of which reside in the C-













the C-terminal tail are nonessential for activity of the protein and even deleting the last 18 
acidic residues only showed a slight reduction in the stability of the protein while retaining 
full activity.57,60 In fact, alignment of the acidic residues from the Ocr homodimer with the 
DNA bound by the EcoKI enzyme, demonstrated that the recognition site corresponds to the 
amino acid residues D43 and D93 on the Ocr protein, Figure 1.12.  
 
Figure 1.12: Alignment of the primary structure for the target recognition site of EcoKI and 
wtOcr from T7. The alignments highlight that D43 and D92 appear to align with the target 
adenine basepair. Atanasiu et al, 2001.6561 
 
Clearly, many of the acidic residues that reside on the Ocr protein, particularly within the 
region D43-D93, are important to the interaction of Ocr with the EcoKI enzyme. As a result, 
studies on the importance of DNA mimicry and the charge of the Ocr protein were 
investigated by A. Stephanou and colleagues to ascertain which acidic residues are important 
for the interaction between EcoKI and Ocr.62 A number of mutagenesis studies were carried 
out; initially single mutants were targeted for a number of acidic residues that were 
distributed across the whole Ocr sequence.62 Activity assays in vivo and in vitro showed that 
each of these mutants were active and only very minor, if any, differences were detected 
compared to the activity of the wtOcr protein. The largest difference was demonstrated by 
the mutants E16, D25 or D26, however these differences were barely detectable when 




















































As a result, a larger study was carried out to chemically modify the acidic residues on the 
surface of the Ocr protein. The chemical 1-ethyl-3-(3-dimethylaminopropyl)carboiimide 
hydrochloride (EDC) was used to modify the carboxyl groups present on the side chains of 
the two acidic residues Asp and Glu, producing a neutral and stable amide in each case. A 
series of reactions exhibited an increasing number of modifications. Analysis demonstrated 
that the removal of 46% (~16 amino acids) of the 34 acidic amino acid residues decreased 
the binding affinity by 50-fold.57 This binding affinity was equivalent to the binding 
interaction between M.EcoKI and dsDNA. Analysis showed that protein stability and the 
protein fold were maintained. Binding between Ocr and the enzyme was still apparent even 
with an 86% loss of surface charge. The protein was able to bind although the interaction 




The ArdA genes were first discovered in the late 1980s. By the 1990s the first ardA genes 
were sequenced and the primary sequence showed that the protein was ~170 amino acids 
long with a total negative charge of -10 to -30. Sequence homology among conjugative 
plasmids and transposons demonstrated the widespread nature of the ardA gene among the 
community.63 Like the Ocr protein, the ArdA protein also inhibits all of the Type I RM 
families. The activity of the ArdA protein and the Ocr protein were compared using a 
controlled promoter which controlled the expression of both antirestriction proteins.64 The 
results showed that the antirestriction activity of the ArdA protein was 1700 times weaker 
than the Ocr protein, comparison of Kd values of both antirestriction proteins with M.EcoKI 
shows that Ocr has a much tighter interaction, at 1×10-10M whereas the Kd for ArdA is 
1.7×10-7M.65,66    
ArdA is one of the first genes transferred into the host cell upon infection. However unlike 
Ocr, Orf18 ArdA is found on conjugative plasmids/transposons not lytic bacteriophage. 
Where conjugative plasmids aim to produce a symbiotic relationship with the host cell upon 
infection, lytic phage do not require the presence of the host cell after replication of the 
phage virion. The lifetime of lytic phage infection is short with the one aim of producing 
more bacteriophage, even at a cost to the host cell.63  
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The analysis of the antirestriction and antimodification activity of several different ArdA 
proteins shows that the ArdA proteins exhibit different antirestriction and antimodification 
properties towards different Type I families.67 For instance, ArdA proteins possess weak 
antimodification activity when interacting with Type IC enzymes in comparison to the 
activity demonstrated for other Type I families. Such differences could be for a number of 
reasons; the number of active complexes that reside in the cell at any one time differs for 
each Type I RM system or the expression of each ArdA protein may vary.67  
In 2009 McMahon and colleagues solved the first structure revealing a rod-like structure for 
the Orf18 ArdA homodimer, as seen in figure 1.13.68 The protein was a mimic of B-form 
DNA and the large number of acidic residues upon the surface of the protein corresponded to 
the sugar phosphate backbone of a 42bp unit of dsDNA. This elongated structure is 
composed of three domains.68  
The third domain contains the dimer interface which is small and rich in hydrophobic 
residues. Upon dimerisation the structure produces the pre bent structure of the 42bp dsDNA 
identified from the crystal structure.68 The central kink in the protein structure is reminiscent 
of the kink exhibited by DNA upon binding to the TRD sites on the HsdS subunits and that 
exhibited on the Ocr protein.  
The structure of the ArdA protein has been aligned to a model of dsDNA bound to the 
MTase complex on EcoKI from Kennaway et al, 2009. The analysis carried out by 
McMahon et al, 2009, showed that domain 2 is located on the outer reaches of the TRD 
domains of the HsdS subunits and within the catalytic domain of the HsdM subunits.68 Using 
the EM model proposed for DNA, the DNA bound to MTase was used to superimpose the 
DNA mimic, replacing the DNA in the model. This showed that the first domain did not 
interact with the MTase core complex as this domain ‘juts’ out from the MTase complex. In 
fact a loop was identified that linked domain 2 and domain 1. This link suggested a rotational 
freedom for the first domain; as such it is thought that this domain is likely to be in contact 
with the HsdR subunit. The binding interaction of the ArdA protein with the EcoKI enzyme 
has been measured at <1nM in vitro and 170nM in vivo. Although it is a tight binding 
interaction, it is not as tight as the Ocr: MTase interaction. 
Truncations of the ArdA protein at the N and C terminal appear to have little effect on the 
antirestriction activity.66 However, the hydrophobic residues V163A and F164A severely 
affected the antirestriction activity of the protein; this important region on the ArdA protein 
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is identified as a conserved motif among several homologues of the ArdA protein and is 
defined as the VF motif.  
Single mutations for a number of polar residues thought to be important for the binding 
interaction of the ArdA protein were also examined by site directed mutagenesis. Many of 
these mutants reside in the C-terminal domain and their substitution with alanine caused no 
effect on the antirestriction activity of ArdA.    
 
 
Figure 1.13: The crystal structure of the Orf 18, ArdA homodimer from the transposon 
Tn916. The acidic residues have been highlighted in red spheres and resemble the double 
stranded helix of B-form DNA.68 
DNA mimicry is not just restricted to the antirestriction proteins, many other DNA mimics 
exist among the prokaryotic and eukaryotic communities.69 The protein DinI mimics single 
stranded DNA and in doing so, inhibits the interaction of RecA with DNA. RecA is a protein 
which is involved in the DNA repair pathway. The inhibition of this protein could lead to the 
induction of the SOS response in the cell with deleterious consequences. Another example is 
the protein UGI which mimics kinked DNA like Ocr, with the inhibition of the uracil 








1.9 Acquisition of hsd genes and regulation of Type I RM 
systems 
Hsd genes that specify Type I systems are readily transferable. Successful transfer has been 
carried out by conjugation, transformation and by P1 transduction with only a slight 
reduction in cell count observed.70,71,72,73 Expression levels of each subunit were measured 
after conjugational transfer and no differences were observed for the expression of each 
subunit. The promoter for pmod is slightly stronger then pres, however both  are weak.30,72 As 
there appears to be no difference in the expression state or any regulation associated with the 
plasmid and the hsd genes, it suggests that the bacterial strain itself enforces a regulatory 
mechanism upon the acquisition of a new RM system.1,64,74  
The conjugational transfer of both Type IA and Type IB to the recipient bacterial strain can 
cause a reduction in the cell count but overall the host cell survives. The transfer of a Type 
IC system appears to generate no loss in the host cell population.75,76 This difference is 
thought to be associated with differential binding of the R subunits to the MTase 
core.43,29,77,73 
Studies on the archetypal Type IA enzyme EcoKI show that more MTase is present in the 
cell then REase. However, as mentioned previously, the promoters are equally active and 
this reinforces the suggestion that the regulation may come from the recipient bacterial 
host.78 The ability of the host cell to be unaffected by the introduction of new hsd genes is 
known as a state of restriction alleviation. This has been witnessed as a result of infection by 
phage, conjugation and transformation.70  
 
1.10  Restriction alleviation mechanism 
In 1985 researchers proposed a regulation mechanism for Type I enzymes. Extensive 
research carried out in the late 1980s by GB Zavilgelsky and AA Belogurov suggested that 
restriction alleviation was activated by the SOS response, upon exposure to DNA damaging 
agents like UV light or high doses of nalidixic acid. These DNA damaging agents lead to the 
production of unmethylated DNA which induces restriction alleviation.79 This protects the 
host cell DNA from the indiscriminate restriction of unmodified chromosomal target sites 




1.11  2-Aminopurine 
Belogurov et al. investigated the phenomenon of restriction alleviation using 2-aminopurine 
(2AP).79 2AP renders the chromosomal DNA unmethylated. 2AP induces damage in two 
ways; firstly, as an adenine analogue 2AP can be inserted as a replacement for adenine, and 
secondly as an analogue of guanine, see figure 1.14. Incorporation of the 2AP instead of 
adenine during DNA replication inhibits methylation of the adenine target sites as the RM 
enzymes are able to bind but unable to methylate the 2AP, therefore the DNA remains 
unmethylated and upon further replication the chromosomal DNA becomes unmethylated.81  
 
Figure 1.14: Comparing the Hydrogen bond interaction of; adenine with thymine and 2-
aminopurine with thymine.  
 
2AP can also act as an analogue for guanine and can induce mismatches in the chromosomal 
sequence. This correlates with the onset of restriction alleviation and the generation of 
unmodified target sites, which is only reaching its maximum at 1-1.5 hours for 2AP and 2-
3hrs for UV damage.81 
In the mid-nineties Bickle et al, (1996) showed that the restriction subunit, HsdR, was only 
present in small quantities in the absence of modification by 2AP.8 However, it was two 
years later that a series of experiments by S. Makovets and N.M. Murray, identified the 
proteins ClpX and ClpP as regulating the transmission of the hsd genes.82 In 1999 Makovets 
et al, demonstrated that the HsdR subunit of Type IA enzymes was a target for proteolysis by 
the protease ClpXP, and a necessary component for the restriction alleviation response, 
described in figure 1.15.82 Makovets used phage to infect Clp+ and Clp- E. coli cells in to the 
presence of DNA damage caused by 2AP. Cell death followed treatments of the Clp- strain 
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with 2AP and  the formation of filaments. Cell filamentation is induced by the SOS response 
of the bacterial cells.83,77,80 This is a direct response to the DNA damage inflicted on the cell 
and the filaments dissipate upon recovery of the cells from reversible DNA damage such as 
UV irradiation.  
 
Figure 1.15: A schematic displaying the effects on cell growth when cells are exposed to 
2AP in the presence and absence of the clp gene. E. coli cells when exposed to 2AP 
activate the ClpXP proteolysis of the EcoKI enzyme for continued cell growth. In the absence 
of the clp gene the protease cannot breakdown the EcoKI enzyme which targets the 
unmethylated chromosomal DNA upon exposure to 2AP causing cell death. However the 
presence of the Ocr protein forms a complex with EcoKI inhibiting its restriction activity 
allowing the cell to survive. 
 
These studies showed that the presence of the ClpXP protease induced the alleviation of 
restriction. This was corroborated by experiments which showed that the concentration of the 
HsdR subunit was reduced while the quantities of the modification and specificity subunits 
remained the same.82,3,80 Further mutagenesis of the HsdR subunit reveals that a ClpXP 
dependent degradation was active upon HsdR mutants that inhibit the DNA cleavage 
mechanism of the R subunit. However, ClpXP activity ceases if the HsdR subunits are 
unable to translocate DNA.10,84  
Therefore, ClpXP degradation is initiated during the translocation of chromosomal DNA. 
However, how the ClpXP protease can differentiate between RM enzymes translocating on 





1.12  ClpXP protease 
The ClpXP protease is compromise of the CpX ATPase and the ClpP protease.85 The ClpP 
protease assembles into a complex heptameric ring that consists of 14 subunits which 
produce a peptidase chamber containing 14 peptidase sites. The site of entry to the 
proteolytic centre (ClpP peptidase chamber) is through the ClpX subunit.86,87 The structure of 
ClpX has been solved and shows that the ATPase consists of two large hexameric rings that 
bind to the core of the ClpP peptidase heptameric ring, figure 1.16.88 The hexameric rings of 
the ClpX component contain ATP and Mg2+ binding sites. Therefore, upon recognition of a 
substrate for proteolysis, the substrate is translocated though the ClpX rings into the ClpP 
peptidase chamber where the many peptidase sites degrade the protein into small peptides of 
5-10 amino acids in length. These peptides then diffuse out into the cell after completion of 
the reaction.89 The roles of the protease can be varied and suggests the regulation of a 
number of pathways. For instance, the ClpXP protease regulates the amount of HsdR present 
in the cell upon DNA damage.15,78 
 
Figure 1.4 : Extracted from Sauer et al, 201290a cartoon representation of the ClpXP 
protease. In dark purple the two hexameric rings of the ClpX ATPase stacked onto the large 







1.13  SOS response 
In the event of DNA damage to bacterial cells, many bacteria induce a sophisticated regulon 
known as the SOS response. This pathway was first discovered over 100 years ago, however 
many components in its pathway still remain unresolved. The exposure of DNA to damaging 
agents such as UV irradiation and 2AP, which have been detailed previously, induce the 
SOS response which triggers the expression of numerous genes to repair the damage 
inflicted on the DNA.91 Upon DNA damage, the repressor protein LexA is cleaved and this 
reduces it affinity for the operator sites of several genes which possess the ‘SOS box’. These 
genes are distributed across the whole of the genome.74 The removal of the repressor protein 
induces the expression of over 30 known genes and produces at least 16 known proteins.92,93 
Upon DNA damage the protein RecA binds to ssDNA and stimulates the autoproteolysis of 
the LexA repressor from the operator sites of the genes. Once the repairs have been 
completed by the cell, the RecA protein releases the ssDNA which decreases the proteolysis 
of the LexA protein and increases the amount of LexA which is then able to bind back onto 
to the operator sites. 80, 91,94,95 
The genes that are controlled by the SOS regulon are not expressed at the same time or to the 
same extent. In fact the SOS response of bacterial cells occurs as a cascade, each stage 
attempting more elaborate DNA repair designs. Firstly, UvrABD and the endonuclease UvrC 
catalyse the nucleotide excision repair (NER) for damaged nucleotides from dsDNA. This 
includes the targeted excision of single basepair mismatches. The second stage attempts 
homologous recombination. At the sites of damage, proteins are released that create double 
strand breaks (DSB) using the NER system, and the introduction of the DSB on the DNA 
means that homologous recombination can be performed to repair the DNA.80,96 If damage is 
still present after 40mins then the SOS response initiates the induction of PolV (a DNA 
repair polymerase). These polymerases along with others that are induced by the SOS 
response repair the DNA at the risk of introducing errors onto the genome. LexA is 
continuously produced during the SOS response thereby enabling the tight regulatory 
inhibition of the SOS response as soon as repair has been managed.91,97 
The regulation of the SOS response is determined by the protein DinI. DinI is a DNA mimic 
protein that mimics ssDNA and interacts with the RecA protein, thereby inhibiting the 
ssDNA: RecA filament.94 Although more recent evidence suggests that instead of DinI 
interacting as a competitive inhibitor, the protein binds and distorts the RecA:ssDNA protein 
filament. Whichever mechanism is used, the DinI protein is part of a classical feedback loop 
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where the formation of dimers and tetramers of the protein bind nonspecifically to 
RecA/RecA: ssDNA, preventing its ability to induce the SOS response.96,93,98  
 
1.14  Cell division and formation of filaments 
So that bacterial cells have time to repair DNA, the induction of the SOS response not only 
releases genes that are appropriate for DNA repair but it also induces genes and proteins that 
inhibit cell division. By inhibiting cell division the undamaged portion of the genome is 
continually replicated, therefore the cells become multinucleated elongated cells.96  
Conventionally in E. coli, cell division is initiated once the appropriate size is reached. 
Indentations are formed at the midpoint of the cell which marks the point of septation and 
the bacteria split into two daughter cells. Production of the septum is initiated by a series of 
fts genes, however mutations in the genes fts E, F, H, Q, Z and the protein FtsD can inhibit 
the production of the septum and as a result filaments are formed.99 
Upon DNA damage, the SOS response stimulates expression from the lexA gene which 
expresses the protein SfiA. The SfiA protein acts as a structural inhibitor of the ftsZ gene 
which is involved in the early stages of septum formation. Upon completion of repair, the 
RecA protein is deactivated and SfiA is subsequently degraded by a protease. Providing that 
the cells successfully repair the DNA, the process of filamentation is reversible. However, 
the formation of the septum can shift from the midpoint and division occurs with the outer 
most cells of the filament.100,101,77,94 
There are many examples of how the induction of the SOS response can inhibit cell 
division.92 The inhibition of cell division and the formation of filaments can be a result of 
FtsZ inhibition. Not only by the proteins SfiA and SfiC but also YneA can delay the 
septation and separation of cells and inhibit division, by transiently binding to 
peptidoglycan.102,101 The protein SulA has been shown to inhibit ring formation of the FtsZ 
protein, which inhibits division and produces cell filaments.100 Furthermore, the interaction 
of proteins towards genes and proteins that are present in the SOS regulon could induce the 
SOS response and in turn stimulate the production of filaments via the inhibition of cell 
division. 
The formation of filaments has also been commonly attributed to the overproduction of 
recombinant proteins in E. coli.103 Such an accumulation of protein in the cell can cause the 
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cell to filament. This is usually because the accumulation of protein, especially 
thermosensitive proteins, can lead to the suppression of the FtsZ protein in the cell. The FtsZ 
protein is very sensitive to changes in the cell, as its interaction with FtsA is tightly regulated 
at a specified ratio.99 The reduction in FtsZ activity appears to correlate with an increase in 
the number of inclusion bodies in the cells. Inclusion bodies are pockets in the cell which 
contain insoluble protein, usually as a result of the overproduction of an insoluble 
recombinant protein or a designed mutant.103 
 
1.15  Protein libraries 
1.15.1 Types of libraries 
The production of libraries to gain an insight into the design of proteins has become a major 
research area. Understanding the sequence space that proteins can occupy and their ability to 
evolve new functions has been stimulated by the technique of directed evolution and the 
production of tailor-made protein and DNA libraries.104 Libraries allow the screening and 
selection of a great number of proteins/mutants. This is advantageous if the researcher is 
analysing the global effects of mutations on a protein’s structure, stability and function.105 
However, it is said that libraries are only as good as the selection assays that are designed to 
elucidate activity. Therefore, the selection method needs to be thought through and many of 
the limitations in the design of libraries resides in the capability of the screening 
assays.106,107,108  
Generally the strategy when designing protein libraries is to explore as much sequence space 
as possible while minimising the number of deleterious mutants. The focus is generally to be 
able to explore sequence space by producing the number of mutations that confer a desired 
function.105 However, the diversity of the library needs to be balanced with a minimal 
number of deleterious mutants. Generally the frequency of the beneficial mutants tends to 
include only 0.001% compared to >30% of all mutations inducing deleterious effects upon 
the introduction of mutations.109 
Each library design has its own set of advantages and disadvantages which need to be 
considered. Therefore, the most difficult job is usually to select the appropriate library in the 




The production of small libraries is usually a result of rational design; this is the production 
of a library which considers the location of the target sites on the proteins structure in 
combination with the functional outcome desired. These libraries target specific regions or 
positions with the aid of extensive structural knowledge of the protein and complex. This 
leads to a decrease in the number of assumptions and predictions that need to be addressed 
by the researcher and therefore the smaller the library size.110,107  
Generalisations can be made about the structure-function relationship of many proteins 
however; the ability to predict changes in structure is limited. In this case, the production of 
large libraries using random mutagenesis or saturation mutagenesis is more advantageous. 
Such libraries are required when the structure of the proteins are not well defined.111 An 
example is an adaptation of conventional alanine scanning of a protein; ordinarily shotgun 
phage display has been used to mutate single positions to alanine to study the effects on the 
activity of a protein. However Sidhu and co-workers designed a library which expanded 
alanine scanning into a saturation analysis, which included permutations of all 20 amino 
acids but at only a few selected positions. This was applied to the interaction between human 
growth hormone and the human growth hormone receptor, and revealed that the interaction 
was less tolerant of chemically conserved residues.112  
1.15.2 Analysis of libraries 
Selection methods are ideal for large libraries; large libraries are designed to investigate 
whether the desired function of the protein remains active or changes upon mutation. As 
such, only mutants that exhibit the desired function are of interest. Selection methods can 
screen larger numbers by being able to select for the desired function of interest only.109 In 
such cases the design of the selection assay is very important as assays may not consider 
changes in the expression level, the solubility and the induction capability of each protein. 
Such properties of the library variants will affect their selection capabilities, causing the 
selection of artifacts rather than selecting those proteins/mutants that possess the greatest 
enzymatic activity.105 
In contrast, smaller libraries are generally designed to investigate the effect of particular 
mutations to the functionality of the protein.110 In this case the researcher is interested in the 
changes that are induced on the protein as a result of the mutation. Therefore selections of 
isolates taken at random from the library are analysed. As a result, screens can provide an 
assessment as to the diversity of the library by screening each mutant regardless of activity 
and monitoring a number of activity parameters of the protein.108 A study to analyse tumor 
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derived missense mutations on the function of the protein p53 was used to correlate the 
function of the protein with structure and tumor derived mutations. To do this, PCR 
techniques were used to incorporate 2314 basepair mismatches into wt cDNA; this covered 
all possible single point mutations.113 
Advances in screening capability have been driven by recent developments in the production 
of microfluidic devices and droplet manipulation which allow for high throughput screening 
assays. However, at the current stage of development and design, the capacity of many 
selection and screening methods is incapable of screening the diversity of the library under 
investigation.107 This issue is common and a number of options are available to researchers. 
1.15.3 Library design considerations  
The screening of only a small fraction of the library is only advantageous if functionally 
active proteins/mutants can be selected from this small fraction of the library. The success of 
screening is dependent on the number of active mutants. If the probability is high, then 
screening a small fraction from the library can successfully elucidate a functionally active 
protein to analyse. Hecht and colleagues have designed a number of de novo protein 
libraries.114 These libraries contain non-natural proteins which are designed in a fashion 
which allows them to possess secondary structure.114 These libraries allow an exploration of 
the potential of sequence space beyond natural proteins to gain a greater understanding of the 
evolve-ability and adaptability of protein structure and functions.105,115,116 The complete 
screening of such libraries itself would be a huge task. Due to the nature of the protein, only 
a small fraction of the library needs to be screened to elucidate a number of mutants that 
elicit peroxidise activity, inhibit cell growth and encourage amyloidal formation. 109,117,118  
 Another option is to target each of the target positions in an iterative manner. The idea is 
that a small group of mutations will be targeted. Those which appear to be advantageous or 
neutral are then kept for another round of mutations and in this way selection will be carried 
out after each cycle. However, this strategy excludes ‘epistatic combinations of mutations’; 
mutations that are dependent on the presence of another mutation to provide activity. This is 
particularly difficult to predict and can usually only be resolved by the production of a 
random library107. 
With ever more breakthroughs and techniques in the field of protein engineering, a number 
of new strategies are emerging that bridge the gap. The exploration of a large number of 
residues is balanced by minimising the number of mutations that are present and therefore 
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the size of the library. An example of such a library is the creation of ISOR (Incorporating 
Small Oligonucleotides via Reassembly).108,119 
 
1.16  ISOR library design 
The ISOR library methodology was created to offer parsimonious mutagenesis; this is the 
partial diversification of each residue that is targeted. Rather than creating a saturated library 
where the effect of all amino acids are investigated, by using a restricted codon set, a smaller 
number of residues are substituted in each position.119,108 
ISOR relies on a simple gene shuffling technique; the library can introduce insertions, 
deletions or substitutions by designing specific oligonucleotides for each position of interest 
with the appropriate codon. These oligonucleotides are then shuffled with fragments of the 
wild type gene. Upon reassembly, the gene incorporates the oligonucleotides and this 
produces libraries where specified positions have been mutated in a random manner. The 
libraries should represent each of the mutations that were targeted, but each variant of the 
library produces a random sequence of the gene with an entirely unique subset of mutations. 
The ISOR libraries created by Herman, Tawfik and colleagues have shown how the  libraries 
have been implemented in the design of a series of libraries which target the DNA MTase 
M.HaeIII and the protein serum paraoxonase (PON1).119,107 
A series of libraries were produced to target 45 base pairs for substitution on the M.HaeIII 
protein. By using different oligonucleotide concentrations the average mutation rate of the 
library could be varied. This created a series of libraries of which the average number of 
mutations ranged from 1-6 per library variant at each of the 45 possible target sites. This 
produced a huge library, however the diversity is limited compared to saturation mutagenesis 
and combinatorial libraries. Therefore a selection method was used to analyse the M.HaeIII 
activity of the library. 1010 library variants were screened by selecting for mutants with 
reduced methylation activity. Isolates of the library were then screened to identify library 
variants which exhibit a range of methylation activities.119  
ISOR has also been used to generate a series of libraries that introduce indels of insertions 
and deletions to investigate the structural features of the PON1 active site. The library was 
designed in much the same way as the M.HaeIII library. The library was designed to 
introduce oligonucleotides with indels and therefore the oligonucleotides were designed with 
deleted and inserted codons to a particular region on the protein shown to contribute to the 
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activity of the paraoxonase. A number of the variants from the library were isolated and 
tested. From the small number of mutations screened, each provided variable activity. 
However, mutations in one particular domain (Helix 3) appeared to correlate with a 
reduction in activity. This highlighted the importance of this domain to the esterase activity 





















 Thesis Aims and Objectives 
 
This project will attempt to answer the following questions: 
1. What is the minimal number of acidic residues the Ocr protein needs to perform as a fully 
functional antirestriction protein?  
2. What, if any, is the importance of these residues and what can they tell us about the 
interaction of the Ocr protein with the Type I RM system, EcoKI? 
3. How does the decrease in negative charge affect the protein’s stability and fold and its 
impact on the host-pathogen interaction? 
4. Can differential antirestriction and antimodification activity be designed into the Ocr 
protein by reducing the charge? 
5. Can one explain the evolution from an inactive protein to a fully functional Ocr protein 
by examining the charge to function relationships? 
It is hoped that the answers to these questions will increase our understanding of the 
relationship between RM systems and HGT and provide a window into the ‘game of bluff’ 
played out between bacteria and mobile genetic elements in the protection and the evolution 
of bacterial species.  
To answer these questions, this project had the following objectives: 
1. Design and create a library of Ocr multimutants where each mutant possesses a unique 
sequence and surface charge. 
2. To develop a selection assay that can be used to screen the library for mutants that exhibit 
antirestriction activity and obtain the minimum number of residues that are required for 
activity. 
3. To purify and characterise mutants with minimal surface charge that exhibit 
antirestriction activity by assessing their protein fold, stability and function. 
4. To screen additional mutants from the library at random, to assess the effect, if any, of 
negative charge in every aspect of the proteins existence. Therefore its effect on function, 







Chapter 2. Materials and Methods 
 
2.1 Bacterial strains, phage and plasmids 
 
E. coli Strain Relevant Genotype Reference or Origin 
NM1261 MG1655 ΔhsdREcoK1.:cat 
NM1041 MG1655 clpX ::kan Blakely et al. (2006) 
NM1049 MG1655 lar.:cat Blakely et al. (2006) 
NM1057 
MG1655 clpX ::kan, 
Prepared byDr A. Dawson 
             ΔhsdREcoK1 
NM1056 
MG1655 clpX ::kan    
           Δ(hsdSEcoK1-mcr) 
MG1655 F- λ- ilvG rfb-50 rph1 Blattner et al. (1997) 
Phage     
λv.0 λvir, (unmodified DNA) Donated by  
λv.k λvir, (modified DNA) Prof. N. Murray 
Plasmids     
pTrc99A Carbenicillin Resistant 
Donated by  
Dr. A. Dawson 
   
 
2.2 DNA Techniques 
2.2.1 Subcloning of Ocr multimutants into pTrc99A 
The ocr multimutants that were donated by Dr A. Stephanou were spliced out of pET24b and 




Figure 2.1: A plasmid map of the pTrc99A. This vector was used to insert Ocr multimutants 
using the restriction sites NcoI and BamHI. To note, in order to insert the POcr plasmid 
library into pTrc99A the POcr gene was inserted using the restriction sites NcoI and HindIII 
details in section 2.4. 
 
Linearised pTrc99A plasmid vector  
For preparation of the linearised pTrc99A plasmid; E. coli DH5α cells transformed with 
pTrc99A were used to inoculate 100ml of LB broth and incubated at 37°C, 200rpm for 
12hrs. Plasmid DNA was extracted from the resulting cell pellets of pTrc99A using a 
QIAgen Midi prep kit and the DNA was quantified using UV-Vis spectrophotometry. The 
pTrc99A plasmid was linearised by carrying out a double digestion reaction using the 
restriction enzymes NcoI and BamHI, the digest reaction mix (below) was incubated at 37oC 
for 4hrs. 
Digest Mix  
10(×)NEB Buffer 4 10µl 
MQ Water Make to 100µl 
0.1M BSA 10µl 
pTrc99A DNA  ~4µg 
NcoI 5U 
BamHI 5U 




The linearised plasmid was purified by extracting the relevant band from a 1% Agarose 
DNA gel using a QIAgen DNA extraction kit.  
Preparation of the Ocr mulitmutant gene inserts 
To splice the ocr multimutant genes from pET24b to pTrc99A, the genes were amplified 
with a simple amplification PCR reaction, using primers with the NcoI and BamHI sites. 
These primers were obtained from invitrogen.  
Reaction Cycle 








The amplified genes were purified using the QIAgen PCR Purification KitA double digest 
reaction was carried out as per the manufacturer’s guidelines (New England Biolabs, 
Ipswich, MA). Typically, 5µg of an amplified gene was digested with the restriction 
enzymes NcoI and BamHI, the 50µl reactions were incubated at 37°C for 2.5hrs. The 
digested DNA was purified using a 1% DNA agarose gel and the QIAgen gel extraction kit.  
Ligation Reaction of pTrc99A and ocr multimutant gene insert 
Each ocr multimutant gene was ligated to previously linearised pTrc99A. These reactions 
were setup at room temperature for 2.5hrs and a typical reaction mixture is shown below. 
Ligation Mix 
  Vol (µl) 
MQ Water Make to 20µl 
pTrc99A ~100ng 
DNA Insert ~500ng 
10(×)Ligase buffer 2µl 
T4 DNA ligase 10U 
Total 20 µl 
 
PCR Reaction Mix 
Mq Water Make to 100µl 
10(×)pfu Buffer 10µl 
Ocr DNA Template 2µl (at ~50ng/µl) 
Primer Fwd 1ng/µl 
Primer Rev 1ng/µl 
10mM dNTP Mix 3µl 
pfu DNA polymerase 2.5U 




Transformations of the ocr multimutants in the pTrc99A vector were performed with E. coli 
DH5α competent cells using a similar procedure as outline in section 2.2.3. Successful 
colonies were isolated and overnight cell cultures were grown to isolate the plasmid DNA 
using a Qiagen Mini Prep kit. To ensure that each ocr multimutant had been successfully 
transferred to pTrc99A, there sequences were verified by Sanger DNA sequencing carried 
out by Genepool, Edinburgh.  
2.2.2 Chemically competent cells 
An overnight culture of E. coli NM1041 cells was subcultured (1/200) into LB broth and 
incubated at 37°C, 200rpm. At an OD600 of 0.4-0.6, the 50ml culture was centrifuged 
(13,000rpm, 10mins) and the supernatant removed, the resulting cell pellets were placed on 
ice. The cells were resuspended with ice-cold 0.1M CaCl2 (20ml) and the cells were 
incubated on ice for 40mins and centrifuged (13,000rpm, 3mins).  The pellets were 
resuspended with ice-cold 0.1M CaCl2 (10ml), a second time (10ml) and incubated for a 
further 45mins on ice. The competent cells were stored at -80°C with glycerol (~20%) until 
required for transformations.  
The same protocol was carried out for all the competent bacterial cell strains used in this 
thesis. Furthermore, for large quantities of transformations, the competent cells (200µl) were 
transferred into sterile, 2ml deep, 96-well plates (USA scientific) before storage at -80°C.  
2.2.3 Bacterial transformation 
Aliquots (200µl) of E. coli competent cells were thawed on ice. Each of the newly ligated 
constructs (2µl) was added to an aliquot of cells in a microcentrifuge tube and left to 
incubate on ice for 30mins. The microcentrifuge tubes were heat shocked at 42°C for 30s.  
The cells were incubated with (0.8ml) LB broth at 37°C, 200rpm for 1hr. The transformation 
mix was plated out onto (200µl) LB-Agar plates supplemented with carbenicillin (50μg/ml). 
Once the plates were dry they were inverted and incubated overnight (~12hrs) at 37°C. 
Single colonies were restreaked, on fresh LB-Agar plates and overnight cultures were used 
to purify the plasmid DNA using a QIAgen mini prep kit.  
To verify the successful ligation of the ocr multimutant inserts into the plasmid, pTrc99A, 






2.2.4 In vivo restriction alleviation assay 
E. coli NM1041 cells were transformed with each of the ocr  multimutants in pTrc99A, in 
order to perform the restriction alleviation assay. Transformations were carried out as 
outlined in section 2.2.3. However, due to the low transformation frequency of E. coli 
NM1041 cells heat shock was carried out for 1min 42secs. A single colony was used to 
inoculate an overnight culture. Overnight cultures (100µl) were diluted to 10-fold increments 
from 10−1 to 10−8 and viable counts were spotted in triplicate onto LB-agar plates containing 
different concentrations of 2AP: 0, 20, 40 or 80μg/ml. The plates were supplemented with, 
kanamycin (30μg/ml) and carbenicillin (50μg/ml) or kanamycin (30μg/ml), carbenicillin 
(50μg/ml), IPTG (50μg/ml) and 2AP. Once dry the plates were inverted, sealed in an air-
tight container and incubated at 37°C for 18hrs, after which colony numbers were counted 
and the number of viable cells per ml calculated. 
Viable counts were compared to a negative and positive control; the empty vector pTrc99A 
and either wild type Ocr or wild type ArdA Orf18, which werealso tested alongside each 
restriction alleviation assay performed. 
2.2.5 Cell growth plate assay +/- hsdR gene 
E. coli NM1041(r+m+, ClpXP-) and E. coli NM1057 (r-m+ HsdR-,ClpXP-) were transformed 
with various plasmids expressing Ocr or its mutants. Cultures of the bacterial strains were 
grown in L Broth with aeration at 37°C and shaking at 200 rpm for 18hrs. Ten-fold serial 
dilutions of the cultures were spotted onto LB-agar plates, supplemented with Kanamycin 
(30 mg/ml), Carbenicillin (50 mg/ml) and IPTG (50 mg/ml). The plates were incubated for 
18hrs at 37°C and the resulting colonies (viable counts) were calculated. 
2.2.6 Bacterial growth curves 
Overnight cultures of E. coli NM1041 (r+m+, clpX−) transformed with each of the plasmids 
expressing Ocr or its mutants were incubated at 37°C. Samples (0.2µl) were taken from each 
culture and used to inoculate 1ml L Broth, supplemented with or without IPTG and 
increasing concentrations of 2AP: 0, 20, 40 or 80μg/ml. All of the cultures were in the lag 
phase. Sterile covered microplates (96-well plates) and lids were obtained from Greiner. 
200μl samples from the prepared cultures were pipetted, in triplicate, into the 96-well plates. 
Bacterial growth curves were obtained by measuring the optical density (λ= 600nm) of the 
cultures as a function of time. The optical density measurements were carried out by a 
Fluorostar OPTIMA plate reader (BMG Labtech). The reader was programmed to measure 
the samples on the plate every 5min for 14hrs at a wavelength of 600nm. The reader 
48 
 
maintained a temperature of 37°C throughout the experiment and a medium shaking speed of 
200rpm between readings. 
The same protocol and conditions were used to carry out all of the different types of bacterial 
growth curves covered in this thesis. The bacterial cell strain, and the chemicals/antibiotics 
used to supplement the cultures were dependent on the experiment taking place.  
In addition, large scale bacterial growth was also carried out for overnight cultures. 2ml 
deep, 96-well plates were used to aliquot LB broth (96×1ml) which was subsequently 
inoculated with the appropriate antibiotics and a swab from a single colony, the plate was 
incubated overnight at 37°C, 100rpm. 
2.2.7 Microscopy 
Overnight cultures of E. coli NM1041 (r+m+, ClpX−) cells, transformed with wild-type Orf18 
ArdA or the mutant derivatives, were used to inoculate 10ml of L Broth (50µl). The cultures 
were grown to an optical density of 0.2 at 600nm and subsequently induced with IPTG 
(50µg/ml) and incubated for a further 2.5hrs (the OD600 was measured to ensure each culture 
was still in the logarithmic phase of growth). To condense the nucleoid, chloramphenicol 
(10µl) was added to each culture and incubation at 37°C continued for 30min. The bacterial 
cells were fixed with the addition of methanol at a 2:1 ratio and a further incubation on ice 
for 10min. The cells were collected by centrifugation and resuspended in buffer; 10mM 
Tris–HCl (pH 7.5) 10mM MgSO4 and observed under the microscope. For DAPI-stained 
samples 1µl of a DAPI stock of 1mg/ml in EtOH was added to the fixed cells and the cells 
were observed under a fluorescent microscope. 
 
2.3 Phage techniques 
2.3.1 Phage (λV.0.) amplification 
To amplify phage λV.0/λV.k BBL soft agar (3ml) was equilibrated at 45-46°C, the phage was 
diluted with phage buffer to give a moi (multiplicity of infection) of 103 infectious virus 
particles per cell. 100μl of the diluted phage was combined with 100μl from an overnight 
culture of E. coli NM1056 cells and incubated at 37°C for 15mins. The mixture was added to 
the soft agar, vortexed briefly, and poured onto (wet) LB-Agar plates. After the plate was 
incubated overnight at 37°C, 3mls of phage buffer was added to the confluent lawn, on the 
plate, and incubated at room temperature for 30mins. Subsequently the soft agar top and 
residual buffer was scrapped off using a sterile spatula and placed in a glass universal bottle 
with 1ml of chloroform. The mixture was vortexed for 30 seconds and left on the bench for 
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20mins and then centrifuged at 5000g for 10-15mins.The top layer of supernatant contained 
the amplified phage was transferred to a clean glass universal bottle. A phage titre was used 
to quantify the fresh stock, which was stored at 4°C, above chloroform (200μl to 1ml phage 
stock). 
2.3.2 Phage antirestriction Assay 
Overnight cultures were prepared for each of the mutants in E. coli strains NM1041 and 
NM1057, in addition, restriction proficient and restriction deficient cells were grown as 
(NM1041 and NM1057) negative and positive controls for restriction alleviation. 
For each mutant assayed, 3ml of BBL top agar was equilibrated at 45-46°C and vortexed 
with 100µl of an overnight culture creating a bacterial lawn upon which infection of phage 
can be carried out. The plates were appropriately labelled and left to dry at 37°C for 20-
30mins). A phage titre was performed, in which amplified λV.0 and λV.k with a similar 
concentration were diluted with 10 fold serial dilutions from 10-2 to 10-7, the dilutions were 
spotted in triplicate onto each bacterial lawn, the plates were left to dry, inverted and 
incubated overnight at 37°C. If the presence of the mutant alleviates restriction the number 
of plaques formed from the unmodified phage would not change on restriction proficient or 
restriction deficient cells.  
2.3.3 Phage antimethylation assay 
Single plaques from the phage restriction assay were picked into 200µl of phage buffer with 
10µl of chloroform, vortexed and incubated overnight at 4°C. The phage stocks from 
unmodified phage which have infected the cells expressing each of the mutants were titred 
on plates with restriction proficient and restriction efficient cells as described above. If the 
number of plaques on each plate is the same, the phage has been modified and not 
susceptible to restriction by the R subunit. 
 
2.4 Generation of ISOR Library  
POcr is a synthetic gene that shares the same DNA sequence as the wtOcr gene from T7 
phage except that each of the codons that translate the acidic residues D/E were substituted 
with neutral residues N/Q respectively. The POcr gene was synthesised by Geneart 
(Invitrogen).  ISOR was used to introduce mutation on the POcr gene that targeted the 
neutral residues on the POcr protein and substituted them to acidic residues. The ISOR 




Figure 2.2: A flowchart describing the main stages involved in the development of the library. 
(1) Initially the POcr gene was amplified; (2) the insert was then fragmented using the 
nuclease, DNAseI. (3) The fragments underwent a recombination reaction with DNA primers 
which contained, mutations at specified positions and (4) this was followed by a Nested PCR 
reaction, which trimmed each of the newly combined inserts (5) allowing them to be cloned 
back into a plasmid vector. (6) Finally the library was transformed onto LB-Agar plates, some 
of the colonies were sent to sequencing to ascertain the diversity of the library. Once known, 
transformations were performed to adequately cover the estimated diversity by 120%. The 
library was stored as Plasmid DNA at -20˚C. 
 
1. POcr Amplification 
To obtain a large quantity of the POcr DNA sequence, the insert was amplified from the 
original pET24b vector by a PCR amplification reaction, primers were designed that ensured 
the incorporation of a generous flanking region at either end of the POcr gene (PCR 
parameters and mixtures are displayed below). Several reactions (×20) were carried out to 
achieve a high concentration of the POcr gene, these PCR reactions were subsequently 
pooled and purified using a Qiagen PCR purification kit. The concentration of the DNA 


















2. DNaseI Digestion  
The amplified pOcr insert was fragmented using the DNaseI enzyme. 6µg of amplified insert 
was mixed with 0.05 Units of DNaseI enzyme in a 100µl reaction volume. The digest 
mixture was incubated for 8mins at 37°C. The reaction was quenched using EDTA (0.5M, 
15µl) and mixture incubated at 90°C for 10mins. The resulting fragments from the digest 
were purified by DNA agarose gel. Fragments were expected to be between 0-100bp, 
therefore a 1.6% agarose gel was cast to capture the small fragments. The gel band of 
fragments was excised and the DNA extracted using the Qiagen Gel extraction kit. 
3. Reassembly reaction 
A second PCR reaction was used to reassemble the POcr gene fragments with specifically 
designed primers that were designed with specific mutations, the rationale and the design 
behind these primers are detailed in Chapter 4 and were obtained from Invitrogen. The PCR 

















PCR Reaction Mix 
Mq Water 36µl 
5(×)Phusion Buffer 10µl 
Ocr DNA Template 0.5µl (at ~50ng/µl) 
Primer Rev/Fwd 1ng/µl 
10mM dNTP Mix 1µl 









 4/5/6/7.  Nested PCR and subcloning of POcr gene into the pTrc99A plasmid vector. 
The DNA from the reassembly reaction was used directly in the nested PCR reaction, 
primers were designed to amplify the reassembled POcr gene and insert as well as 
introducing the restriction sites, NcoI and HindIII at the start and stop codons of the gene. 
The PCR reaction followed the same condition as the POcr amplification PCR reaction 
detailed in step1. The resulting products from the nested PCR products were purified further 
with the Qiagen PCR purification kit. A small aliquot of the DNA product was run on a 1% 
Agarose gel (100V) to verify the successfully reassembly of the POcr gene.   
The modified POcr gene was inserted into the plasmid pTrc99A using the same general 
procedures carried out for the Ocr multimutants gene that are detailed in section 2.2.1. The 
modified insert underwent a double digest using the restriction enzymes NcoI and HindIII 
and the ligation reaction inserted the POcr gene into pre-linearised pTrc99A vector.  
Intially, XL-Gold Supercompetent cells were transformed with the POcr library, as per the 
manufacturer’s guidelines (Stratagene). The complete transformation mix was plated out 
onto 20×LB-agar plates supplemented with carbenicillin and incubated overnight at 37°C. 
The resulting colonies from all of the plates were pooled using 3ml of LB-broth per plate, the 
resulting mixture was centrifuged (15000rpm, 10mins at 4°C) and a Qiagen Maxi prep kit 
was used to isolate the plasmid DNA library. The library was subsequently quantified using 
the Nanodrop spectrophotometer.  
PCR Reaction Mix 
Mq Water Make to 50µl 
10(×)pfu Buffer 10µl 
pOcr DNA fragments 100ng 
Primers 200nM/per primer 
 
dNTP's 0.4mM 
Phusion DNA polymerase 2.5Units 
Total 50µl 
Reaction cycle 


















In the event of producing more than one library and increasing the diversity or increase the 
number of sites targeted for mutagenesis the whole library procedure was repeated however 
instead of amplifying the original POcr template an aliquot of the newly modified POcr gene 
was used as the template gene.    
2.4.1 2AP Selective screening assay  
The expression of the antirestriction protein wtOcr can rescue the growth of E. coli NM1041 
cells that have been exposed to the DNA mutagen 2-aminopurine (2AP). The 2AP resistance 
of E. coli NM1041 cells acquired in the presence of the wtOcr protein is indirectly associated 
with the antirestriction activity of the Ocr protein. Hence if E. coli NM1041 cells acquire 
resistance to 2AP in the presence of a POcr mutant it suggests that the POcr mutant has 
antirestriction properties that are equal to wtOcr.  
This was designed into a plate based selection method where the POcr libraries were 
transformed with E. coli NM1041 cells and plated onto plates exposed with high levels of 
2AP (80µg/ml). By selecting for 2AP resistance the growth of E.coli NM1041 cells is 
dependent onthe expression of POcr multimutants that share the same antirestriction activity 
as wtOcr.    
Transformations of E. coli NM1041 cells with the POcr library, LibDg were carried out as 
previously described and LB-agar plates were prepared with 2AP (IPTG, 50μg/ml and 2AP, 
80µg/ml) in addition to the appropriate antibiotics. The plates were incubated at 37°C 
overnight and then left on the bench for a further two days; the number of colonies present 
each day was recorded. 
 
The resulting colonies from the initial screen were restreaked onto fresh LB-agar plates 
supplemented with Km, Carb, IPTG and 2AP. After overnight incubation at 37°C, if cell 
growth was homogeneous, a swab of the colony was used to inoculate 5mls of LB broth to 
produce small scale bacterial cultures. The Qiagen mini prep kit was used to isolate the DNA 
from each overnight culture and E. coli NM1041 cells were transformed with the resulting 
POcr mutant gene and cells were selected for 2AP resistance as above. The POcr genes that 






2.5 Protein techniques 
2.5.1 Protein purification  
E. coli BL21 (DE3) pLysS cells were transformed with each Ocr mutant plasmid. Single 
colonies were picked to grow cells overnight which were subsequently used to inoculate 2L 
of LB Broth (2×1L in 2L conical flask) supplemented with 50µg/ml of carbenicillin. Cells 
were grown at 37°C with shaking (~200rpm), when the cell density OD600 measurement was 
~0.6 gene expression was induced by the addition of IPTG (final concentration of 1mM) 
growth was continued for 2.5 hours before harvesting the cells by centrifugation (8000g for 
10mins at 4°C). Cells pellets were weighed and stored at -20°C. 
Ion exchange chromatography 
Wild type Ocr and its mutants exhibit negatively charged surfaces. Therefore, the first step in 
purification involved an ion-exchange column. The cells were resuspended in ice-cold buffer 
A (20mM Tris-HCl, 300mM NH4Cl,  pH8) in the presence of a protease inhibitor cocktail 
(Roche, Basel, Switzerland). The cells were lysed on ice by sonication using a Soniprep 150 
Sonicator (Sanyo, Tokyo, Japan) fitted with a 9mm probe (1min/g of cell paste). Cell debris 
was removed by high speed centrifugation (17,000g for 1hr at 4°C) and the supernatant was 
filtered using a 0.22µM filter.   
The supernatant was loaded onto a 20 x 1.6cm diameter DEAE-Sepharose fast flow anion-
exchange column (GE Healthcare, Piscataway, NJ), which had been pre-equilibrated in 
buffer A, at a flow rate of 48ml/hr. Upon loading the supernatant the column was extensively 
washed with buffer A and then a 500ml gradient from 0.3-1.0M NH4Cl in buffer A was run 
at 24ml/h. Using an SDS-PAGE gel, fractions containing Ocr multimutants were identified 
and subsequently pooled. UV-spectrophotometry indicated that the samples were 
contaminated with nucleic acid. Therefore the second purification step was TCA 
precipitation. 
Trichloroacetic Acid (TCA) Precipitation 
The crude Ocr preparation was precipitated by the addition of 1.2 volumes of 10% (w/v) 
trichloroacetic acid (TCA) and incubated on ice for ~10min. The precipitate was collected by 
centrifugation at 15,000g for 10min at 4°C and the pellet was resuspended in 95% ethanol 
with gentle mixing for ~10min. After centrifugation (15,000g for 15 min at 4°C) the 
supernatant, which contained the Ocr protein, was transferred to a clean tube. This cycle of 
TCA precipitation followed by resuspension in 95% ethanol was then repeated a further two 
times except the final precipitate was resuspended in 20mM Tris HCl pH 8.0, instead of 95% 




If the sample remained as a precipitate, dialysis was performed against ~4L 20 mM Tris-
HCl, 10mM NaCl pH 8.0 for 16hr at 4°C and concentrated by centrifugation using a 
Vivaspin concentrator (10,000 MWCO; VivaScience AG, Hannover, Germany). UV 
spectrophotometry was used to determine the concentration of the protein and to indicate the 
removal of nucleic acid contamination. Finally, an equal volume of glycerol was added to 
the sample, which was then stored at -20°C until required.  
2.5.2 UV Spectrophotometry 
All protein and DNA concentrations were calculated by measuring the UV-vis spectrum of 
the sample using a HITACHI U2900/2910 Double Beam Spectrometer. Samples were 
filtered through a 0.2µM filter (Sartorius) before checking for UV absorption. Using the 
buffer, the baseline was set to zero. The sample was added to an air-dried 1 cm pathlength 
quartz cuvette (Starna). The spectrum was recorded in the 210–340nm wavelength range, 
with a scan speed of 400nm/min and a slit width of 2nm. The molar extinction coefficient of 
the protein and the Beer-Lambert law were used to calculate the final protein concentration. 
However, to calculate the concentration of DNA the assumption was taken that for dsDNA 
an absorption value of 1 at 260 nm corresponded to 50 μg/ml. 
2.5.3 CD analysis 
Circular dichroism (CD) measurements were carried out on a Jasco Model J-180 
spectropolarimeter (Jasco Corporation, Tokyo, Japan). Protein samples were prepared in 
10mM NaH2PO4 pH 8.0, 10mM NaF. Far-UV CD spectra (190–260 nm) were performed at 
a protein concentration of 30μM using a 1mm path length cell. A bandwidth of 1nm was 
used with a scan speed of 10nm/min. All CD measurements were made at 25°C and each 
spectrum was an accumulation of four individual scans. The spectra were corrected for 
buffer contribution by subtracting the CD absorption signal of the buffer from each of the 
data sets. 
2.5.4 Unfolding studies 
Equilibrium unfolding as a function of guanidinium hydrochloride (GdmCl) concentration 
was monitored by fluorescence spectroscopy (excitation 280nm; emission scan from 330-
450nm; bandwidth 1nm). A stock solution of GdmCl was freshly prepared from ultrapure 
reagents and the precise concentration determined using a refractometer. The protein 
samples in 20mM Tris-HCl pH 8.0 were incubated overnight at 4°C in the presence of 
various concentrations of GdmCl. Fluorescent data was then measured and the data was 
fitted to a two-state unfolding model assuming a linear relationship between ΔG of unfolding 
and the concentration of GdmCl. 
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2.5.5 Cross linking 
Cross linking studies were carried out using the cross linking agent glutaraldehyde. 
Concentrated protein solutions were diluted to 25µg/250µl using a 10mM HEPES, pH7.0 
buffer. 1% of a 25%w/v glutaraldehyde solution was added and incubated for 2mins, at room 
temperature. The reaction was quenched using freshly prepared 2M NaBH4 (in 0.1M NaOH) 
and incubated for a further 20mins at room temperature. 10%w/v sodium deoxycholate was 
added. TCA precipitation was carried out using 78%w/v trifluoroacetic acid and the resulting 
precipitate was spun down (13k for 10mins). The pellet was resuspended in 12µl of SDS 
loading buffer and small amounts of Tris-HCl were added to neutralise the buffer. The 
samples were heated for 5mins at 90°C and the pellets spun down. The supernatant was 
loaded onto an SDS-PAGE gel; the samples ran at 100volts for ~1hr. The gel was 
subsequently stained with Coomassie blue. After destaining, the gel was analysed on a light 
box.   
2.5.6 ITC 
Isothermal titration calorimetry (ITC) was carried out using an Auto-iTC200 (Microcal, 
Northampton, MA). The stocks of Ocr and M.EcoKI were buffer exchanged into 20 mM 
HEPES, pH 8.0, 6 mM MgCl2, 7 mM 2-mercaptoethanol using a PD-10 gel filtration column 
(GE Healthcare). The concentration of the protein solution was then adjusted appropriately 
by dilution into the same HEPES buffer. To avoid degradation, SAM was added to the final 
protein solutions (100 µM). The ratio of Ocr:MEcoKI was 10:1 in each case with 
30µM:3µM concentrations. All titrations were carried out at 25°C. The heat of dilution was 
obtained by injecting Ocr (0.2µl×19) into buffer. The calorimetric data were converted into 
differential binding curves by integration of the resultant peaks. The data were fitted into a 
single-site binding model. The automated protocol degassed all solutions before each run and 
carried out an automated wash cycle between each sample investigated. 
2.5.7 In vitro nuclease assay 
The in vitro assay indirectly measured antirestriction activity by the cleavage of 
unmethylated pBRsk1 using purified EcoKI in the absence or presence of the Ocr protein. 
Reactions were performed in a 50 μl in 10 mM Tris-acetate pH 7.5, 10 mM magnesium 
acetate, 7 mM 2-mercaptoethanol, 50 μg/ml bovine serum albumin, 2 mM ATP, 0.1 mM 
SAM, 2 nM pBRsk1 and 10 nM EcoKI at 37°C. Ocr (~100 nM for example) was briefly 
preincubated with EcoKI in the reaction mix prior and reactions were initiated by the 
addition of DNA substrate. The reactions were incubated for 10 min before quenching by 
incubation at 68°C for 10 min. Samples were mixed with gel loading buffer and loaded onto 
a 1% agarose gel containing 0.1 μg/ml ethidium bromide and subjected to electrophoresis in 
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Chapter 3. Ocr multimutants 
 
3.1 Introduction 
The protein Ocr mimics the charge and shape of bent B-form DNA. Charge mimicry is 
produced by a negatively charged protein surface which results in an isoelectric point, pI, of 
3.9, for the Ocr monomer. To understand the importance and necessity of the large number 
of acidic residues on the surface of Ocr, which are responsible for the extremely low pI, an 
investigation on the importance of charge for antirestriction activity was carried out by 
producing a plasmid library. The aim was to produce a library of Ocr multimutants 
possessing a range of isoelectric points and assess their activity with a sensitive in vivo 
assay. However, the value of such libraries is a reflection of the sensitivity of the screening 
assay.  
This chapter describes the development of an in vivo screening method which has the ability 
to select for mutants with antirestriction properties similar to wtOcr. Previous studies of the 
in vivo anti-restriction activity of DNA mimics and their mutants have relied on phage 
lambda infection experiments; although highly sensitive this technique is laborious and 
costly in consumables. In addition subtle differences in antirestriction activity cannot be 
easily identified by phage lambda experiments; such differences have only been elucidated 
from the in vitro characterisation of the purified proteins. The development of an in vivo 
selection assay that is sensitive enough to differentiate between the anti-restriction activity of 
DNA mimics can eliminate the time spent characterising purified proteins, which are 
biologically irrelevant to the purposes of the researcher.120,61  
 
3.2 Specific aims 
In this chapter an in vivo assay was developed to exploit the natural restriction alleviation 
system residing in E. coli NM1041 cells, in response to the DNA mutagen, 2-aminopurine 
(2AP). By selecting for 2AP resistance, the assay can assess the anti-restriction behavior of 
DNA mimic proteins like wtOcr and Orf18 ArdA. A series of Ocr multimutants that targeted 
clusters of acidic residues on the surface of Ocr were also investigated. These Ocr 
multimutants have been extensively investigated with in vitro experiments, therefore the 
characterisation of these mutants can act as a validation of the 2AP assay and allow for 
comparisons between the in vivo and in vitro results. 
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3.3 Proof of principle 
The antirestriction proteins, wtOcr from T7 bacteriophage and Orf18, ArdA from the 
conjugative transposon Tn916, mimic DNA and function as competitive inhibitors of the 
EcoKI enzyme. The introduction of these proteins into a ΔClpXP- bacterial strain, treated 
with 2AP, alleviates restriction allowing the continued growth of the cells as described in 
chapter 1.  
E. coli cells of the bacterial E. coli strain, NM1041 ∆ClpXP- (a kind gift from Dr. Angela 
Dawson, School of Physics and Astronomy, Edinburgh) were transformed with wtOcr and 
wtOrf18 ArdA along with the empty plasmid vector pTrc99A (each of the antirestriction 
genes, wtOcr and wtOrf18 ArdA were inserted into the plasmid pTrc99A to maintain 
consistency between results).  E. coli NM1041 cells expressing either wtOcr, wtOrf18 ArdA 
or pTrc99A, were grown on two types of LB-agar plates; a plate supplemented with 
antibiotics and a plate containing the antibiotics, IPTG, as an inducing agent and 80µg/ml of 
2AP, (80µg/ml was the concentration needed to induce restriction alleviation from 
unpublished work carried out with Dr. Angela Dawson).   
 
 
Figure 3.1: Viable counts of 10-fold serial dilutions from left to right of E. coli NM1041 
(ClpXP-) cells were plated onto two plates. Above the plate is supplemented with antibiotics 
and the inducing agent IPTG whereas the plate below has an additional supplement of 2AP, 
at 80µgml-1 per plate. Cells grown in the presence of the either antirestriction protein; wtOcr 




The resulting plates in figure 3.1 suggest that the presence of either antirestriction protein 
rescued the viable count of E. coli NM1041 cells from 2AP treatment, whereas E. coli 
NM1041 cells transformed with the empty vector pTrc99A did not survive 2AP treatment. 
The presence of the ArdA protein in E. coli NM1041 cells, treated with 2AP, maintains 
~70% of the cells. This is increased to a 100% survival rate for E. coli cells transformed with 
wtOcr. This implies that the protein ArdA does not completely negate the effects of 2AP 
treatment. In fact, in vitro data published on both antirestriction proteins does show that, the 
wtOcr protein has a tighter binding affinity to M.EcoKI compared to the ArdA protein.121  
 
3.4 Ocr multimutants 
The ability to differentiate between the antirestriction activity of wtOcr and wtArdA by the 
in vivo RA assay was unexpected. It suggests that the screen could be sensitive enough to 
elucidate changes in activity induced by mutants of the proteins. To investigate this, the 
assay was adapted to perform a titration of 2AP to enhance the sensitivity of the assay to 
distinguish between the antirestriction activity of a number of Ocr multimutants.  
Overnight E. coli NM1041 cell cultures, expressing either wtOcr or a mutant of Ocr, were 
plated onto LB-agar plates supplemented with increasing concentrations of 2AP. The 
reduction in 2AP concentration could lead to a decrease in the number of unmodified sites, 
resulting in fewer sites of targeted restriction. Although this should have no effect on the 
viable count for wtOcr, the decrease in unmodified sites might cause weak binding mutants 
of Ocr to display resistance at decreased levels of 2AP.   
To assess this hypothesis and determine the capability of the RA assay, a number of 
multimutants of the T7 wtOcr protein were accepted as a kind gift from Dr. Augoustinos 
Stephanou (Dryden Lab, Edinburgh). The mutants from A. Stephanou neutralised clusters of 
negative charge by substituting residues of aspartic acid and glutamic acid with asparagine 
and glutamine, according to their position in the crystal structure of wtOcr (figure 3.2). The 
mutants were created to investigate the effect of negative surface charge on antirestriction 
activity and elucidate regions of importance for the interaction of the protein with Type I 
restriction enzymes.  
The genes for each of the mutants were ligated into the plasmid vector pTrc99A to allow a 




Figure 3.2: Color coding of the amino acids targeted for mutagenesis for each Ocr 
multimutant. The protein and corresponding DNA sequence of wild-type Ocr is shown. The 
panel on the right shows the color coding used to highlight the amino acids targeted for 
mutagenesis. Extracted from A. Stephanou. PhD Thesis, 2010.122 
 
 
3.5 Restriction alleviation titration assay 
The restriction alleviation (RA) titration assay screened E. coli NM1041 cells expressing 
each of the Ocr multimutants exposed to 2AP concentrations ranging from 0-80µg/ml, figure 
3.3. Viable cells were recorded from several plates; a control plate (containing antibiotics 
only) and plates supplemented with IPTG and 0, 5, 10, 20, 40 and 80µg/ml of 2AP.  
1   M  A  M  S  N  M  T  Y  N  N  V  F  D  H  A  Y  E  M  L K             
1  ATGGCTATGTCTAACATGACTTACAACAACGTTTTCGACCACGCTTACGAAATGCTGAAA
21   E  N  I  R  Y  D  D  I  R  D  T  D  D  L  H  D  A  I  H M             
61  GAAAACATCCGTTATGATGACATCCGTGACACTGATGACCTGCACGATGCTATTCACATG
41   A  A  D  N  A  V  P  H  Y  Y  A  D  I  F  S  V  M  A  S E
121  GCTGCCGATAATGCAGTTCCGCACTACTACGCTGACATCTTTAGCGTAATGGCAAGTGAG           
61 G  I  D L  E F  E  D S  G  L  M  P  D T  K  D  V  I  R 
181  GGCATTGACCTTGAGTTCGAAGACTCTGGTCTGATGCCTGACACCAAGGACGTAATCCGC
81   I  L  Q  A  R  I  Y  E  Q  L  T  I  D  L  W  E  D  A  E D 
241  ATCCTGCAAGCGCGTATCTATGAGCAATTAACGATTGACCTCTGGGAAGACGCAGAAGAC






mut7 (mut2+ mut4) 
Ocr/POcr 
mut11 (mut12+ mut2) 
mut12 
mut13 (mut12+ mut4) 







Figure 3.3: The RA assay measuring cell survival of E. coli NM1041 (∆ClpXP-, r+m+) when 
transformed with various plasmids expressing Ocr or its mutant forms. The graph shows 
growth on LB-agar plates supplemented with antibiotics (cyan) only, antibiotics and IPTG 
(green) and, in the presence of antibiotics, IPTG plus increasing concentrations of 2AP (5, 
10, 20 and 40 µg/ml are red, magenta, blue and olive, respectively). 
 
Cell survival was calculated for E. coli NM1041 cells transformed with each of the mutants, 
upon increasing levels of 2AP and compared to the survival rate of cells grown with 
pTrc99A, wtOcr and the control plates, which were used to determine the concentration of 
each of the mutants concerned. Viable cells counts in the presence of wtOcr survived to a 
2AP concentration of 80µg/ml, this level of 2AP resistance represents a fully active 
antirestriction protein. In contrast, cells grown with the empty vector pTrc99A did not 
survive concentrations of 2AP that exceeded 20µg/ml. The 2AP resistance demonstrated by 
cells grown with pTrc99A is equivalent to an inactive antirestriction protein; therefore 
mutants that have a resistance to 2AP that is greater than 20µg/ml are exhibiting some level 
of antirestriction activity and if 2AP resistance is ≥80µg/ml then the mutant protein is 
demonstrating full antirestriction behavior. 
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As such, the RA titration assay in figure 3.3 indicates that the mutants; M1, M2, M4, Ocr99 
and Ocr109 retained the same 2AP resistance as wtOcr, whereas the mutants M7, M11 and 
M13 shared the same resistance as pTrc99A. This suggests that these mutants retain full 
activity or no activity respectively.  
The titration assay revealed a third phenotype induced by the Ocr multimutants M3, M12, 
M16 and Ocr/pOcr. The mutant M3 appears to maintain 2AP resistance to a concentration of 
10µg/ml. This level of resistance is lower than the pTrc99A vector and indicates that the 
mutant is actively reducing cell growth. Moreover E. coli NM1041 cells grown in the 
presence of mutants M12, M16 and Ocr/pOcr had a reduced viable cell count of 104 cells per 
ml when grown on plates with the inducing agent IPTG. This implies that the expression of 
these mutants also effects cell growth without the addition of 2AP. Incidentally upon 
exposure to 2AP, these mutants exhibit the same 2AP resistance as pTrc99A, which suggests 
that they possess limited, if any, antirestriction activity. 
 
3.6 Colony appearance 
Upon exposure to increasing concentrations of 2AP the viable cell count does not result in a 
gradual reduction in E. coli titre, instead the quantitative data from the assay is limited to 
observing either complete cell survival or total cell death. Further analysis of the assay 
shows that 2AP concentration causes a reduction in the cell density of the colonies produced, 
colonies become fainter with increasing levels of 2AP. This reduction in the density of the 
colonies is demonstrated in figure 3.4, where initially the density of colonies is uniform 
between E. coli cells expressing either pTrc99A or wtOcr. However, at a 2AP concentration 
of 10µg/ml the contrast and colour between the colonies is noticeably fainter for cells grown 
with pTrc99A, upon 20µg/ml the cells are misty in appearance until eventually at 40µg/ml 
there is no growth. This reduction in the size of colonies indicates that the cell growth has 









Figure 3.4: A representation of the 2AP plate assay. E. coli NM1041 cells transformed with 
either pTrc99A or wtOcr was grown overnight. Serial 10 fold dilutions were plated in a 
clockwise rotation on LB agar plates supplemented with increasing concentrations of 2AP 




Changes in colony morphology were also observed for E. coli NM1041 cells in the presence 
of the Ocr mutant, M3. Figure 3.5 vividly shows that the expression (+IPTG) of the Ocr 
mutant M3 causes a change in the size of the colony. The total viable cell count of E. coli 
NM1041 cells transformed with mutant M3, +/-IPTG, demonstrates that cell count is 
unaffected but the size of the colonies in the presence of IPTG and M3 are visibly smaller.  
 
Figure 3.5: Serial 10 fold dilutions of an overnight cell culture of E. coli NM1041 cells 
transformed with the Ocr multimutant M3, were plated out in an anticlockwise direction in 
triplicate. The left plate is supplemented with antibiotics (Km & Carb) only whereas the right 
plate is supplemented with antibiotics and the inducing agent, IPTG. 
 
The assessment of colony morphology supplements the quantitative data. For example, the 
quantitative data suggests that M3 induces a 2AP resistance of 10µg/ml of 2AP in E. coli 
NM1041 cells and the morphology shows that the cells are sensitive to the expression of the 
mutant M3. In some ways the phenotype of M3 is similar to the phenotype induced by the 
mutants M12, M16 and Ocr/pOcr. Both phenotypes show that expression of the Ocr mutant 
is affecting the growth of E. coli NM1041 cells, however the extent of this effect is greater 
for the Ocr mutants; M12, Ocr/pOcr and M16.  
 
3.7 Bacterial growth curves 
The expression of the Ocr multimutants M3, M12, Ocr/pOcr and M16 seem to be deleterious 
to the cells compromising cell growth or causing cell death. To investigate the apparent 
toxicity caused by these Ocr mutants, bacterial growth curves were monitored for each of the 
mutants. The use of LB-agar plates provides a result from a fixed time point (18 hours of 
growth) whereas bacterial growth curves observe the growth of E. coli cells in real time.  
Overnight cell cultures of E. coli NM1041 cells transformed with each Ocr multimutant, 




agent IPTG. Subsequently the E. coli cells were incubated at 37°C and 200rpm, cell growth 
was monitored by measuring the optical density at a wavelength of 600nm, with readings 
taken every 5 minutes for 500mins. 
 
Figure 3.6: Cell growth with the Ocr multimutants expressed in E. coli, NM1041 (ClpXP-, 
r+m+) cells in the absence of 2AP. It is clear that cells expressing different Ocr multimutants 
grow at different rates. pTrc99A is the vector alone, all other data are for cells expressing 
Ocr wild-type (wt) or Ocr mutants. OD600 measurements were recorded every 15min for 
500min a) cells growth without the inducing agent IPTG, b) cells grown with the inducing 
agent IPTG. Errors are ±7% for triplicate measurements (error bars not shown for clarity). To 
maintain clarity those mutants which shared the same growth pattern as wtOcr and pTrc99A 
(M1, M2, M4, M7, M13) can be found in the appendix (Figure A.1).  
 
The bacterial growth curves show that the expression of wtOcr or pTrc99A has no effect on 





archetypal growth curve, producing a doubling time of ~130mins. Typically, bacterial 
growth curves occur in four stages; the lag phase is the initial slow growing phase where 
cells adapt to the their new environment, the log phase is where cells grow exponentially in 
nutrient rich environments, the stationary phase where growth is reduced almost completely 
due to depleted nutrients, and the death phase where nutrients are scarce.  The expression 
(addition of IPTG) of the mutants M1, M2, M4, M7, M11 and M13 produced the same 
growth profile as wtOcr and pTrc99A, a lag phase of ~150mins followed by a doubling rate 
of ~130mins (Appendix, figure A1).  
However, comparisons between E. coli NM1041 cells with and without expression (+/-
IPTG) of the Ocr multimutants M3, M12, M16 and Ocr/pOcr displayed different growth 
profiles. E. coli NM1041 cells expressing the Ocr multimutants M3 or Ocr/pOcr showed an 
increase in the doubling time to ~150mins and ~200mins causing a reduction in the growth 
rate. Furthermore, the OD600 absorbance was ~0.7 at stationary phase; this is much lower 
than the OD600 of E. coli cells expressing wtOcr which reached an absorbance value of 2, see 
figure 3.6a for cell growth patterns without IPTG and figure 3.6b for changes in cell growth 
upon expression (+IPTG) of the Ocr multimutants. The results are consistent with the 
appearance of small ‘sick’ colonies observed with M3, in Figure3.5, and the reduced cell 
count observed for cells in the presence of the mutant Ocr/pOcr in Figure 3.3.   
Cells grown with mutants M12 and M16 showed slow growth rates in the presence and 
absence of IPTG. For cells grown with either mutant, in the absence of IPTG a lag time of 
~300 mins and a doubling time of ~150 mins were observed. In the presence of IPTG, 
growth was inhibited, the expression of Ocr mutant M12 in E. coli NM1041 cells inhibited 
growth completely and the expression of M16 reduces growth rate and induces an early 
stationary phase after ~200 mins. Like the mutant Ocr/pOcr, the mutants M12 and M16 
reached at an absorbance OD600 no greater than ~0.6 at 500 mins, figure 3.6b.  
The bacterial growth curves were able to differentiate between the deleterious effects 
induced by the mutants M3, M12, M16 and Ocr/pOcr. The Ocr multimutants M3 and 
Ocr/pOcr are not as deleterious as the mutants M12 and M16. Such a distinction could not be 





3.8 Cell toxicity and the restriction pathway 
The reduction in cell viability caused by the mutants M12, M16 and Ocr/pOcr in E. coli 
NM1041 cells indicates toxicity, an intolerance of the proteins by the cell. To pinpoint 
whether this toxicity is specific to the restriction pathway, plate assays were performed 
which measured cell viability upon expression of the mutants in restriction proficient and 
restriction deficient E. coli cells. E. coli NM1041 and NM1057 cells respectively were 
grown in the presence of the Ocr multimutants M3, Ocr/pOcr, M16 and M12. Viable counts 
were determined using LB-agar plates supplemented with IPTG. For comparisons, the plate 
assay was carried out for E. coli cells expressing wtOcr and pTrc99A both of which do not 
induce deleterious effects in E. coli cells (+/-HsdR).  
 
Figure 3.7: Loss of cell growth of E. coli NM1041 (ClpXP-, r+m+) and NM1057 (ClpXP-, r-m+) 
expressing the mutants mut3 (m3), OCR/POCR, mut16 (m16) and mut12 (m12) compared to 
cells expressing wild-type Ocr (wtOcr) or transformed with vector alone (pTrc99A). Serial 
dilutions of cultures were spotted onto LB-Agar plates supplemented with appropriate 
antibiotics. The dilutions of 10-2, 10-3 and 10-4 fold of the liquid culture are spotted in triplicate 
clockwise for E. coli NM1041 and anticlockwise for E. coli NM1057 from the top of the plate. 
 
Serial dilutions show that viable cells grew to a dilution of 10-4 for mutants grown in 
restriction deficient E. coli NM1057 cells. This is identical to the viable counts observed for 
wtOcr and pTrc99A. In comparison, the viable count of restriction proficient E. coli 
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NM1041 cells was much reduced for the mutants M12, M16, Ocr/pOcr and to a lesser extent 
M3, as shown previously. This indicates that the toxicity induced by the expression of these 
mutants is a result of the restriction pathway.  
 
3.9 Evidence of cell filamentation 
Figure 3.7 shows, that the interaction between EcoKI and the Ocr multimutants M3, M12, 
M16 and Ocr/pOcr is deleterious to E. coli cells. As toxicity only affects E. coli in the 
presence of EcoKI it suggests that the toxicity is a result of restriction activity on the host 
chromosome. This suggests that the expression of the Ocr mutant induces a phenotype that 
inhibits the methylation but not the restriction process of EcoKI. If so, expression of the Ocr 
mutant could induce the SOS response in E. coli cells preventing cell division and producing 
filamentous cells. 
 
Figure 3.8: Fluorescence microscopy images of cell morphology of bacterial cultures of E. 
coli NM1041 (clpX-, r+m+) cells transformed with plasmids expressing wtOcr or its variants. 
Control cells were transformed harboring the empty plasmid vector, pTrc99A. Cell nucleoids 
were revealed with DAPI staining. Scale bar is 10 microns. 
 
This phenomenon was observed by inducing E. coli NM1041 cells, at an OD600 of 0.3, 
transformed with the expression constructs pTrc99A, wtOcr or an Ocr mutant. After a further 
2hr incubation the cells were fixed with methanol, stored in Tris buffer, stained with DAPI 
and examined by fluorescent microscopy.  
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Micrographs displaying E. coli NM1041 cells expressing the mutants M1, M2, M4, M7, 
M11, M13, Ocr99 and Ocr109 contained intact nucleoids upon DAPI staining with the cell 
morphology identical to E. coli (NM1041) cells expressing either wtOcr and pTrc99A, as 
shown in figure 3.8. However, those mutants which appear to induce deleterious effects i.e. 
M3, M12, M16 and Ocr/pOcr, displayed extensive filamentation which is indicative of the 
SOS response in E. coli which has prevented cell division. The extent of filamentation seems 
more severe in the presence of the Ocr multimutants M12, M16 and Ocr/pOcr, compared to 
M3. It suggests that cells in the presence of these mutants appears to inhibit the methylation 
activity but not the restriction activity of EcoKI, resulting in unmodified sites on the 
chromosome susceptible to restriction. 
 
3.10  In vivo versus in vitro 
By adapting the 2AP screen from Makovets (2003) and Serfiotis-Mitsa (2010)123,121 to 
include a titration of increasing 2AP concentrations the screen can assess the antirestriction 
activity of several Ocr multimutants in vivo. The assay has elucidated several phenotypes 
suggesting that different antirestriction behaviors have been induced. As such active, inactive 
and partially active Ocr multimutants have been identified. In addition, analysis has revealed 
that the level of antirestriction activity produced by the partially active mutants affects the 
growth of E. coli cells in the presence of the restriction pathway. To be sure of this 
interpretation the results in this chapter were compared with an in vitro study of the same 

















Binding to M.EcoKI 
in vitro 
WtOcr Y Uncut Too tight 
M1 Y Uncut Too tight 
M2 Y Uncut Too tight 
M4 Y Uncut Too tight 
Ocr99 Y Uncut Too tight 
Ocr109 Y Uncut Too tight 
M7 Y Partial Cut Too tight 
Ocr/pOcr Y Cut Too tight 
M12 Y Cut 20+/-9 nM 
M16 Y Cut 71+/-30 nM 
M3 Y Cut 79+/-21 nM 
M13 N Cut 41+/-16 nM 
M11 N Cut No binding 
Table 3.1: A table extracting results of in vitro characterisation of the Ocr multimutants from 
the thesis of Dr. A Stephanou.122 
 
The results in Table 3.1 are an extract of previous data kindly donated by Dr. A Stephanou. 
It shows extensive investigations of the interaction between each of the Ocr multimutants 
with the EcoKI enzyme. Antirestriction activity was investigated in vivo by comparing the 
phage titre of unmodified λV.0. phage, on restriction proficient and restriction deficient cells, 
in the presence of each mutant.  This showed that all of the mutants appeared to be actively 
inhibiting the nuclease except M11 and M13, these both appear to possess no antirestriction 
activity from the phage assay, however the phage assay relies on leaky gene expression and 
production of the protein or Ocr mutant.  
In vitro data provided more direct measurements of the interaction between the mutants and 
the EcoKI enzyme. The interaction between the mutants and the endonuclease were 
investigated by carrying out an in vitro nuclease assay. This assay incubates the unmodified 
DNA plasmid, pBrsKI, which possesses a single recognition site for EcoKI, with the wtOcr 
protein or an Ocr mutant protein. The reaction mix is introduced to the EcoKI nuclease in a 
10:1 ratio of mutant: nuclease. A decrease in the restriction activity of the nuclease signifies 
an increase in the antirestriction activity exhibited by the Ocr mutant protein. The results 
show that the mutants Ocr/pOcr, M12, M16, M3, M13 and M11 failed to inhibit the 
restriction activity of the nuclease, with mutant M7 producing partial protection.  
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Finally antimodification activity was assessed through ITC experiments investigating the 
binding interaction between M.EcoKI and each of the mutants. The results showed that no 
binding is observed for the mutant M11, whereas the mutants M12, M16, M3 and M13 bind 
weakly to M.EcoKI, with binding affinities ranging from 20nM-79nM. The remaining 
mutants seem to bind tightly to M.EcoKI.  
The results from the separate investigations were compared. Comparisons between the RA 
assay and the ITC data showed that the results from both investigations shared a great 
number of similarities. These correlations provide an idea of the relationship between the 
phenotype observed from the RA assay and the interaction of the mutant with the MTase 
and/or REase, figure 3.9. 
 
Figure 3.9: A scatter graph which looks at the relationship between the Kd values obtained 
for the interaction of the Ocr multimutants with the M.EcoKI complex in vitro, as a measure of 
antimodification activity compared to the restriction alleviation that each mutant exhibited as 
a value of antirestriction activity in vivo. The binding interaction between M.EcoKI with 
MTase complex was measured by ITC for weak binding mutants; M3, M12, M13 and M16 
but for tight interactions between the mutants; M1, M2, M4, M7, Ocr/pOcr, Ocr99 and 
Ocr109 with M.EcoKI fluorescent anisotropy was performed. A clear relationship shows that 
an increase in the Kd value leads to a reduction in 2AP resistance. Ocr mutant M11 has not 
been shown because a binding interaction between the mutant and the M.EcoKI complex 
could not be measured, M11 appears to be inactive and appears unable to bind to the 
M.EcoKI enzyme.  
 
The in vitro investigations measured the interaction of the Ocr multimutants with either the 
M.EcoKI or EcoKI active complexes separately whereas the in vivo studies measured the 
activity of the mutants within the whole cellular environment which contains a mixture of 
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the two active complexes of EcoKI. Nevertheless correlations were observed between the 
data sets in vivo and in vitro comparing the level of 2AP resistance induced by an Ocr mutant 
with the strength of its interaction with the M.EcoKI/EcoKI active complexes. The mutants 
M1, M2, M4, Ocr99 and Ocr109 induced a high level of 2AP resistance and possessed tight 
binding affinities towards the M.EcoKI complex similar to the wtOcr protein. However the 
mutant M11 exhibited no resistance to 2AP and no binding interaction with M.EcoKI, both 
studies indicate that mutant M11 does not exhibit any antirestriction or antimethylation 
activity. Furthermore it was revealed that the Ocr mutants; M12, M16, M3 and Ocr/pOcr that 
induced a deleterious effect in E. coli NM1041 cells exhibited intermediate binding affinity 
towards M.EcoKI. This confirms that the intermediate binding affinity of the protein to 
M.EcoKI/EcoKI can induce the phenotype m+/-r+/- which effects the growth of cells in the 
presence of a Type I RM enzyme.  
However there were some inconsistencies between the in vivo and in vitro data. For example, 
the mutant M7, presumed inactive from the 2AP assay, exhibited poor antirestriction and 
antimethylation activity in vitro. In addition the mutant M13, which appeared inactive from 
the 2AP assay, phage assay and in vitro nuclease inhibition, appeared to successfully bind to 
the M.EcoKI enzyme by ITC, albeit with reduced affinity.  
In conclusion the 2AP RA assay is able to differentiate between mutants which possess full, 
partial and zero antirestriction activity. Multimutants that exhibit full antirestriction activity 
possess a 2AP resistance  >80µg/ml, whereas multimutants with no activity possess a 2AP 
resistance of 20µg/ml. In addition those mutants which appear to be toxic to E. coli NM1041 
cells upon induction are partially active displaying weak binding affinity towards the MTase 
and nuclease.  
 
3.11 Discussion 
3.11.1 Development of a robust in vivo assay 
The importance of an informative screening method when assessing possibly hundreds of 
mutants is paramount. Not only should the method provide fast, reliable and reproducible 
results but the results should provide as much detail as possible to justify the investment in 
time for construction of the library. Measuring the 2AP resistance of E. coli NM1041 cells 
without the clp gene, provides a robust technique to assess the inhibitory activity of 
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antirestriction proteins such as wtOcr. The assay relies on the ability of the antirestriction 
protein to rescue cell growth and by doing so provides a highly visible phenotype.  
This chapter has shown that the presence of the antirestriction proteins wtOcr and ArdA, 
rescue E. coli NM1041 cells treated with 2AP. The assay was enhanced to select for 
resistance to different concentrations of 2AP and then used to assess mutants of Ocr known 
to have variable antirestriction activities. Screening of the Ocr multimutants revealed several 
phenotypes, the mutants M1, M2, M4, Ocr99 and Ocr109 exhibited 2AP resistance at the 
maximum concentration of 2AP, 80µg/ml, indicating fully active antirestriction properties. 
Mutants M7, M11 and M13 provided no antirestriction activity, while a third phenotype, 
reduce the growth rate of E. coli NM1041 cells.  
The third set of Ocr multimutants that induced a deleterious effect on the growth of E. coli 
NM1041 cells were examined further. Bacterial growth curves of E. coli NM1041 cells 
expressing each of the Ocr multimutants showed that the cellular growth rate differed for 
each of the deleterious mutants. Cultures grown with the mutants M12 and M16 possessed a 
reduced growth rate.  Upon over expression this rate was further reduced to no growth. The 
mutants Ocr/POcr and M3 have a lesser effect on the growth rate and only when over 
expressed. Therefore the activity of the intermediate mutants has been further differentiated; 
the mutant M3 inducing minor decreases in cellular growth, this negative effect on the 
growth of cells increases upon expression of the mutants Ocr/POcr, M16 and M12. M12 
reduces growth to the greatest extent.  
3.11.2 Partially active phenotype  
To pinpoint the cause of the deleterious effect, viable cell counts in the presence and absence 
of the restriction subunit, HsdR, were compared. If viable cell counts were reduced in both 
bacterial strains it would suggest that the mutants are interacting with another component of 
the cell. However, viable cell counts show that the cells were rescued in the absence of the 
restriction subunit for each of the mutants (M3, M12, M16, Ocr/pOcr ). This implies that the 
reduction in cell count is dependent on the HsdR subunit suggesting that the restriction 
enzyme EcoKI is targeting the host DNA. Microscopy was carried out to see if cells grown 
with these particular mutants had become susceptible to restriction, from the HsdR subunits. 
These results show that expression of the deleterious mutants caused cells to filament. Upon 
damage to DNA the host cell initiates the SOS response and, as part of this response, cell 
division is inhibited but replication continues. This indicates that the deleterious mutants are 
not inhibiting restriction efficiently in agreement with the in vitro studies carried out by A. 
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Stephanou which showed that these mutants possess a poor binding affinity towards the 
M.EcoKI enzyme. The deleterious mutants M3, M12, M16 and Ocr/pOcr induce an M+/-R+/- 
phenotype which is detrimental to the growth of E. coli cells in the presence of a Type I RM 
enzyme.  
Such a phenotype could be caused by differential binding of the Ocr multimutants to the 
methylase or nuclease complex although it seems unlikely that the Ocr multimutants could 
inhibit the methylase completely and not the nuclease, or vice versa, given the nature of the 
Ocr binding pocket on EcoKI. The difference in location of the two active complexes and 
their accessibility could cause differences. The nuclease is thought to mostly reside outside 
the nucleoid compared to the methylase which needs to be in close proximity to the hemi-
methylated product of DNA replication to modify the DNA accordingly.40 Furthermore the 
quantity of M.EcoKI in the cell is slightly greater than the amount of R.EcoKI. In the 
presence of weak binding inhibitors, the efficiency of the methylation and restriction activity 
will not be equally affected and as such the unmodified chromosomal target sites could 
become susceptible to restriction.   
3.11.3 Charge-function relationships 
The Ocr multimutants targeted specific clusters of acidic residues on the surface of the Ocr 
protein, these acidic residues mimic the charge displayed by the phosphate backbone of B-
form DNA. The mutations targeted groups and clusters of acidic residues from different 
domains from the structure of the Ocr monomer and the acidic residues were substituted for 
analogous neutral amino acid residues; hence D/E residues were substituted with N/Q 
respectively. Examination of the activity of each Ocr multimutants and the location of its 
mutations on the Ocr protein can identify regions and clusters of negative charge that are 




Figure 3.10: The Ocr dimer crystal structure. Each of the domains that have targeted in the 
mulitmutants has been represented in a different colour, M1-Helix A, M2-Loop 1, M3 and 
M12-Loop2, M4-Helix D, M7-Loop1+HelixD, M11-Loop1+Loop2, M13-Loop2+HelixD, M16- 


















Figure 3.11: The Ocr homodimer structure with the location of the mutations for each of the 
multimutants, the colours coordinate with the table below which outlines the specific 
mutations carried out and the domain these mutations reside in from the Ocr crystal 
structure, Walkinshaw et al, 2002.(46) Domains include; Helix A, aa7-24 (HA), HelixB, aa34-
44 (HB), Helix D, aa78-106 (HD), C-terminal region, aa107-117 (Tail), Loop1, aa25-33 (Lp1) 
and Loop2, aa58-77 (Lp2). 46 
 




pTrc99A n/a n/a n/a 
wtOcr 0 0 n/a 
M1 D12N, E16Q, E20Q, D25N, D26N 5 HA 
M2 D25C, D26N, D29N, D31N, D32N, D35N 6 Lp1 + HB 
M3 E60Q, D62N, E64Q, E66Q, D67N, D73C 6 Lp2 
M4 D92N, E95Q, D76N, E98Q, D99N 5 HD 
M7 M2+M4 11 Lp1+HD 
M11 M2+M12 11 Lp1 + Lp2 
M12 E60Q, D62N, E64Q, E66Q, D67N 5 Lp2 
M13 M4+M12 10 HD + Lp2 
M16 M1+M12 10 HA + Lp2 
O/P 
D76N, E87Q, D92N, E95Q, D96N, E98Q, 
D99N, E103Q, E106Q, E107Q, E109Q, E110Q, 
E112Q, E113Q, D114N, E115Q, E116Q 17 HD + Tail 
Ocr99 Truncation at L99 16 HD + Tail 
Ocr109 Truncation at E109 6 Tail 
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The mutants M1, M2 and M4 appear to have no effect on the antirestriction or 
antimodification activity of the protein. However, the combination of M2 and M4 to make 
mutant M7, seems to reduce binding between the Ocr mutant and the nuclease complex. On 
the other hand the mutants M3 and M12 produce deleterious effects in E. coli cells in the 
presence of the HsdR subunit. The residues targeted by M12 and M3 dominate the Loop 2 
region of the Ocr structure, the mutations are identical with the exception of D73C in mutant 
M3. This single amino acid change reduces the deleterious effect induced by the mutant M3 
compared to M12, suggesting an increase in the stability of the interaction with the Type I 
RM enzyme. The loop region is centrally located on the homodimer and the Ocr:M.EcoKI 
models show that this region is in close proximity to the HsdS subunit, in particular the TRD 
domains. The combination of the mutant M12 with either M2 or M4 appears to inactivate the 
Ocr protein and no binding is exhibited by the mutants M11 (M12+M2) and M13 
(M12+M4). This confirms that the acidic residues mutated in M2 and M4 have a smaller 
impact on the activity of wtOcr. The residues on mutant M2 are located on Loop1, which is 
also shown to be in close proximity to the TRD domains of the HsdS subunit and possibly 
the HsdM subunit.  
In contrast the acidic residues targeted on mutant M4 reside on the elongated Helix D, see 
figure 3.10. Models of the EcoKI and Ocr homodimer indicate that this domain may interact 
with the HsdR subunit, the models show that this helix domain does not appear to contact the 
HsdS or HsdM subunits (Figure 3.12). This could account for the difference in binding 
affinity that is exhibited by the mutant M13 upon binding to the M.EcoKI (weak binding) 
and the EcoKI enzyme (no activity) and the reduced antirestriction activity of mutant M7. 
Both of these mutants contain the mutations targeted in M4 in combination with other 
regions of interest. However it is the acidic residues located on the loop regions of the Ocr 
homodimer which appear important for its interaction with M.EcoKI with the Loop 2 region 
being of primary importance.   
Overall the results show that the central loop region represented by mutant M12 contains 
acidic residues that are important for the interaction with the EcoKI enzyme. The residues 
represented in M2 (loop1) and M4 (Helix D) are also important but to a lesser extent. Early 
indications suggest that the residues in M2 bind to the M.EcoKI complex whereas the 
residues in M4 may interact with the HsdR subunit and contribute by stabilising the 
interaction of the EcoKI nuclease with the Ocr protein. However it is important to note that 
on their own these regions have no noticeable effect on the antirestriction or antimodification 
activity of the protein. 
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Another series of mutations measured the effect of C-terminal truncations on the 
antirestriction activity of the Ocr proteins. Previous investigations of the negatively-enriched 
C-terminal region showed that it appeared to be of little importance to the overall 
antirestriction function of the protein. Analysis of the truncations Ocr99 and Ocr109 confirm 
this as each induced no effect in the 2AP assay and only nominal effects were found in vitro. 
However mutations that combine the M4 region and the C-terminal region with the addition 
of D76N (OCR/POCR) appeared to cause a deleterious effect in the 2AP assay even though 
the in vitro data showed a strong interaction with M.EcoKI. This suggests that the residues in 
mutant M4 are important for the interaction of Ocr with the nuclease complex.  
 
Figure 3.12: Left- Structure of M.EcoKI with Ocr. Structural domains on the Ocr homodimer 
have been highlighted as shown in figure 3.10. Right- A closer look at the HsdS interaction 
with the Ocr homodimer, demonstrating the importance of loop 1 and 2 towards the 
interaction. The domains of Ocr have been highlighted using the same colours as shown in 
figure 3.10. 
 
To conclude, this chapter has outlined the development of an assay that is relatively fast and 
reproducible and displays a strong phenotype to select for active antirestriction proteins. By 
extending the assay to include a titration of 2AP, the assay can select for inactive and 
partially active antirestriction proteins, these phenotypes correlate with in vitro binding 
affinity measurements. The results have shown that mutants that possess a weak binding 
affinity also affect the viability of E. coli cells in the presence of the HsdR subunit and 
display a phenotype of m+/-r+/-. Overall, the results show that acidic residues that reside in the 
loop 2 region and, to a lesser extent, the loop 1 region of the Ocr homodimer make important 
electrostatic interactions to EcoKI. Furthermore the acidic residues in M4, (Helix D) may 
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interact with the HsdR subunit of EcoKI and this could indicate a secondary binding site on 




























Chapter 4. Development of a POcr library 
 
4.1 Introduction 
The surface of the protein Ocr is replete with acidic residues, many of which mimic the 
phosphate backbone of DNA. Initial studies in chapter 3 have shown that these acidic 
residues are important for the interaction of Ocr with the restriction endonuclease EcoKI. 
However, it has also been shown that many of these acidic residues appear to possess little or 
no functional advantage towards the inhibitory activity of Ocr, which suggests that the 
positional context of the acidic residues as well as the number of acidic residues could both 
play an important role in the antirestriction activity of the protein Ocr.  
This chapter attempts to produce a plasmid library which targets each of the acidic residues 
in a random manner, to produce mutants of Ocr with differential pI values in order to 
determine the minimum number of acidic residues needed to provide full antirestriction 
activity. To achieve this, the gene POcr, ‘positive Ocr’, was synthesised by Geneart (now 
part of Invitrogen) using their GeneAssembler process. When the gene encoding POcr was 
engineered for expression no recombinant protein could be detected. This was not surprising, 
given that 34 out of the 117 residues (~30%) of Ocr had been substituted. Such a large 
number of mutations were likely to adversely affect the overall structural integrity of the 
protein leading to folding/stability issues. Nonetheless, the synthetic gene encoding POcr 
could be used as a template, in a PCR-based approach, to gradually reintroduce the acidic 
residues of wtOcr. It was essential that the reintroduction of acidic residues at the specified 
positions was a random process without bias. Although POcr displays no antirestriction 
activity, it was envisaged that the gradual introduction of acidic residues would at some stage 
generate an active protein.  
 
4.2 Aims 
This chapter will describe how a series of libraries were developed that could target specified 
positions in the protein sequence of POcr and reintroduce acidic residues randomly with a 
controlled mutation rate. Mutations targeted neutral residues located on the POcr protein 
sequence, which correspond to the acidic residues on wtOcr. By slowly reintroducing the 
negative charge of wild type Ocr onto the POcr protein, nine libraries were generated 





To introduce each acidic residue in an unbiased manner, ISOR was used to generate a series 
of libraries. Each library introduced an increasing number of acidic residues, by 
manipulating the POcr gene. Due to the close proximity of some target sites the 
oligonucleotides developed that substituted Q/N residues to E/D residues were separated into 
four groups and this produced four initial libraries; Lib1, Lib2, Lib3 and Lib4. Collectively 
these libraries targeted each of the neutral amino acid residues on the POcr protein, which 
are acidic on wtOcr. As a result, the four libraries were subsequently combined to produce a 
fifth library, the Shuffle Lib, which targeted all of the appropriate sites on POcr.   
The recombination of fragments from the libraries Lib1-4 to produce the Shuffle Lib 
produced POcr mutants with a range of only 1-8 acidic residues out of a possible 34 
(explained in detail below).  As such, additional oligos were redesigned with degeneracy. 
However, because of overlapping target sites these oligos were separated into two groups 
generating a further two libraries; 1D and 2D. These two libraries were subsequently 
combined using ISOR to produce the library 1D+2D. The final library, LibDg, was created 
to increase the number of acidic residues further by introducing a third group of degenerate 
oligos to library 1D+2D.  
Hence nine libraries were generated; the rest of this chapter will describe in detail the efforts 




Figure 4.1: A flowchart that shows how the nine POcr libraries were developed. Staring from 
the original template of the POcr gene, a group of specifically designed primers that targeted 
neutral residues across the surface of the POcr protein were each reassembled with 
fragments of the POcr gene producing four libraries, each of which contained a different set 
of target sites. Each of the four libraries was recombined to produce the Shuffle Lib. In turn 
the Shuffle Lib was exposed to two different sets of degenerate primers which targeted 
groups/clusters of neutral residues this generated the libraries Lib 1D and Lib2D which were 
subsequently combined to produce the library 1D+2D. A final set of degenerate primers were 











4.4 POcr Libraries: Lib1-4 
The ISOR method for producing plasmid mutant libraries is described in chapter 2, figure 
2.2. The ISOR cycle consists of a series of stages, each stage requires a large amount of 
DNA. Therefore, stage 1 consists of a PCR amplification step of the POcr DNA sequence 
followed by a digestion reaction. The POcr insert was digested to produce fragments, which 
upon recombination with specifically designed primers introduced the appropriate mutations. 
For non-specific digestion the DNAseI nuclease was used. DNAseI cleaves DNA at 
phosphodiester sites adjacent to a pyrimidine nucleotide (C or T).  The POcr insert is a small 
gene, 351bps long and as such the digest reaction was developed to yield fragments that 
were ≤100bps in length. This was regulated by varying the digestion time and optimal 
fragments were observed with an 8min digestion, (Figure 4.2).  
 
Figure 4.2: A 1.5% DNA agarose gel of the POCR amplification product digested with the 
enzyme DNaseI for 8mins and 10mins. Both digest reactions have yielded fragments of the 
insert which are 100bp or smaller. However the 8min digest appears to yield a greater 
number of fragments, the 10min digest may lose more fragments in the agarose gel.  
 
The POcr fragments were recombined with the addition of primers, however many of the 
target sites on POcr are in close proximity to each other. An effort was made to design oligos 
with close target sites on opposing sense and antisense strands of the POcr gene. However 
this was balanced with the need to design oligos that were the same length and with a similar 
GC content in order to reduce variability in the Tm temperature. As a result, many of the 
designed oligonucleotides contained flanking regions that overlapped other target sites. As 
such the oligos were split into four groups, to avoid primers with overlapping regions 
competing for positions upon the reassembly of POcr gene fragments, see figure 4.3. 
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Subsequently the four groups of oligos were reassembled with fragments of the POcr gene to 
generate four mini libraries. 
 
 
Figure 4.3: Above, the POcr DNA and resulting protein sequence. Highlighted in colour are 
of all the neutralised residues that were targeted for mutagenesis using the ISOR library 
methodology. Each color represents the targets for each of the four libraries where; Red is 
Lib1, Green Lib2, Blue Lib3 and Yellow Lib4. Below, the chemical structures of the amino 
acid residues involved in the mutagenesis, the neutral residues; asparagine and glutamine 
were targeted for mutagenesis to aspartic acid and glutamic acid, respectively. 
 
From previous work carried out by the Tawfik lab, it was found that the mutation rate of an 
ISOR library could be controlled by varying the oligonucleotide concentration.119,107 A total 
oligonucleotide concentration of 144nM could give an average of 6 mutations per library 
variant, however if the concentration exceeded 360nM it would inhibit the reassembly 
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reaction.119 To produce the four libraries Lib1-4 a total primer concentration of 200nM was 
used in the reassembly reaction, with the aim of achieving the maximum mutation rate (8 
mutations per gene). Each of the four groups contained 8/9 oligos resulting in a 
concentration of 25/22nM for each oligo.  
The reassembled POcr genes were subsequently amplified using a nested PCR reaction. This 
is achieved by designing primers which amplify a target within the original template, in this 
case within the POcr gene insert. Oligos were designed to overlap the start and stop codons 
of the gene insert, incorporating the restriction sites NcoI and HindIII to insert the gene into 
the pTr99A plasmid. The nested PCR products were purified using a 1% DNA agarose gel 
resulting in only one DNA species which was between 300-400bp in size (Figure 4.5), the 
same size as the original POcr gene (379bp).  
 
Figure 4.4: A small amount of the nested PCR reaction of the group 1 library was run on a 
1% DNA agarose gel. By comparing the gel band present in the Group 1 PCR product with a 
DNA ladder the DNA species is between 300-400bp long. 
 
To test the success of the four initial libraries each was subcloned into the plasmid vector, 
pTrc99A. In order to plate out the complete diversity of the library onto LB-agar plates, XL-
gold supercompetent cells were used to carry out the initial transformation. Supercompetent 
cells have a high transformation frequency of 5 x 109 transformants/μg therefore, these cells 
are ideal when plasmid product is limited such as for ligation reactions and for obtaining the 
full capacity of the libraries from using a small sample. Each library targets 8 sites providing 
two potential residues per site. The maximum number of variants for each of the libraries is 
28 = 256 different mutants. In addition transformation frequencies of the empty pTrc99A 
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vector and the library showed that ~1% of the transformant mix of the library could 
potentially be background colonies of the empty plasmid.  
To ensure that enough of the library is represented, the transformation mix was plated out to 
accommodate 10-fold more colonies (2560) than the maximum 256 variants, this was to 
accommodate for repeating sequences, background colonies and any potential non-targeted 
point mutations incurred through the ISOR process. To assess the success of the initial 
libraries ~10 colonies were picked from each library; the plasmids were isolated and sent for 
DNA sequencing.  
 
Figure 4.5: Ten POcr multimutants were isolated from each library. The bar chart is a 
histogram representing how many acidic residues were introduced to POcr multimutants 
belonging to  Lib1, Lib2, Lib3 and Lib4. The distribution of the number of acidic residues that 
were introduced to all 40 mutants that were isolated from the libraries Lib1-4 was fitted to a 
Gaussian curve. 
 
From the sequencing results 37 unique POcr mutants were isolated, each targeting different 
combinations of the eight target sites presented in the libraries Lib1-4. Each of the libraries 
produced POcr mutants with a range of 0-8 acidic residues, therefore a high diversity appears 
to be present in each of the four libraries. A Gaussian fit (Figure 4.5) shows that on average 






Figure 4.6: From the 10 colonies that were sequenced from each of the libraries 1-4, each 
graph above represents the mutation coverage for each target site covered by these 
sequences, as a representation of the diversity and mutational coverage of the sites in each 
library. Where; Red is Lib1, Green Lib2, Blue Lib3 and Yellow Lib4. 
 
A closer look at sequences of POcr mutants from each library, shows that some mutations 
were more abundant compared to others. Figure 4.6 shows that the sequences from Lib1 and 
Lib3 appear to mutate all of the target sites with a mutational coverage of 20-100% for each 
site. However, the libraries Lib2 and Lib4 both contain target sites which have not been 
mutated at all. However this difference is slight when considering the sample size, the 10 
sequences used to assess each of the libraries barely represents 3% of their total population.  
The production of non-specific mutations and indels within the libraries were measured. 
These represent the introduction of mutations; deletions, insertions and substitutions on the 
POcr insert that have not been targeted. These could arise from multiple rounds of PCR 
amplification or upon reassembly to the wrong fragment. The table below accounts for all 
these anomalies, these have been kept to a minimum representing on average 1 in 10 





Library Number of Indels Anomaly type 
1 1 Truncation 
2 1 Unable to Sequence 
3 1 Unable to Sequence 
4 0  
Table 4.1: A table displaying the number of sequences that contain anomalous mutations or 
deletions from each of the libraries 1-4 and the type of mutations that were exhibited. 
 
As randomisation of the mutations in the ISOR method relies on the reassembly of fragments 
from a non-specific digestion, it is impossible to know the full diversity of the libraries, 
which is why any conclusions that these sequences give us are a rough guide. Therefore to 
compensate for any bias a 10 fold increase is added to any predicted values in the population 
size and diversity of the libraries.   
4.5 Shuffle Library 
The four separate libraries provide a broad and diverse range of mutations, although in each 
library only a quarter of the desired sites are targeted. Therefore, the four individual libraries 
were combined in order to obtain a single library in which all potential sites are targeted. 
Fragments of each library from a DNAseI digest were combined and reassembled using 
ISOR. After the reassembly of the fragments this ‘shuffle’ library was cloned back into 
pTrc99A as previously described, 15 colonies were isolated and sequenced from the 






Figure 4.7:  A bar chart representing the total number of mutations and whether they 
were targets from libraries 1, 2, 3 or 4. This highlights the extent of shuffling present 
in each of the sequences from the shuffle library (NB, 11 out of the 15 colonies 
isolated were successfully sequenced. 
  
Fifteen POcr mutants were sequenced producing 11 unique sequences and 4 sequences with 
non-specific mutations/indels. Disregarding those mutants with non-specific mutations the 
average number of acidic residues per gene remained at ~5. Analysis of each of the 
sequences from the shuffle library showed that sequences contained only small mixtures of 
target sites from each of the libraries, for example >60% of the sequences had target sites 
from only one of the four original library groups. Those that did show mixtures were limited, 
no greater than two groups were shuffled in a gene and the distribution of the sequences was 
limited, see figure 4.7. This is highlighted by the fact that almost none of the sequences had 
mutations on target sites that were next to each other as shown in figure 4.8. 
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Figure 4.8: A graph depicting the percentage mutation coverage of each of the 
target site residues. The mutations coverage is the percentage of mutations from 
neutral to acidic residues that have been identified at each target site from the 
sequences that have been solved for the shuffle library. 
In fact, sequences isolated from the shuffle library showed that the mutational coverage 
ranged from 0-40% for each acidic residue. Acidic residues had not been introduced to 17 
different target sites.  A closer look at the mutational coverage in figure 4.8 does show a 
correlation between those mutations underrepresented and target residues which are in close 
proximity to each other. The shuffle library showed that residues next to each other were 
especially difficult to target; for example, residues at positions 26-27 and 67-68. In order to 
reduce bias oligonucleotides were designed to be the same size and therefore possessed 
overlapping target sites. Due to this and insufficient fragmentation, it was realised that the 
shuffling could inadvertently mutate the acidic residues that were present in one library, back 
to neutral residues once shuffled. This would be most prominent for target sites in close 
proximity to each other.  
 
4.6 POcr Libraries: Lib1D and Lib2D 
To increase the number of acidic residues on the POcr gene, degenerate oligonucleotides 
were used to target cluster regions in close proximity on the POcr gene. The results of the 
shuffle library showed that gaining mutations from residues next to each other was difficult 
using separate oligonucleotides so the use of degenerate sequences can overcome this, by 
targeting a series of neutral residues at the same time with one oligonucleotide. However the 
design of these primers needed to be carefully considered; each of the residues targeted must 
have adequate flanking regions to anneal; they must be the same, contain the same GC 
92 
 
content, with no overlapping target sequences and to ensure equal representation of each 
residue, the degenerate codons should translate to a 1:1 ratio of acidic: neutral residues for 
all mutations concerned.  
Due to the size of POcr, overlap between non-targeted regions of the wild type POcr protein 
could not be avoided in the design of the primers. Therefore the newly designed degenerate 
oligonucleotides were separated, this time into two groups to avoid any overlapping wild 
type sequence in the same reassembly reaction and prevent the primers from competing to 















Figure 4.9: Above, the POcr DNA and complementary protein sequence. Highlighted in color 
are of all the residues that were targeted for degenerate oligonucleotides. Each color 
represents the targets for each of the two libraries; green refers to Lib1D oligos and in blue 
the oligos in 2D. In black are stray residues that have been targeted previously but are not 
present in clusters therefore not targeted in this round of ISOR.  
 
Using ISOR, the degenerate primers 1D and 2D were incorporated into fragments of the 
shuffle library, producing two different libraries, Lib1D and Lib2D. The agarose gel which 
displayed the products of the nested POcr reaction for both libraries showed that the POcr 
gene had successfully reassembled at ~385bp. However, additional bands were present on 
the agarose gel, showing the presence of DNA species which were 200bp long for both 
libraries and an additional band at ~300bp for library 1D, (Figure 4.10), which could be a 
result of mispriming events. Fortunately, the truncations observed in figure 4.10 could be 
Primer Name Target Sites Primer Sequence 
N113-117 113,114,115,116,117 CGCCAAGCTTTTACTSTTSGTYCTSCTSATA 
N96-100 96,97,99,100 CTGTGGSAARACGCGSAGRACCTGCTGAAC 
N74-77 74,77 GAATACGGATTACGTCTTTGGTGTCCGGCATC 
N60-63 60,63 GCGTTATGGCTTCTGAGGGTATCGACCTG 
N26_27 26,27 CATTCGCTACGATGACATTCGTAATACC 
N26_30 26,30 CATTCGCTACGATAACATTCGTGATACC  
N27_30 27,30 CATTCGCTACAATGACATTCGTGATACC  
N107-111 107,108,110,111 TATCTGSAASAGGTGSAGSAATAT 
N88 88 CTGCAGGCTCGTATCTACGAGCAGCTGAC 
N63-68 63,65,67,68 GGTATCRACCTGSAGTTCSAGRACTCCGGC 
N13-17 13,17 CGTTTTTAATCACGCATATGAGATGCTG 
N17 17 CGTTTTTAATCACGCATATGAGATGCTG 
N30-36 30,32,33,36 ATTCGTRATACCRACRACCTGCACRACGCC 
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easily removed upon purification of the nested PCR products, by excising the gel band that 
corresponds to the size of the fully reassembled gene, at 385bp.  
 
Figure 4.20: The DNA species present in the PCR products of the reassembled libraries 1D 
and 2D.Lib 1D contains DNA products of sizes 200bp, ~300 and 400bp long. The weakest 
band represents the gel band of interest (400bp). Similarly the library 2D has multiple 
species however only two different species a band at ~400bp long appears to be the same 
size as the pOcr gene and the band at 200bp could represent a mispriming event which 
produces a truncated pOcr sequence. 
 
4.7 POcr library: 1D+2D 
The libraries Lib1D and Lib2D were shuffled using ISOR in the same way as described 
previously. The diversity and successful introduction of acidic residues in close proximity 
was assessed by, isolating colonies to be sequenced before and after the shuffle of the 







Figure 4.31: The bar chart shows the average number of mutations per gene from the 
colonies sequenced (3  10) for the libraries 1D and 2D and the resulting shuffle library 1D 
and 2D. The probable distribution is a Gaussian fit of the mutation rate of all the sequences 
from each of the three libraries; it gives an estimation of the potential diversity of the libraries. 
 
The average mutation rate increased to 10 acidic residues per POcr going up to a maximum 
of 15 acidic residues reintroduced, this is a marked increase from an average of 5 acidic 
residues per POcr mutant from the shuffle library. This suggests that the incorporation of the 
degenerate primers had been successful.   
 
Figure 4.42: A graph depicting the percentage mutation coverage of each of the target site 
residues. The percentage mutation coverage has been compared between sequences 




Upon closer examination of the sequences isolated from the 1D and 2D library, the 
mutational frequency of each target site was quantified for 30 sequences isolated from the 
library. Although this is relying on the results from a small subpopulation of the library, the 
values obtained provide a rough average of the mutational coverage. It is likely that if an 
oligonucleotide has not annealed successfully to POcr in the reassembly reaction, then the 
percentage coverage should be extremely low.  
Figure 4.12 shows that from the 30 POcr multimutants sequenced that at least 40% of the 
neutral amino acids at the target sites 26, 30, 60, 63, 74 and 77 have been mutated to acidic 
residues. This is a large mutational coverage in such a small population therefore, a good 
indicator that the oligonucleotides that possessed these target sites were successfully 
incorporated into the library. Positions 27, 99 and 100 possess 30% mutation frequency. This 
also highlights that primers targeting these sites were successfully incorporated into the 1D 
and 2D library.   
The percentage of acidic residues introduced at other target sites remained low; for example, 
the percentage of acidic residues introduced at the target sites 65, 67 and 68 were below 5%. 
It is difficult to discern whether the low frequency of mutations is because the sampling size 
is small or whether the oligos designed failed to anneal. However, due to the relatively low 
frequency exhibited in contrast to other target sites it was assumed that the oligonucleotide 
containing these positions failed to anneal to the POcr sequence. As such the small 
percentage of acidic residues at these target sites are thought to be a result of residues 
incorporated previously from the shuffle library.  
 
4.8 POcr Library: LibDg 
To ensure that acidic residues were incorporated at each target site to the same extent, those 
target sites that possessed a mutational frequency that was less than 5% in the library 1D+2D 
(figure 4.13) were assumed to be present on primers that did not successfully reassemble, to 
the POcr library. Therefore a third set of primers were designed for these designated 
positions (mainly by designing the reverse complement primer) and were incorporated into 






Primer Name Target Sites Primer Sequence 
N32-36_dg 32,33,36 GATGGCGTYGTGCAGGTYGTYGGTATCACG 
Q65-68_dg 65,67,68 CGGAGTYCTSGAACTSCAGGTCGATACC 
N88+93_dg 88,93 CACAGGTYGATAGTCAGCTGCTSGTAG 
N43D 43 GGGACTGCGTTGTCCGCGGC 
N52D 52 CTACGCGGACATCTTCAGCG 
Q21E 21 GCTGAAAGAGAACATTCGCTAC 
Table 4.2: The table displays the oligonucleotides that were used to target the residues 
underrepresented in Lib 1D and 2D. Those target sites with less than 5% mutation coverage 
have been represented in primers in this table. This included the addition of a number of 
single mutations. 
 
No attempt was made to increase the mutation rate of the target sites 100-117, for two 
reasons. Firstly, experiments have shown that the C-terminal domain appears to have no 
effect on the antirestriction activity of the Ocr protein. Secondly, and more importantly, the 
number of residues to target on the C-terminal tail led to the design of primers with large 
amounts of degeneracy (Table 4.1). The large degree of degeneracy led to a higher rate of 
mis-priming events during the reassembly PCR, resulting in the mixed DNA species found 
in the nested PCR products of Lib1D and Lib2D (Figure 4.10). Not only this, the 
introduction of largely degenerate primers appeared to correlate with an increased number of 
non-specific mutations/indels from the later libraries. As such, primers targeting residues in 
the C-terminal tail region of POcr were omitted from further rounds of the ISOR. Therefore, 
the primers shown in Table 4.2 were used to reassemble fragments of the library 1D+2D in 
order to generate another library, LibDg. As before, 15 colonies were isolated from the 








Figure 4.53: The graph compares the average number of mutations per gene, calculated 
from isolates sequenced from each of the libraries. 
 
A closer analysis of the average number of acidic residues introduced from the 15 POcr 
mutants sequenced from library LibDg were compared to the average from the libraries 
1D+2D and the Shuffle library. The average number of acidic residues introduced into POcr 
mutants from LibDg is 12, with a range of 8-17 acidic residues per gene. This is a slight 
increase of 3 mutations per gene, from the previous 1D +2D library.  
From the graph below (Figure 4.14) it can be seen that the POcr mutants isolated from the 
library LibDg possess acidic residues at each of the target sites. The only exceptions are 
observed for the target sites, at the C-terminal, 100-117. Omitting these positions and 
assuming that the control parameters enforced in the design of each of the primers provides 
equal representation, it is assumed that each of the target sites have been exposed to 























































Figure 4.14: Comparison of the mutation coverage, the % of mutants that had acidic 
residues present at each of the target sites. From the libraries LibDg (green), Lib1D and 2D 




The estimated diversity of library LibDg can be calculated from the sum of the binomial 
coefficient for the range of acidic residues introduced. For instance, for LibDg the range of 
mutations introduced is ~8-16 acidic residues from a total of 34. Even if the target sites from 
the C-terminal region of POcr were omitted as they were not targeted in the later libraries 
estimations suggest that potentially 7.8 million POcr mutants are present in LibDg. This 
number is incredibly large and reflects the need for robust screening techniques.  
 
4.9 Discussion 
In summary, a series of nine libraries have been developed that slowly reintroduce codons 
that translate to acidic residues at specified sites on the POcr protein, slowly converting the 
POcr gene to the wtOcr gene. Table 4.3 shows that mutagenesis using ISOR has introduced 
an increasing number of acidic residues to POcr from an average of 3-13 acidic residues per 
gene. Furthermore, each library contains POcr mutants possessing a range of acidic residues 
producing diverse libraries with large numbers of unique POcr mutants.  
Libraries   
Average number of 
mutations per gene 
 
 








Lib1 3-9 5 10 1 
Lib2 0-7 4 10 1 
Lib3 2-6 3 10 1 
Lib4 5-8 6 10 0 
Shuffle 2-8 5 15 4 
1D 7-14 12 15 1 
2D 2-14 13 10 1 
1D and 2D 6-14 9 15 4 
Lib Dg 8-16 12 15 5 
Table 4.3: A table of the libraries resulting from multiple rounds of the ISOR library, the table 
summarises the vital statistics from each of the libraries, Their diversity, the average number 
of mutation per gene, the number of sequences with random point mutations /anomalous 
sequences and finally the number of sequences that were sequenced from each library. 
In the following chapters the libraries will be used to carry out two different screening 
procedures.  
In Chapter 5, the newly developed 2AP assay from chapter 3 will be used as a selection 
method to screen one million POcr mutants from the LibDg library. POcr mutants that 
exhibit a high level of 2AP resistance and therefore exhibit antirestriction properties similar 
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to the wtOcr protein will be isolated, examined in vivo and in vitro and the minimum number 
of acidic residues that allows the POcr protein to function like wtOcr will be ascertained.   
The second screening method is a large scale screen of 100 POcr mutants that were selected 
at random from each of the nine POcr libraries produced in this chapter. The Table 4.3 
shows that each library contains POcr mutants that exhibit a wide range of pI values. By 
screening 100 POcr proteins at random the charge-function relationship can be further 
understood. These POcr mutants were characterised using the 2AP titration assay developed 
in chapter 3 and possessed variable antirestriction activities and surprising phenotypes.  
In summary the production of the POcr libraries successfully reintroduced the acidic residues 
of wtOcr onto the POcr gene. The gradual reintroduction has resulted in the generation of 
nine POcr libraries that can be used to select for antirestriction properties. The development 
of  libraries that have incrementally decreased the pI value of POcr allows the investigation 
of not only the functional advantages of the acidic residues on Ocr but also to investigate the 
role of these residues towards the general fitness of the protein, therefore how charge might 















Chapter 5. Maximum activity with minimal 
charge 
5.1 Introduction 
In chapter 4 a series of libraries were successfully produced. Using a template of the positive 
Ocr protein POcr, acidic residues were reintroduced onto the surface of the protein to 
gradually convert the positive POcr protein into the wtOcr DNA mimic. This chapter 
describes how the restriction alleviation assay developed in chapter 3 was used as a selective 
screen to isolate POcr multimutants, from the POcr library LibDg that exhibited 
antirestriction properties comparable to wtOcr. Library screening for 2AP resistance gives us 
the means to not only highlight the relative importance of each acidic residue towards the 
function of the wtOcr protein but also discern the minimum number of acidic residues for 
antirestriction activity.  
 
5.2 Aims 
a) The largest library, Lib Dg, was screened to select for 2AP resistance of ≥80µg/ml. 
Initial hits from the library screen were further verified using phage antirestriction 
and antimethylation assays to identify whether these mutants induce the same 
antirestriction and antimethylation activity as wtOcr. POcr mutants that display 
activity that is equal to that of the wild type protein were sequenced to discern any 
commonality and to identify key acidic residues important in the interaction and 
activity of the wtOcr protein.  
b) To ensure that the POcr mutants selected from the 2AP screen contain the absolute 
minimum number of acidic residues for activity, a further three libraries were 
generated from the active POcr mutant M2.1. These libraries targeted the enriched 
number of acidic resides that reside on each of the loop regions. The aim was to 
decipher whether the acidic residues that are present on each loop region can 
interchange whilst maintaining full antirestriction activity and whether the acidic 
residues that are conserved among all four active mutants are essential for the 






5.3 Selective screening 
To select for antirestriction activity with the 2AP assay E. coli NM1041 cells, transformed 
with the POcr library, were spread onto LB-Agar plates supplemented with carbenicillin, 
kanamycin and 2AP at a concentration of 80µg/ml. In order to carry out a plate screen, it is 
important to ensure that the number of library variants per plate is not excessive compared to 
the concentration of 2AP. If there is an over abundance of cells the 2AP will not be effective, 
allowing cells to survive and generating a large number of negative results. To avoid this, 
previous investigations by Dr. Angela Dawson showed that 80µg/ml of 2AP would be 
effective on two thousand colonies per LB-agar plate (15cm diameter petri dish). It has been 
shown from previous studies that the maximum number of cells that can be plated is ten 
thousand per plate in order to allow for; (i) sufficient area for each colony and (ii) full 
representation of the library. This value of 2000 colonies per plate considers the number of 
transformed and non-transformed cells which can sequester the 2AP, as well as the number 
of colonies that can be efficiently plated. To be able to control the number of colonies plated 
onto each plate the transformation frequency of the E. coli NM1041 cells with the library 
LibDg was determined by plating out viable counts of the transformant mix. 
The transformation frequency was determined by plating viable counts of E. coli NM1041 
cells transformed with 1µl of the plasmid library, at concentrations of 0.99ng/µl, 3.97ng/µl 
and 39.7ng/µl. The transformant mix for each concentration was plated out onto two LB-
agar plates supplemented with the appropriate antibiotics (Km and Carb) with a volume of 
100µl and 10µl each. The plates were incubated at 37°C overnight and the number of 














(per µg of DNA) 
0.99 100 21 2.12×105 
0.99 10 1 1.01×104 
3.97 100 100 2.52×105 
3.97 10 10 2.52×104 
39.7 100 267 6.73×104 
39.7 10 37 9.32×103 
Table 5.1: The number of colonies observed by transforming E. coli NM1041 cells with 




Table 5.1 shows that the transformation frequency of E. coli NM1041 cells is very low 
compared to cloning strains such as DH5 alpha. The parent strain for NM1041 is the 
bacterial strain MG1655, which is also not readily transformed. The cells were made 
chemically competent using CaCl2 because NM1041 cells have proved difficult to handle 
with electroporation techniques (unpublished work by Dr Angela Dawson). The table also 
shows that a similar transformation frequency was observed with 1ng or 3ng of DNA (2×105 
transformants/ per µg of plasmid DNA).  
Therefore, to obtain enough DNA to represent at least 1 million mutants of the library, 
approximately 6.132µg of the plasmid DNA from LibDg needed to be screened. Therefore if 
1ml of transformant mix which uses ~1ng of plasmid DNA produces a total of 210 colonies 
then 94ng is needed to plate ~20,000 colonies per 1ml which would mean that a total of 
20,000 variants of the library would be screened per transformation, this would use 10 LB 
agar plates supplemented with antibiotics and 2AP at a concentration of 80µg/ml. This 
results in ~2000 colonies per plate using 100µl of the transformant mix. Therefore to screen 
1million POcr mutants from LibDg, a total of 64 transformations need to be performed and 
so 640 plates need to be poured for the full screen. 
The screening process was carried out in three batches. Each batch screened 20 
transformations each, which is a total of 400,000 variants of the library. Upon 
transformation, the plates are incubated for three days. Initially, the transformations are 
incubated overnight at 37°C however the plates are then left on the bench for a total of 2-3 
days and the number of colonies that emerge with each day was recorded.  
Batch Number 1 2 3 
Day1 9 5 10 
Day2 13 14 12 
Day3 30 10 33 
Day4 21   
Total  73 29 55 
Table 5.2: The number of colonies that were produced after three days of incubation for the 
plates that were screened in batch 1 to 3. Each batch screened 400000 mutants of the 
library with 200 LB-agar plates with 2AP (80µg/ml).  
 
Each of the three screens that were carried out for LibDg produced 2APR colonies. The 
colonies that were produced were streaked onto fresh LB-agar plates supplemented with and 
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without 2AP for a second screening process; this ensured that 2APR is due to the POcr 
mutant expressed.  
 
Figure 5.1: A selection of the colonies that were 2APR for batch 1. Colonies that were 2APR from the 
initial screen were re-streaked onto a control plate supplemented with antibiotics only and a plate with 
2AP 80µg/ml). Both plates were used to compare the growth of the cells, if cells were truly resistant 
then homogenous growth would be apparent on both plates. For ease of comparison the colonies were 
streaked in corresponding positions on the two plates. 
 
POcr mutants that retained their 2APR grew colonies on both the control plate and the 2AP 
enriched plate (Figure 5.1, red squares). However many of the initial hits from the screen did 
not retain their resistance and so did not grow in the presence of 2AP (Figure 5.1, black 
squares). For those colonies that did appear to retain their resistance to 2AP, the plasmid 
DNA of the POcr mutant expressed was isolated. These plasmids were retransformed onto 
2AP-enriched plates as a triple assurance of their resistant properties. 
A total of 73 library mutants were retransformed with E. coli NM1041 cells and examined 
for 2APR by comparing the viable counts of the mutants in the presence and absence of 2AP. 
From this only seven out of the 73 mutants that were retransformed appeared to maintain 
2AP resistance. Two of these mutants seemed to be partially active displaying a reduced cell 
count upon 2AP exposure (Figure 5.2, M2.8 and M1.1).  Plasmid DNA from each of the 





Figure 5.2: Viable cell counts on plates with and without 2AP for mutants screened from the 
Lib Dg plasmid library of Ocr mutants, which retained 2AP resistance upon retransformation. 
The viable cell counts show that five out of the seven selected clones retained the total cell 
count. Mutant clones M1.1 and M2.8 showed reduced cell count. Below: protein sequence of 
each mutant translated from the corresponding DNA chromatographs. Each mutant is 
compared to wtOcr. 
 
The viable cell count is much reduced for the POcr mutants M1.1 and M2.8, when exposed 
to 2AP compared to the other mutants. Therefore, because the resistance of these two 
mutants to 2AP is reduced in comparison to the other five mutants, one might expect these 
mutants to display reduced antirestriction activity relative to the other mutants and wtOcr. 
Thus, the library seems to have selected for partially active and fully active mutants.  
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5.4 Active POcr mutants 
The protein sequences of the seven POcr mutants isolated from LibDg possessed between 
13-15 acidic residues. Even though the number of acidic residues has been reduced by ~60%, 
from wtOcr, these POcr proteins retain an activity that is almost/if not completely equivalent 
to the wtOcr protein. 
Interestingly, closer inspection of the isolated clones reveals that a number of the sequences 
that were isolated were in fact the same. Mutants M1.7 and M1.9 had the same gene 
sequence as did the mutants M1.4, M2.1 and M2.11. Therefore of the seven sequences that 
have been selected from the screen four of the protein sequences are unique. The acquisition 
of repeated sequences is however encouraging because it strongly suggests that the particular 
array of acidic residues on these POcr proteins are important in producing antirestriction 
activity. 
5.4.1 Phage infection assays 
To be sure that the 2AP resistance exhibited by the selected POcr proteins is a result of their 
antirestriction properties, the proteins were examined using phage infection assays which are 
designed to measure antirestriction and antimethylation activity. These phage assays are 
similar to those that have been performed previously in chapter 3 for the Ocr multimutants. 
Restriction proficient and restriction deficient cells are transformed and then unmodified 
phage lambda, λv.o., is used to infect the cells. The phage titre was calculated upon overnight 
incubation of the cells at 37°C. If a reduction in the phage titre was demonstrated in 
restriction proficient cells, then the presence of the POcr mutant did not alleviate the 
restriction enzyme. As previously mentioned this assay does rely on leaky expression but if 
the mutants exhibit a 2AP resistance that is equal to 80µg/ml, then these mutants should still 




   wtOcr  pTrc  M2.8  M2.1  M1.1  M1.9 
NM1049  1.10×109  1.00×104  2.00×108  2.00×108  3.00×108  4.00×108 
NM1261  3.00×108  2.00×108  1.00×108  1.00×108  1.00×108  4.00×108 
eop of phage λ  4  0.00005  2  2  3  1 
Antirestriction  73333  1  40000  40000  60000  20000 
Figure 5.3: The phage titre of the in vivo phage infection restriction assay. Restriction 
proficient (NM1049) and restriction deficient (NM1261) E. coli cells were infected with 
unmodified phage lambda. The number of plaques per ml were calculated from viable plaque 
counts for each bacterial strain and displayed in the graph above. Below: A table which 
compares the phage titre and the efficiency of plating of the phage (eop) in the presence of 
each of the mutants compared to wtOcr and pTrc99A. The antirestriction value is a ratio of 
the eop in the presence of the mutant/protein compared to the absence of any protein.  
Comparisons of the phage titre show that each of the POcr proteins demonstrates full 
antirestriction activity. There is no difference between the number of plaques present on 
restriction proficient and deficient cells in the presence of wtOcr and each of the mutants. By 
contrast, the phage titre is much reduced for restriction proficient cells harboring the empty 
pTrc99A vector. Therefore each of the POcr proteins successfully inhibits the restriction 
activity of the EcoKI enzyme. The ratio between the phage titre of restriction proficient and 
deficient cells is known as the eop (efficiency of plating) of phage. and is used to calculate a 
value for antirestriction. The two mutants that demonstrated reduced activity in the 2AP 
assay, M2.8 and M1.1 appear to possess the same antirestriction activity as the other POcr 
proteins from the phage in vivo assay. However, this reduction in activity could be a result of 
reduced antimodification behavior, as witnessed for a number of the Ocr multimutants in 
chapter 3. Therefore the phage plaques that successfully infected restriction proficient cells 
in the restriction phage assay above can be used to investigate the antimodification activity 
of each of the mutants. 
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The unmodified phage that had successfully infected cells, transformed with each of the 
POcr mutants, in the antirestriction assay, can be extracted and used to infect restriction-
proficient and deficient cells. If a POcr mutant inhibits the activity of M.EcoKI in the initial 
infection, then the phage DNA would have remained unmodified, and upon infection of 
restriction proficient cells the phage will be recognised by the restriction enzymes as foreign 
DNA and destroyed. If the mutants did not inhibit the M.EcoKI enzyme during the initial 
infection, then the phage is methylated. Upon a secondary infection of this phage into 
restriction proficient cells, the restriction enzyme will not differentiate between its own DNA 
and the phage, as both are modified. Thus, the phage will be immune to restriction, allowing 
successful phage infection and producing a large phage titre. 
   wtOcr  pTrc  M2.8  M2.1  M1.1  M1.9 
NM1049  1.40×104  1.00×108 9.00×103 8.00×103 1.40×104  5.00×103
NM1261  3.00×108  3.00×108 1.00×108 1.40×108 2.00×108  9.00×107
eop of phage λ  21429  3  11111  17500  14286  18000 
Antimodification  7143  1  3704  5833  4762  6000 
TTable 5.3: The calculated values for the phage titre, eop of antimodification activity of the 
mutants selected from the Library LibDg compared to the antimodification activity of the 
wtOcr protein and the empty vector pTrc99A. 
 
The phage titre showed a large difference when infecting bacterial cells in the presence and 
absence of the HsdR subunit. This indicates that the phage has remained unmodified from 
the initial infection; therefore the POcr mutants have successfully inhibited the M.EcoKI 
enzyme. This is in contrast to the phage titre retrieved from cells in the presence of the 
empty pTrc99A vector. Furthermore the POcr proteins M2.8 and M1.1 both exhibit 
antimodification activity comparable to wtOcr and the other POcr proteins, which suggests 
that all four of these mutants inhibit the methylase successfully. 
 
5.5 Minimum charge for maximum activity 
The phage assays have verified that the four unique POcr mutants isolated from LibDg all 
induce the same antirestriction and antimodification activity as the wild type protein, even 
though the number of acidic residues present on these mutants is considerably lower 
compared to wtOcr.  
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To identify any commonality between the POcr mutants, their protein sequences were 
aligned in Figure 5.4 below. Each of the POcr mutants has a similar number of acidic 
residues ranging from 13-15 acidic residues. In addition eight acidic residues were 
conserved; E21, D30, D43, D52, E60, D68, D77 and E88. In chapter 3 the analysis of the 
multimutants showed that the presence of acidic residues at the two loop regions appeared to 
be particularly important for antirestriction activity, However this accounts for only three of 
the conserved residues, D30, E60 and D68, on the four POcr mutants, whereas most of the 
conserved residues are located at sites just outside the loop regions, suggesting that these 
residues may be more important than the supposed loop regions.  
 
Figure 5.4: Sequence alignment for each of the Ocr mutants. Each of the 34 target sites 
were either highlighted in red or yellow, red if the residue was acidic and yellow if the residue 
was the neutral amino acid analogue. The acidic residues have also been highlighted in red 
on the wtOcr protein, of which all have been targeted on POcr proteins, from the library 
LibDg.  
 
The residues that were found to be common among all of the proteins accounts for about 
60% of the acidic residues. Although the other 40% of residues are not common throughout 
the sequence of each mutant, they could be located in regions that are similar in each mutant. 
A number of these regions comprise of clusters of acidic residues. As a result it is possible 
that the representation of 1 or 2 acidic residues from each of these clusters may contribute to 
the activity of the protein, rather than individual residues. 
 
5.6 Further analysis of M2.1 mutant. 
Table 5.4 outlines the residues that were targeted on M2.1, highlighting whether these 
residues are already acidic on the mutant M2.1 and if these acidic residues are conserved 









Conserved on active 
mutants 
% Mutated in 
Lib Dg 
D26N I N N 40 
D27N I Y N 70 
D30N I Y Y 80 
D32N I N N 50 
D33N I N N 40 
D36N I N N 30 
E60Q II Y Y 45 
D63N II Y N 45 
E65Q II Y N 10 
E67Q II Y N 20 
D68N II Y Y 10 
E21Q III Y Y 80 
D43N III Y Y 50 
D52N III Y Y 65 
D74N III Y N 60 
D77N III Y Y 65 
Table 5.4: A table which highlights which mutants will be targeted in each group and 
therefore each of the three libraries produced. Comparisons have been made to 
demonstrate the conserved residues from all four active mutants and those acidic residues 
present on the mutant M2.1. In addition the percentage coverage of acidic residues at each 
of the positions from a sample population of the library Lib Dg has been recorded.  
 
The table shows that the acidic residues that belong to group3 are almost all conserved on 
the four POcr proteins and are present in the POcr library LibDg in high abundance. The 
residues that belong to group 1 and group 2 are located in the loop1 and loop2 regions of 
wtOcr. Results in chapter 3 highlighted that acidic residues belonging to these loop regions 
are likely important to the activity of the Ocr. However, only three out of the ten acidic 
residues that dominate these regions are conserved on the active POcr proteins. Closer 
inspection of the sequences above implied that both loop regions are highly represented in 
each of the POcr proteins, however the acidic residues present differed with each protein. 
To determine whether; i) the acidic residues present on the loop regions of the POcr protein 
M2.1 are interchangeable with no effect on activity, ii) M2.1 contains the minimum number 
of acidic residues to induce wild type antirestriction activity and iii) the conserved residues 
highlighted on each of the POcr proteins are essential towards the activity of the POcr 
protein M2.1, three small combinatorial libraries were generated that targeted acidic residues 
on the POcr mutant M2.1 and substituted them with neutral amino acid species. If the 
activity diminished or reduced with the absence of any acidic residues that were otherwise 
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present on M2.1, then it would show that all the acidic residues present on the sequence of 
M2.1 are essential for its activity.    
The multisite mutagenesis kit from Stratagene was used to generate the libraries. A 
degenerate primer was designed for targeting each of the loop regions as the residues are all 
in close proximity to each other, whereas a series of primers were designed to target those 
sites highlighted in group III which are scattered throughout the sequence of the M2.1 gene 
sequence. 
 
Figure 5.5: Above is the DNA sequence of the mutant M2.1, highlighted in green, pink and 
blue are the target sites for each of the three libraries. The remaining codons that are 
highlighted in yellow signify other acidic residues on the sequence of M2.1 which will remain 
untouched. Below the primers designed to mutate the groups belonging to each of the target 
sites. 
 
The multisite kit contains three steps, the PCR round anneals the specifically designed 
primers to the template DNA (M2.1) and generates dsDNA, then DpnI nuclease is used to 
digest the parental DNA template. Super competent cells are transformed with the DNA 
mixture producing a library of mutants from either the use of a degenerate primer for groups 
1 and 2 or a multitude of primers in group 3. As a result three libraries were generated.  
Instead of isolating individual samples from the library, which is very laborious, costly and 
could throw back many isolates of the original M2.1 template, the successful incorporation 
of each primer was assessed by sequencing an aliquot of the plasmid library mixture. The 
















and post multisite mutagenesis, with the exception of the target sites where the signal would 
be noisy on account of a mixture of codons which correspond to D /N or Q/E accordingly. 
This was made easier because each pair of residues shared similar DNA codons that differ 
only by one basepair. If the library has a mixture of the two residues then the two different 
base pairs should show up as a mixture on the DNA electropherogram at specific target sites, 
with predictable noisy signals. Although not definitive this method can provide a quick 




Table 5.5: The DNA codons that translate to the acidic and neutral amino acids D/E and N/Q 
residues, involved in the mutagenesis. The codons show that there is only one bp change 
between the acidic and neutral amino acid. 
5.6.1 Library 1: group 1-loop1 
To target each of the residues that are found in Group 1 (aa26-36) which includes the target 
sites that are located on the Loop 1 region, a degenerate primer was introduced to POcr 
M2.1, by multisite mutagenesis. The resulting library that was formed was sequenced in 
figure 5.6 below, which compares the DNA electropherogram from an aliquot of the newly 












Glu/D GAA Gln/N CAA 
 GAG  CAG 
Asp/E GAT Asn/Q AAT 
 GAC  AAC 
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Figure 5.6: Electropherograms showing mutations introduced into the DNA 
sequence of mutant M2.1, by a degenerate primer. The original template sequence 
of M2.1 is shown above. Whereas the electropherogram underneath is the aliquot 
from the generated library. The sites of mutagenesis are labeled and the specific 
basepairs involved in the mutagenesis are indicated by green boxes. 
 
The incorporation of the primer was successful, the codons that translate to each of the target 
sites are captalised and labeled accordingly. The individual nucleotides that changed the 
codon from D/N or E/Q are underlined in Figure 5.6. The signal for each basepair is clearly 
reduced and in its place a mixture of two signals for two different basepairs is present on the 
sequence of the DNA electropherogram. The intensity of the signals for either basepair 
appears to be near equal for positions 32, 33 and 36 given the equal intensity exhibited by 
each of the basepairs concerned. However the intensity of one basepair appears to dominate 
for residues 26, 27, and 30, nevertheless an almost equal distribution is assumed because the 
mutations were introduced using a degenerate primer with equimolar concentrations. 
To see if the mutations on loop 1 affect the antirestriction activity of the mutants the library 
was screened using the 2AP assay developed in chapter 3. The screening process was similar 
to the screening process carried out for the library LibDg but on a much smaller scale. In this 
case 6 target sites were designed and one of two residues could be present on each site giving 
a total number of 26, therefore 64 possible sequences.  
E. coli NM1041 cells were transformed with the plasmid DNA from group 1 and library 
mutants were selected from LB agar plates supplemented with 80µg/ml of 2AP. A plasmid 
preparation was carried out to extract the remaining library that exhibited 2AP resistance, an 
aliquot was set aside for sequencing and the process was repeated for a second round of 




identify if there were any changes to the number of the acidic residues that are required to 
induce the antirestriction activity of M2.1. 
 
Figure 5.7: Electropherograms showing the ratio of basepairs which correspond to a change 
in the amino acid residue translate, therefore a ratio of acidic: neutral amino acids upon 
section of 2APR. The sequence of the colonies that were selected from the first round of 
screening is shown above and the sequence for the second round of screening is shown 
below. The sites of interest are labelled and the specific basepairs involved in translating 
either an acidic or neutral amino acid at this position are indicated by green boxes. 
Comparison of these electropherograms indicates that none of the target sites have 
maintained mixtures of both the bp indicating the loss of one residue upon selection. 
 
By sequencing each round of the screening process, the sequences above in Figure 5.7 
represent the remainder of the library that appears to be resistant to 2AP and consists of 
M2.1 mutants which retain the antirestriction activity of M2.1 template.   
The sequences show that no change is exhibited for the residues 32, 33 and 36; at each target 
site mixtures of two bps are present at near equal intensity therefore these mutants contain 
both acidic and neutral amino acid residues at each of these positions. This implies that these 
acidic residues are not essential in any of these three positions. On the other hand the target 
sites 27 and 30 are dominated by a high intensity peak of the basepair guanine which 
translates to the acidic residue D. This suggests that the acidic residues in these two 
positions; 27 and 30 are absolutely necessary for M2.1 to function as an active antirestriction 
protein, whereas the absence or presence of acidic residues at the positions 32, 33 and 36 can 
be either acidic or neutral. Notable is the slight peak signaling the basepair adenine for the 
equivalent neutral amino acid at position D27N, comparisons of all the electropherograms 
identifies the presence of a small signal of the opposing basepair; however it is hard to 
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distinguish whether this is an artifact or the emission of a real fluorescent signal. This could 
only be confirmed from extensive sequencing of the library. 
5.6.2 Library 2: group 2-loop2 
The entire loop2 region was mutated to acidic amino acids in the POcr mutant M2.1. Due to 
the close proximity of these target sites, a degenerate primer was designed to introduce 
neutral residues onto M2.1.  
 
Figure 5.8: Electropherograms showing mutations introduced into the DNA sequence of 
mutant M2.1, by a degenerate primer. The original template sequence of M2.1 is shown 
above. Whereas the electropherogram underneath is the aliquot from the generated library. 
The sites of mutagenesis are labelled and the specific base pairs involved in the 
mutagenesis are indicated by pink boxes. 
 
The DNA sequence of the resulting library was compared to the original M2.1 template in 
figure 5.8. Each of the target sites were originally acidic residues however, mixtures of two 
basepair signals were clearly displayed for the codons targeting the residues E63, E65 and 
D68. Although the signals expressed for the target sites E60 and D67 were dominated by the 
parental codon each of the target sites were present on a single degenerate primer, therefore 
all of the target sites were assumed to be successfully targeted.  
Library 2 targets 5 sites with the possibility of two different residues and so there is the 
possibility of 32 different samples and therefore over 320 sequences were screened for 2AP 
resistance. The colonies from the screen were collated and rescreened as previously seen 
with library 1. The plasmid DNA from the collated colonies of screen 1 and 2 were extracted 
and sequenced, to identify whether some acidic residues were more selectively advantageous 




Figure 5.9: Electropherograms showing the ratio of base pairs which correspond to a change 
in the amino acid residue translate, therefore a ratio of acidic: neutral amino acids upon 
section of 2APR. The sequence of the colonies that were selected from the first round of 
screening is shown above and the sequence for the second round of screening is shown 
below. The sites of interest are labelled and the specific base pairs involved in translating 
either a acidic or neutral bp at this position are indicated by pink boxes. Comparison of these 
electropherograms indicates that none of the target sites have maintained mixtures of both 
the bp indicating the loss of one residue upon selection. 
 
The analysis of the sequences seems to suggest that all of the acidic residues that were 
present on the mutant M2.1 are essential for antirestriction activity. However, a closer look 
at the sequence from the second screen does show a small signal for the opposing adenine 
basepair for the residues D67 and possibly E60. The sequence of library 2 does appear to 
have varied signals for each basepair but the mutagenesis was carried out with a degenerate 
primer. This makes it hard to decide whether residues such as D67 are in fact present as a 
mixture of D67 and N67. The high intensity peaks exhibited for each of the codons that 
translate the acidic amino acid residues at each of these positions seems to dominate, 
therefore the mutant M2.1 seems to require all of the acidic residues in Loop 2 to function as 
a fully active antirestriction protein. 
5.6.3 Library 3: multiple target library 
The target sites for this library are present across the whole DNA/protein sequence of the 
mutant M2.1; therefore the use of one degenerate primer would not be adequate. The 
residues that were targeted included E21, D43, D52, D74 and D77, these residues reside on 
helices A, B, and C, and on loop2 of the Ocr crystal structure. Therefore to produce this 
library separate oligonucleotides were designed for each target site except for the residues 
D74 and D77, where a primer with a double mutant was designed. The residues that were 
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targeted for mutagenesis in this library were acidic residues that were conserved in all four of 
the active mutants selected from Lib Dg.  
Figure 5.10: Electropherograms showing mutations introduced into the DNA 
seqyuence of mutant M2.1, by a number of oligonucleotides. The original template 
sequence of M2.1 is shown above. Whereas the electropherogram underneath is 
the aliquot from the generated library. The sites of mutagenesis are labelled and the 
specific base pairs involved in the mutagenesis are indicated by blue boxes. 
 
The results showed that only two of the target sites obtained mixtures of both acidic and 
neutral codons. The target sites E21Q and D52N have in fact been superseded by a larger 
proportion of neutral residues when compared to the original codon. Mixtures of acidic and 
neutral amino acid residues were not successfully introduced to the target sites D43N, D74N 
and D77N. Although there is the possibility of a signal for D43N, the mutagenesis appeared 
to be unsuccessful for D74N and D77N. Nevertheless the screening process was carried out 





Figure 5.11: Electropherograms showing the ratio of base pairs which correspond to a 
change in the amino acid residue translate, therefore a ratio of acidic: neutral amino acids 
upon section of 2APR. The sequence of the colonies that were selected from the first round 
of screening is shown above and the sequence for the second round of screening is shown 
below. The sites of interest are labelled and the specific base pairs involved in translating 
either an acidic or neutral bp at this position are indicated by pink boxes. Comparison of 
these electropherograms indicates that not of the target sites have maintained mixtures of 
both the bp indicating the loss of one residue upon selection. 
 
The sequence from the first screen is much noisier than the sequence from the second screen. 
However both clearly show that only codons that translate acidic amino acids are present 
upon selection of 2AP resistance. This confirms that the each of these residues is essential to 
the activity of mutant M2.1.  
In summary, it appears that all of the acidic residues that are present on the mutant M2.1 
appear to be essential to the antirestriction activity of that POcr mutant. This confirms that 
for POcr M2.1, the minimum number of acidic amino acid residues needed to retain full 
antirestriction activity has been obtained. Furthermore, if this is the case for all four active 
mutants then the minimum number of acidic residues that are essential for antirestriction 




The largest library, LibDg, was screened using a plate-based assay which selects for 2APR at 
a concentration of 80µg/ml. LibDg was initially screened not only because it contained the 
greatest mutation rate of all the libraries but it also successfully targeted each of the mutation 
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1 400000 73 
38 
 
7 2 400000 29 
3 400000 55 35 0 
Total 1200000 157 73 7 
Table 5.6: A table that shows the screening process of each of the mutants, the number of 
mutants that were screened from each batch, those that were initially screened with 2APR, 
those mutants that grew once plated onto fresh 2AP exposed LB-agar plates and the 
number of these that successfully retransformed with 2APR in the same E. coli NM1041 cells. 
 
The screening was carried out in three batches. In total, 106 clones were screened. Each 
screen produced a large number of initial hits from the library. However, upon replating the 
number of positive hits was much reduced as many of the colonies did not grow on fresh 
2AP plates. A rather liberal estimate of homogeneous cell growth was considered and carried 
forward for retransformation. This panning process resulted in a total of 7 mutants that 
maintained 2APR. From these seven clones, four unique sequences were found.  
5.7.2 Active POcr mutants 
Four unique sequences were selected from the library LibDg and two of these mutants, M2.1 
and M1.9, displayed a resistance to 2AP that exceeded 80µg/ml. Like the Ocr protein both of 
these mutants displayed a high degree of antirestriction and antimodification activity upon 
phage infection comparable to wtOcr. On the other hand, the POcr mutants M2.8 and M1.1 
were also selected from the library exhibiting a slightly reduced resistance. However, these 
two POcr proteins also exhibited high levels of antirestriction and antimodification activity 
upon phage DNA again comparable to the activity of wtOcr. Each of the sequences 
contained 13-15 acidic residues of which seven are conserved. This results in a loss of 60% 
of the acidic residues that are present on wtOcr. This suggests that ~40% of the acidic 
residues on the protein wtOcr are nonessential for the activity of the protein in vivo.  The 
seven conserved residues are distributed throughout the whole of the POcr sequence and 
correspond to acidic residues that are located across the surface of Ocr. Most notably only 3 
of the conserved residues D30, D60 and D68 are present in either of the two loop regions 
that were deemed important in chapter 3. The alignment of the active POcr proteins below is 
complemented with a table that shows the number of acidic residues that were introduced to 
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each POcr mutant and their location on the sequence and the structure of the protein. The 
actual number of acidic residues has been recorded as well as the percentage number of 
acidic residues, to gauge the distribution of the acidic residues across the structure of Ocr. 
 
wtOcr MAMSNMTYNNVFDHAYEMLKENIRYDDIRDTDDLHDAIHMAADNAVPHYYADIFSVMASE       
M2.1 MAMSNMTYNNVFNHAYQMLKENIRYNDIRDTNNLHNAIHMAADNAVPHYYADIFSVMASE       
M1.1 MAMSNMTYNNVFNHAYQMLKENIRYDNIRDTNDLHDAIHMAADNAVPHYYADIFSVMASE   
M1.9 MAMSNMTYNNVFNHAYQMLKENIRYNDIRDTDDLHNAIHMAADNAVPHYYADIFSVMASE         
M2.8 MAMSNMTYNNVFNHAYQMLKENIRYDDIRDTDDLHDAIHMAADNAVPHYYADIFSVMASE       
************:***:********::****::**:************************ 
wtOcr GIDLEFEDSGLMPDTKDVIRILQARIYEQLTIDLWEDAEDLLNEYLEEVEEYEEDEE   
M2.1 GIDLEFEDSGLMPDTKDVIRILQARIYEQLTIDLWENAQNLLNQYLQQVQEYQQNQQ   
M1.1 GIDLQFEDSGLMPNTKDVIRILQARIYEQLTIDLWQDAQNLLNQYLQQVQEYQQNQQ   
M1.9 GINLQFQDSGLMPDTKDVIRILQARIYEQLTIDLWQNAQNLLNQYLQQVQQYQENQQ   







Helix A  
(3) 
Helix B  
(2) 













14 1 33% 1 50% 1 100% 3 43% 
2 40% 7 100% 0
0% 
M1.1 
15 1 33% 2 100% 1 100% 3 43% 3 60% 5 71% 1 11% 
M1.9 
13 1 33% 1 50% 1 100% 2 29% 4 80% 4 57% 1 11% 
M2.8 
15 1 33% 2 100% 1 100% 2 29% 5 100% 5 71% 1 11% 
Table 5.7: Above is an alignment of the sequences for each of the active POcr mutants that 
demonstrate wtOcr functionality. Comparisons in the number and position of acidic residues 
(highlighted in red) on each POcr protein were compared to each other and to wtOcr. The 
four different domains present on the Ocr monomer were highlighted in colour on the wtOcr 
protein sequence. Below the table looks at the distribution of acidic residues across each of 
the five domains on the Ocr monomer structure. In brackets is the possible number of acidic 
residues that could be targeted within each domain. 
 
The table 5.7 shows that on Helix A, the acidic residue E21 is conserved. In addition the 
acidic residue D52 located on Helix C is also conserved. Both acidic residues are located in 
areas of the protein isolated from the cluster regions and it suggests that these residues may 
provide a structural rather than a functional role.  
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However, the majority of acidic residues are located on Helix D, Loop1 and Loop2. At least 
57% of each loop region is represented in each of the mutants. Generally if poor 
representation is found in one of the loop regions, it is compensated by a high representation 
in the other loop region. These mutants appear to mutually compensate for any lack of acidic 
residues found in the other. So even though the number of conserved acidic residues found 
among the two loop regions is low, the overall representation of each loop is high and so 
there is a disproportionate number of acidic residues that have been reintroduced into the 
POcr scaffold in order to generate an active antirestriction protein.   
5.7.3 Comparisons between the active POcr mutants and Ocr homologues 
Alignment studies were carried out with a BLAST search of Ocr homologues found on other 
phage entities. The BLAST searched showed a similar pattern of acidic residues on each of 
the different proteins. There were eleven amino acids that were conserved completely on 
each of the proteins and an additional five residues that possessed conserved acidic residues 
(E or D). The specific residues these refer to are; E21, D26, D32, D33, D36, D65, D68, D77, 
E88, D93, E103 and E106 which are conserved and the following amino acids which display 
a negative charge are; D52, E60, E67, D74 and E108. A comparison with the conserved 
residues of the active POcr proteins selected from LibDg showed that the residues E21, D68, 
D77 and E88 were commonly conserved across the mutants and the Ocr proteins, suggesting 













Table 5.8: Residues that were commonly conserved on each of the Ocr proteins from the 
different phage entities and are also present on the selected mutants of the POcr library 
LibD.The last row highlights the total number/percentage of commonly conserved acidic 
residues found on each POcr mutant that are also conserved on Ocr proteins from different 
phage entities.  
 
 
Figure 5.12: The structure of Ocr from phage T7, highlighted in red are residues that are 
conserved on the Ocr homologues and the active POcr mutants, in magenta are residues 
that are acidic (either D or E) on Ocr protein and the active POcr proteins. Finally, in green 


















Total 77 58% 88 67% 77 58% 99 75%
Y N N Y
Y Y Y N
N N N N
Y Y Y Y
Y Y Y Y
Y N N N
Y Y Y Y
N Y Y Y
N Y N Y
N Y N Y
N N Y Y
M2.1 M1.1 M1.9 M2.8
Y Y Y Y
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5.7.4 Maximum activity with minimum charge 
The results from the mutagenesis of the mutant M2.1 showed that further mutation of M2.1 
to reduce the number of acidic residues knocked out any antirestriction or antimethylation 
activity that the mutant possessed. This seems to stress the importance of each acidic residue 
that is present on mutant M2.1. The only exception appears to be E21Q, the 
electropherogram shows that a small signal is present for the adenine base alongside the 
large signal of the Guanine base that encodes the acidic residue. The total number and 
position of the acidic residues on M2.1 appears to be finely balanced to provide 
antirestriction activity.  
In summary, the 2AP screening assay developed in chapter 3 was used to select for POcr 
mutants that display antirestriction properties from the plasmid POcr library, LibDg 
generated in chapter 4.  One million POcr mutants were screened from LibDg using 2AP and 
four unique mutants were isolated that possessed a high level of antirestriction and 
antimodification activity. Sequence alignment showed that there were a number of 
conserved residues among the four mutants. The targeting of these acidic residues on the 
mutant M2.1 showed that each one was important for its antirestriction activity; the 
substitution of even one of these residues could knockout the antirestriction activity of the 
mutant. As a result this also shows that each of the mutants are likely to exhibit the absolute 
minimum number of residues to allow for antirestriction activity and that the position of the 
residues and their combinations are equally important. 
Overall the conserved residues appear to be distributed across the whole of the POcr protein. 
The loop regions were previously deemed important for the interaction of Ocr with EcoKI in 
chapter 3. The results in this chapter highlight this, by selecting for POcr proteins with a 
large number of acidic residues within the loop regions, but these were not conserved.   
Alignment of the conserved residues with the phosphate backbone of dsDNA indicates that 
many of the conserved acidic residues overlap with the phosphate groups on DNA. However, 
there are a number of acidic residues that don’t overlap with the phosphate backbone and this 
suggests a different reason for their conservation, for instance these residues may be 
important for structure/stability. The sequences of the POcr proteins showed that the 
minimum number of acidic amino acids needed for POcr to be fully functional in vivo is a 
total of 13. This is a reduction of over 60% of the acidic residues that are present on the 
wtOcr protein. These findings indicate that many of the acidic residues of wtOcr appear to 
play no direct role in the activity of the protein. The reason why Ocr contains such an 
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overabundance of acidic residues that have apparently been conserved through the 
evolutionary process, is not immediately apparent.  
               
Figure 5.13: Alignment of conserved acidic residues on the Ocr homodimer with DNA 
phosphate backbone of dsDNA. Left: A cartoon representation of the Ocr homodimer, 
highlighted in red spheres are the acidic residues that are conserved across each of the four 
mutants. Middle: The structure of dsDNA as it binds to EcoKI, taken from the M.EcoKI model 
(2yc2) yellow spheres indicate phosphate groups on the structure. Right: Alignment of the 
Ocr homodimer and the dsDNA structures to align the conserved acidic residues with the 














The synthetic gene POcr encodes a protein that is a multiple mutant of the antirestriction 
protein wtOcr in which all the acidic residues have been substituted for neutral amino acids 
i.e., aspartic acid for asparagine and glutamic acid for glutamine. The POcr gene is not easily 
expressed in E. coli and the resulting protein possesses no antirestriction or antimodification 
activity. Therefore, in order to ascertain the number of acidic residues that are needed to 
produce a fully functional antirestriction protein, the POcr gene was used as a template to 
create a series of libraries, where acidic residues were slowly reintroduced onto the POcr 
gene.  
The largest library, LibDg, was screened using a 2AP assay to obtain POcr mutants that 
exhibited full antirestriction behavior. Out of the one million POcr mutants that were 
screened only four unique POcr proteins have been selected that regained full antirestriction 
and antimethylation properties. Sequencing results showed that the four active mutants 
possessed less than 60% of the acidic residues that reside on wtOcr. This suggests that over 
half of the acidic residues on wtOcr are redundant in its functionality as an antirestriction 
protein.  
Why does wtOcr have an excessive number of acidic residues that appear to impart no 
apparent selective advantage? Such a large number of acidic residues cannot be favorable to 
the stability of such a small protein.  
 
6.2 Aims 
The four active POcr proteins selected from the library LibDg were purified for a series of in 
vitro investigations to probe their structure, stability and functionality. These investigations 







6.3 Protein expression 
Before “large scale” protein expression was carried out, a small expression test in E. coli 
BL21 (DE3) cells (10ml of LB medium) was used to confirm the expression of soluble 
protein. The resulting SDS PAGE gel (figure 6.1) displays the soluble cell lysate generated 
after induction of protein expression with IPTG. 
 
Figure 6.1: An SDS-PAGE gel of the soluble extract of E. coli BL21 (DE3) cells which 
produce each of the mutants. The size marker is a sample of previously purified wtOcr 
protein (kind gift from Mr. Laurie Cooper). Except for M2.8, soluble protein that co-migrates 
with the wtOcr was detected for each of the mutants. 
 
SDS-PAGE analysis confirms, with the possible exception of M2.8, successful expression of 
each POcr protein in a soluble form.  
6.4 Protein purification 
The protein expression was repeated at a larger scale (~3L of LB medium) producing a cell 
pellet of 10-15g. The purification protocol consists of two steps; a DEAE 
(diethylaminoethyl)–Sepharose fast flow anion exchange column, followed by TCA 
precipitation of the protein solution to remove contaminating nucleic acids and other residual 
protein contaminants.  
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Initially, the cell pellets in ice cold buffer A (20mM Tris, 300mM NH4Cl, pH8) were 
lysed by sonication and the clarified cell-free extract was loaded onto a DEAE ion exchange 
column. The column was thoroughly washed with buffer A and bound proteins were 
subsequently eluted on a salt gradient (0.3-1.0M NH4Cl in buffer A). A typical UV 280nm 
transmission profile is shown below. The protein of interest was located by selecting 
fractions from across the elution profile to be analysed by SDS-PAGE gel electrophoresis. 
As anticipated, each of the mutant proteins eluted earlier in the salt gradient than wtOcr. 
 
Figure 6.2: Elution profile from a DEAE column with a salt gradient for the purification of Ocr. 
The 5 ml fraction numbers are indicated on the x-axis. The y-axis shows the transmission % 
at 280 nm of the eluate. 
 
Contaminating DNA was removed by treating the sample with trichloroacetic acid (TCA). 
The POcr proteins were successfully purified however the proteins failed to resuspend in 
buffer B (10mM Tris-HCl, pH8.0). The protein samples were subsquently dialysed with ~4 
L of buffer B for 16hrs at 4°C. This resuspended the proteins and removed any traces of 
TCA. The samples were subsequently concentrated and each POcr protein was stored at -























Figure 6.3: A UV A280 trace of the purified active mutants that were selected by the 2AP 
assay and wtOcr that were used for the preceding experiments. Each trace is a diluted 
solution of the protein.  
 
From unique protein sequences were successfully selected from the library LibDg therefore, 
the mutant proteins that were successfully purified were M2.1, M1.9, M1.1 and M2.8. 
 
6.5 Protein structure 
The secondary structure of each POcr protein was examined by crosslinking studies and 
circular dichroism (CD) analysis. 
6.5.1 Dimerisation of the mutant 
Crosslinking studies were carried out to investigate whether the active POcr proteins exist as 
a homodimer in solution, like wtOcr. The crosslinking agent used was glutaraldehyde, which 
is a commonly used homobifunctional reagent that reacts with the ε-amino groups of lysine 
residues. The reaction proceeds via a poorly stable Schiff base, which upon reduction with 
NaBH4 gives a hydrazone linkage. Hence, exposure of a protein to glutaraldehyde will cause 
covalent crosslinks between closely spaced lysines that can then be detected by SDS-PAGE 
analysis. The mutant proteins and wtOcr were exchanged into 10mM HEPES buffer (pH 7.0) 
because the Tris-HCl buffer used to store the proteins would quench the glutaraldehyde 
reaction. The reaction between each POcr protein (25µg in 25ml) and 1% glutaraldehyde 
was quenched with NaBH4 and the proteins concentrated by TCA precipitation (full protocol 
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in chapter 2). If the POcr proteins do exist as homodimers then analysis by an SDS-PAGE 
gel should show the existence of the homodimer, as well as the monomer for each of 
proteins. 
  
Figure 6.4: SDS PAGE gel of the glutaraldehyde cross linked products. There are two 
species present in each lane, corresponding to Ocr monomer at 13kDa and another species 
that appears to be approximately double the size i.e. just above 26kDa. 
 
The SDS-PAGE gel in figure 6.4, shows that each of the mutants exist as two species, the 
first and most distinct band is between 10-15kDa and is indicative of the Ocr monomer 
protein. This is confirmed by the size marker, which is a sample of the Ocr monomer. 
However a second species exists that appears to be double the monomer size suggesting the 
presence of a cross linked homodimer. This higher molecular weight species is very faint but 
is present for each of the mutant proteins and wtOcr. Notably, the wtOcr cross linked 
homodimer appears to run slower than the homodimer of the mutant proteins, the reason for 
this observed difference in migration speed is thought to be due to the difference in charge 










6.6 Secondary structure  
Although the mutant proteins exist as homodimers in solution, the loss of so many acidic 
residues could affect the local secondary structure and the fold of the protein compared to 
wtOcr. A common technique used to examine conformational changes between proteins and 
their mutants is circular dichroism (CD). CD analysis can investigate conformational 
changes to the secondary structure of the whole protein, by measuring the differential 
absorption patterns of left and right circularly polarised light. Protein secondary structure (i.e. 
α-helices, β-sheets and random coils) gives a distinctive CD spectrum in the far UV region. 
Each of the proteins was exchanged into a buffer containing 10mM sodium phosphate, 
10mM sodium fluoride (pH8.0). The concentration of each protein was then determined 
accurately by UV spectrophotometry by carrying out an absorption scan (210-340nm) on 
each sample at a concentration of 14.5µM +/-0.5µM. 
 
Figure 6.5: The Far UV CD spectra of the active mutants selected from LibDg compared to 
the spectrum of the wtOcr protein. 
 
The spectra obtained for each of the POcr proteins were very similar to each other and wtOcr, 
see figure 6.5. This suggests that there were only very slight changes, if any to the secondary 




6.7 Protein stability 
The removal of more than half of the acidic residues appears to have no effect on protein 
fold. Therefore the focus moved to investigating the stability of the POcr proteins. Protein 
stability was examined by thermal and chemical stability studies.  
6.7.1 Thermal stability assay (TDA) 
Thermal stability of the protein was measured by a thermal denaturation assay (TDA). This 
assay measures the transition melting temperature (Tm) of the protein of interest. The thermal 
denaturation assay measures the fluorescence emitted by the dye SYPRO orange, which is an 
environmentally sensitive dye. This dye is quenched in an aqueous environment. However, 
denaturation of the protein exposes the proteins hydrophobic core which can then bind to the 
dye and cause an increase in the fluorescence signal. The assay is carried out using a thermal 
cycler measuring the emission of the SYPRO orange dye (emλ: 575nm) as a function of 
temperature. TDA is greatly affected by the buffer. Therefore all the experiments were 
conducted using the same buffer system (10mM HEPES, pH8.0).  
Figure 6.6: The peaks that result from the emission of fluorescence from the SYPRO orange 
dye as a function of temperature. The intensity of the emission peak is thought to be 
dependent on the concentration of the protein, which appears to be relatively reduced for 
wtOcr and M1.9. The peaks are similar for proteins wtOcr, M2.1 and M2.8 whereas the 
peaks for proteins M1.9 and M1.1 have shifted to a higher temperature.  
The fluorescent signal produces an emission signal corresponding to the unfolding transition 
state of the protein. The transition state of wtOcr, M2.1 and M2.8 is simlar with a Tm of 54°C. 
However the transition state has shifted to higher temperatures for the mutants M1.1 and 
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M1.9. M1.1 has a Tm temperature of 57°C and M1.9 a Tm of 67°C, figure 6.6. The increase 
in temperature suggests that more heat energy is needed to denature the mutants M1.1 and 
M1.9, hence these proteins are more stable. The mutants M2.1 and M2.8 appear to possess 
the same thermal stability as wtOcr which suggests that the charge state is not the only factor 
which could affect the stability of the active POcr proteins. 
6.7.2 Chemical stability 
The salt, guanidine hydrochloride (GdmCl) can act as a chemical denaturant of peptides and 
proteins. Most proteins are completely denatured in the presence of 6M GdmCl. However, 
there is still a debate as to how GdmCl breaks down the secondary structure of proteins. The 
unfolding process of the denaturant is usually measured either by changes in the intrinsic 
fluorescence of the protein or changes in an extrinsic fluorescent probe. The aromatic residue 
with the greatest intrinsic fluorescence is the amino acid residue tryptophan. Tryptophan 
(Trp) has an excitation wavelength of 280nm and an emission wavelength range of 300-
350nm. The intensity of the fluorescence emitted from Trp residues depends on the number 
of Trp residues and the local microenvironment in which each Trp residue resides. The 
fluorescence of Trp is quenched in hydrophobic environments. Hence the residue is an ideal 
candidate for monitoring the unfolding of proteins. The unfolding process of the active POcr 
mutants, in the presence of increasing concentrations of GdnHCl, was monitored by 
measuring the intrinsic fluorescence of the only Trp residue on the Ocr monomer (W94). 
W94 is located on Helix D of the Ocr protein, which is towards the C-terminal end of the 
protein.  
Each of the POcr proteins and wtOcr (3µm) were incubated overnight at 4°C with increasing 
concentrations of GdmHCl, from 0-6M (see chapter 2 for details). Trp florescence was 






Figure 6.7: Denaturation curves induced by increasing the concentration of the denaturant 
GdmHCl for wtOcr and each of the mutants. Measurements were taken at an excitation 
λ=295nm and an emission λ340-380nm was measured for changes in the Trp fluorescence. 
All data points were fitted using a two state model (Equation 1) which calculated the midpoint 
value (D50%) and the ∆G of unfolding. 
 
Denaturation curves were plotted using the emission ratio of 350:380nm, this took into 
account any discrepancies in protein concentration, figure 6.7. The denaturation curves were 
fitted to a two-state model using Equation 1, a linear relationship was assumed between the 










F – fluorescence at a given denaturant concentration 
D – molar concentration of denaturant 
R – gas constant  =       8.314Jmol-1 
T – Temperature  =       293 K 
Realistic estimates were used for the parameters below for each POcr mutant and 
wtOcr 
αF - native signal   
αU - denatured signal   
βF - native slope   
βU - denatured slope  
  
The fitted data was used to obtain the midpoint value (D50%) and the transition slope 
(m) Furthermore the free energy of unfolding at 0M GdmCl was calculated using 
Equation 2, see table 6.1 below.   
 









Free energy of 
unfolding 
(ΔG in kJmol-1) 
  
M2.1 3 15.2 45.7 
M2.8 3.1 29.5 91.5 
wtOcr 3.4 7.4 25.1 
M1.1 3.7 8.9 33 
M1.9 3.8 9.7 36.9 
Table 6.1: The midpoint value, the gradient of the transition slope and the free energy of 
unfolding calculated from fitting the experimental chemical denaturation data of each POcr 







The midpoint value is the concentration at which 50% of the protein molecules are unfolded. 
Comparisons between the midpoint value of wtOcr and the POcr proteins indicate that M2.1 
and M2.8 are less stable then wtOcr whereas, M1.1 and M1.9 are more stable. However this 
is not reflected for the values of free energy that were calculated for each of the POcr 
mutants. The ΔG values suggest that all of the POcr proteins are more stable than wtOcr. In 
fact the mutants M2.1 and M2.8 appear to be more stable with greater ∆G values. 
The discrepancy between the values is a result of the transition slope. The gradient for the 
transition slope is notably steeper for the POcr mutants, the slope is dependent on changes to 
the surface area, in particular the accessibility of surface area between the native and 
unfolded state. For the POcr proteins accessibility increases compared to wtOcr due to the 
large reduction in the number of acidic residues on each POcr protein. However, additional 
differences between the transition state of each POcr protein could be due to the specific 
microenvironment of the tryptophan, W94. The tryptophan is located on Helix D of the Ocr 
monomer, located in a hydrophobic pocket flanked by several acidic residues. This could 
explain the differences in the local stability of the proteins, indicated by the differences in 
the initial slope. 
Protein Stability Tests 











Free energy of 
unfolding 
(ΔG in kJmol-1) 
M2.1 54 3 15.2 45.7 
M2.8 54 3.1 29.5 91.5 
wtOcr 54 3.4 7.4 25.1 
M1.1 57 3.7 8.9 33.0 
M1.9 67 3.8 9.7 36.9 
Figure 6.8: The transition midpoints for the chemical and thermal stability studies on the 
wtOcr protein and the mutant proteins selected from the library LibDg. Right is the midpoint 
concentration of the step transition from the chemical denaturation curves and left is the Tm 
temperature calculated from the TDA assay. 
The thermal and chemical stability assays showed that the mutants M1.9 and M1.1 
consistently show slight increases in stability compared to wtOcr. However, the mutants 
M2.1 and M2.8 appear to maintain the same stability as wtOcr from the thermal studies. 
However, the free energy of unfolding calculated from the chemical denaturation studies 
indicates that wtOcr is less stable then all of the POcr proteins with POcr mutant M2.1 
exhibiting the greatest stability.  The values obtained for wtOcr are in agreement with 
previous results obtained and literature values. 122 
137 
 
6.8 Protein function 
The ability of each of the selected mutant proteins to prevent restriction and modification 
was assayed by measuring the interactions of the POcr proteins with the two active 
complexes of EcoKI; the M.EcoKI methylase complex and the complete EcoKI 
endonuclease.  
6.8.1 Interaction with the M.EcoKI complex 
ITC measures the heat produced or expended upon titration of a ligand (i.e., Ocr) into a cell 
containing an interacting partner (i.e., M.EcoKI). The heat changes are measured against a 
reference cell that is maintained at a constant temperature. Sensitive thermopiles produce a 
feedback circuit to the sample cell containing the interacting species. Any fluctuations in 
temperature from the sample cell are equilibrated and accounted for against the conditions of 
the reference cell. Therefore the signal is a measure of the time it takes for the sample cell to 
return to the equilibrated conditions of the reference cell and the heat energy evolved in that 
time.  
 
Figure 6.9: LEFT: A schematic of the ITC instrumentation. IT consists of two cells a 
reference cell and a sample cell (enzyme). Syringe contains the ligand of interest, which is 
titrated into the sample cell and mixed using the stirrer; any fluctuations in temperature are 
equilibrated by the feedback power linked to the reference cell. RIGHT: The heat change is 
recorded as a function of time as shown in graph A, the integral of this data produces a 
curve exhibited in graph B, where the gradient is the binding affinity value (Kd), midpoint of 
transition the stoichiometry (n) of the reaction and the initial heat change equals the enthalpy 
(∆H) of the reaction measured. 
 
To perform ITC experiments the proteins were exchanged into 20mM HEPES, 6mM MgCl2 
and 7mM 2-mercaptoethanol (pH8.0). The ligand proteins were diluted to a concentration of 
~30µM (wtOcr/ POcr mutant) and the enzyme, M.EcoKI, to 3µM for a 1:10 fold ratio of 
138 
 
enzyme: ligand. The concentrations of the various proteins were determined from their UV 
absorbance. Samples were subsequently analysed using an Auto-iTC200 instrument.  
 
 
Figure 6.10: The ITC traces which follow the energy dynamics of the reaction between 
M.EcoKI with wtOcr and each of the four mutants selected from the library LibDg. The 
"Sample Cell" contained the M.EcoKI, while the "Syringe" contained corresponding Ocr 
protein. 
 
The ITC traces for each for the mutants and wtOcr are displayed in figure 6.10. The graphs 
monitor heat changes as a function of time with each of the spikes in heat energy 
representing an injection of the ligand species into the cell. The baseline for each of the 
mutants appears to show a good signal to noise ratio. Anomalous spikes are thought to be the 



















only minor errors in the baseline they appear to be large because the scale of the heat change 
is very small).  
By representing the heat change per injection as a function of the molar ratio, transition 
curves for each POcr protein and wtOcr were produced. Each curve in Figure 6.11 displays a 
steep step wise transition which is indicative of a tight binding interaction. A comparison 
between the transition curve of wtOcr and the POcr mutants does not distinguish much 
difference between the slopes of each curve. The experimental data highlighted in table 6.2 
shows that each POcr protein has a subnanomolar binding affinity towards the M.EcoKI 
enzyme. Although, the sensitivity of the ITC instrument means the technique can only 
accurately determine the binding affinity of interactions that are 10nM or weaker.  
ITC Properties  wtOcr  M2.8  M2.1  M1.1  M1.9 
N  0.76 +/‐0.01  0.74 +/‐0.01  0.77 +/‐0.003  0.8 +/‐0.01  0.82 +/‐0.02 
Kd (nM)  0.54 +/‐0.26  0.49 +/‐0.25  0.4 +/‐0.12  0.34 +/‐0.22  0.75 +/‐0.01 
∆H (kcal/mol)  ‐13.5 +/‐0.22  ‐9.9 +/‐0.17  ‐11.3 +/‐0.12  ‐13.5 +/‐0.25  ‐5.71 +/‐0.22 
∆S (cal/mol/Deg)  ‐5.45  6.58  1.63  ‐6.34  23.6 
Temperature (K)  298.16  298.16  298.16  298.16  298.15 
Table 6.2: A summary of the thermodynamic data extracted from the ITC traces for the 
interaction of M.EcoKI with each of the mutants and wtOcr. 
 
Furthermore, the stoichiometry for each of the mutants and wtOcr appears to be the same at 
0.7-0.8 of dimer:M.EcoKI. The discrepancy from a 1:1 ratio allows for errors in the active 
concentration of the enzyme and protein but it would appear that a 1:1 ratio is observed for 
each M.EcoKI:Ocr/mutant interaction. 
The striking difference between each POcr protein is the ∆H value displayed in Figure 6.13. 
The enthalpy change upon binding, between wtOcr or POcr mutants with M.EcoKI is 
exothermic. Wild type Ocr the mutants M2.1 and M1.1 display similar enthalpies of -
13.5kcal/mol and -11.3kcal/mol. However, the enthalpy of the proteins M2.8 and M1.9 is 
greatly reduced to -9.9kcal/mol and -5.6kcal/mol, respectively. From the table above the 
decrease in the exothermic enthalpy appears to loosely correlate with an increase in positive 




Figure 6.11: A comparison of the ITC heat energy exchange traces. Each trace has been 
altered to the same scale as the wtOcr trace to make the traces directly comparable. Each 
spike represents the injection of the ligand, Ocr/mutant protein in the cell sample, M.EcoKI. 
 
6.8.2 Interaction with the nuclease 
The interaction of each mutant with EcoKI was measured by performing a nuclease assay. 
This assay measures the linearisation of the unmethylated plasmid pBrsk1, which contains a 
unique recognition site for the EcoKI nuclease. In each case, wtOcr or the POcr proteins 
were preincubated with EcoKI in the presence of other cofactors required for digestion (i.e., 
ATP and SAM) and then the reaction was initiated by the addition of plasmid DNA. The 
reaction was stopped after 8mins and the extent of digestion was analysed by agarose gel 
electrophoresis. The EcoKI enzyme was initially incubated with a 20-fold or 10-fold excess 











Figure 6.12: In vitro nuclease assay, displaying the inhibition activity of the Ocr multimutants 
and wtOcr protein on EcoKI. The nuclease was incubated with a 10 fold (below) and 20 fold 
(above) excess amount of each mutant before the reaction was initiated. 
 
The inhibition of the EcoKI enzyme was successful for wtOcr and the mutant M2.8 at a 20-
fold and 10-fold excess of the Ocr/mutant protein, with no detectable plasmid digestion. 
However, some partial digestion was observed when EcoKI was incubated with the mutants; 
M1.9 and M1.1 at a 20-fold excess. Comparisons of the two gels in Figure 6.12 show that 
M1.9 and M1.1 exhibited the weakest antirestriction activity whereas, the POcr proteins 
M2.1 and M2.8 produced the same antirestriction activity as wtOcr.  
Further analysis investigated the restriction ability of the nuclease incubated with 5–fold 
excess of the mutant proteins and wtOcr. In addition, wtOcr and M2.8 were also incubated 
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with the nuclease using a 2-fold excess in an attempt to assess whether there any difference 
in antirestriction activity could be distinguished between these two proteins, figure 6.13.   
 
Figure 6.13: The in vitro nuclease assay displaying the inhibition activity of the Ocr mutant 
and wtOcr protein on EcoKI. The nuclease was incubated with a 5 fold excess of each 
mutant protein and 2 fold excess for the mutants M2.8 and wtOcr before the reaction was 
initiated. 
 
A similar pattern of inhibition was observed when these results were compared to those 
shown in Figure 6.12.  
In summary although all of the POcr proteins retain some antirestriction activity, this activity 
appears to vary in vitro. M2.8 appears to be the only mutant protein that retains full 
antirestriction activity comparable to wtOcr. M2.1 retained slightly weaker antirestriction 
activity and M1.9 and M1.1 displayed the weakest antirestriction activity. 
 
6.9 Discussion 
6.9.1 Protein structure 
In solution wtOcr exists as a stable homodimer in order to function effectively. Cross linking 
studies carried out using the reagent glutaraldehyde showed that a stable homodimer was 
also present in solution for each of the mutant proteins. Furthermore, CD analysis revealed 
that the removal of 60% of the acidic residues had no effect on the structural fold of the 
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proteins secondary structure compared to wtOcr. Remarkably the extensive reduction in the 
number of acidic residues does not affect the secondary structure or dimerisation of the POcr 
proteins when compared to wtOcr. 
6.9.2 Protein stability 
The stability of the protein was assessed using two methods, thermal stability by a thermal 
denaturation assay and chemical stability using the denaturant, Guanidine Hydrochloride 
(GdmCl).  
The results from the chemical stability study exhibited changes in stability related to the 
hydrophobic properties of each POcr proteins, rather than the electrostatic interactions which 
are masked by direct interaction with Guanidine ions.124 The free energy of unfolding 
calculated from these studies showed that the removal of acidic residues reduced exposed 
hydrophobic domains which has resulted in an increase in the stability of the POcr proteins. 
Furthermore, the differences between the numbers of acidic residues in close proximity to 
the tryptophan residue could affect the resulting free energy value. On the other hand thermal 
denaturation determines the overall stability of a protein and takes into account all properties 
that may affect stability. With this in mind the thermal studies showed that the proteins M2.1 
and M2.8 were less stable than M1.1 and M1.9. In fact the same trend is noticeable from the 
calculated D50% midpoint value from the chemical denaturation study which also suggests 
that M2.1 and M2.8 are less stable than the proteins M1.1 and M1.9. This suggests that any 
increases in stability gained by the accessibility of hydrophobic residues in the chemical 
denaturation of M2.1 and M2.8 are compensated by other properties of the proteins, 
according to the thermal stability results.  
6.9.3 Protein function 
The ITC results showed that each of the mutants exhibited tight binding towards the 
M.EcoKI. The interaction between each POcr protein and M.EcoKI was comparable to 
wtOcr, all exhibiting subnanomolar binding affinities. As such, ITC is not sensitive enough 
to differentiate any subtle differences between the affinities of each POcr protein to 
MEcoKI.  
Furthermore, the ∆H of the interaction is more favorable for wtOcr, M1.1 and M2.8 and 
considerably less favorable for POcr protein M1.9 and M2.8. The decrease in the exothermic 
value of the enthalpy cannot be correlated to a decrease in the number of acidic residues but 
the decrease in enthalpy is compensated by an increase in entropy, suggesting the production 
of a more ordered protein: enzyme complex. Anomalous contributions from the ligand or the 
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buffer were discounted by carrying out a control experiment which injected the ligands; 
wtOcr and the POcr proteins into buffer, (see appendix, Figure A.2).  
From ITC, the interaction between M.EcoKI and the POcr proteins is indistinguishable from 
wtOcr with M.EcoKI. In contrast the results from the nuclease assay indicate that the POcr 
proteins elicit variable antirestriction activities. The POcr protein M2.8 retains  
antirestriction activity as effective as wtOcr, whereas antirestriction activity exhibited by 
M2.1 is moderately weaker and for the mutants M1.1 and M1.9 partial antirestriction activity 
is observed in vitro. Each of the POcr proteins possess a similar number of acidic residues 
therefore the difference in antirestriction activity does not reflect a decrease in the number of 
acidic residues. However the reduction in antirestriction activity for the mutants M1.9 and 
M1.1 correlates with an increase in the protein stability of the POcr protein M1.9 and M1.1. 
This may indicate that increased flexibility is more favourable for binding to the M.EcoKI; 
this could possibly be due to slight changes in conformation of the Ocr protein, upon 
binding. 
Previous investigations carried out by A. Stephanou et al, 2009 revealed that the removal of 
16 acidic residues from each Ocr monomer reduced the binding affinity of Ocr with the 
M.EcoKI complex from a Kd of 44pM  to ~20nM, which incidentally matches the interaction 
between the M.EcoKI enzyme and dsDNA.120 In contrast, the results from this chapter 
indicate that the removal of 21 acidic residues had no distinguishable effect on the binding 
interaction of the protein to M.EcoKI, which remains subnanomolar for each of the active 
POcr mutants. The structure of each mutant protein was comparable to wtOcr and revealed 
no apparent differences. Stability studies showed that the reduction in acidic residues 
generally increased the stability of the POcr mutants but not enough to affect the interaction 
of these proteins with M.EcoKI. On the other hand, the antirestriction activity of the POcr 
proteins was reduced, this implies that the POcr proteins differentially bind to the M.EcoKI 
and R.EcoKI enzyme. Sequences do show the absence of acidic residues present on Helix D 
which are thought to interact with the R subunits.61  
 In conclusion the need for acidic residues on the Ocr protein beyond the 13-15 acidic 
residues essential for the active POcr proteins, selected from the library LibDg, is still 
unknown. The effect and advantage of these acidic residues which represent ~60% of the 
total number on the Ocr protein is unknown in regards to the antimethylation activity. 
However, the reduction in acidic residues does appear to affect the efficiency of the 
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antirestriction activity of the protein, furthermore this decrease in antirestriction activity in 



























Chapter 7. Partially active POcr mutants 
 
7.1 Introduction 
It is known that the production of the synthetic positive Ocr gene, pOcr, in which all of the 
acidic residues were substituted by their neutral analogue, induced a loss of activity but also 
a loss of protein solubility and even protein expression. Expression trials failed to produce 
the POcr protein in E. coli cells (unpublished work carried out by Dr GA Roberts/Dr JH 
White). This shows that the acidic residues of the protein are clearly important in terms of 
protein folding/stability. However, two issues need to be addressed: (i) At which point do the 
acidic residues become such a vital component of the protein?; (ii) how many (and which) of 
the acidic residues reintroduced into POcr are required for expression, solubility and finally 
biological function?  
 
7.2 Aims 
The aim of this chapter was to investigate the role of acidic residues in every aspect of the 
activity, structural integrity and expression of the wtOcr protein, by investigating POcr 
mutants with varying pI values, variable functionality and induce different phenotypes 
compared to wtOcr. These POcr mutants were assessed by relating their activity to the 
following important factors; 
(i) The number of acidic residues that are present on each POcr mutant protein.  
(ii) Positional context of the acidic residues in the primary amino acid structure of POcr.  
As a result a large screen was carried out on POcr mutants isolated from each of the nine 
libraries that were generated in chapter 4. Approximately 50 POcr mutants that displayed 
various activities and possessed unique pI values were investigated more thoroughly. 
Furthermore, the sequences from the library LibDg (which includes the active POcr mutants 
isolated from LibDg in chapter 5) were assessed thoroughly to produce a map of Ocr which 
demonstrates the relative importance of each acidic residue towards the structural integrity 
and activity of Ocr.  
The aim of the work was to investigate how negative charge can affect the activity of the 
POcr mutants in vivo.  
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7.3 Initial screening  
Table 7.1 identifies the total number of POcr mutants that were screened and which library 
they were isolate from. In total 102 POcr mutants were isolated and screened using the 2AP 
assay developed in chapter 3.   




Lib4  7 
Shuffle Lib 10 
Lib 1D 14 
Lib 2D 9 
1D+2D 11 
Lib Dg 30 
Total 102 
Table 7.1: To carry out a large scale screen 102 POcr mutants were selected at random 
from each of the POcr libraries generated in chapter 4. The table shows the distribution the 
102 POcr sequences screened and from which of the POcr libraries they belong to of the 
nine POcr libraries generated in chapter 4.  
 
In chapter 3, the 2AP assay managed to elucidate three different phenotypes; inactive, active 
and partially active mutants. The level of 2APR induced by the expression of Ocr 
multimutants in E. coli cells was successfully correlated with their antirestriction and 
antimodification activity. In the same manner the POcr mutants highlighted in table 7.1 were 
screened and categorised as inactive, active or partially active depending on whether the 
mutants exhibited 2AP resistance at, 20µg/ml and 80µg/ml or whether induction of the POcr 





7.4 Initial 2AP studies 
Initial studies assessed 2APR by transforming E. coli NM1041 cells with the plasmid 
encoding the appropriate POcr mutant. Single colonies of each mutant were then streaked 
onto four types of plate; (i) a control plate supplemented with antibiotics only, (ii) an 
induction plate supplemented with antibiotics and IPTG, (iii) a plate supplemented with 
antibiotics and 80µg/ml of 2AP (2AP80) and (iv) a plate supplemented with antibiotics and 
20µg/ml of 2AP (2AP20). The resulting viable cell count from these two concentrations of 
2AP and the addition of a plate supplemented with IPTG was used to determine whether the 
mutants exhibited no 2AP resistance (green), partial resistance (blue) or affected the growth 
of cells (red). 
 
Figure 7.1: The growth of a single colony that has been streaked onto four different LB-agar 
plates supplemented with a) antibiotics only, b) antibiotics and IPTG, c) antibiotics, IPTG and 
2AP (20µg/ml) and d) antibiotics, IPTG and 2AP (80µg/ml). The plates were incubated 
overnight at 37°C. Highlighted in green are colonies which appear to have no resistance to 





An example of the mutants that were investigated is shown in Figure 7.1. Plate a) contains 
antibiotics only and each streak produces a homogenous growth pattern and represents a 
mutant that has been successfully transformed. Changes in cell viability upon induction of 
protein expression by the addition of IPTG are displayed in plate b for each of the POcr 
mutants. Furthermore, plates c and d contain increasing concentrations of the DNA mutagen 
2AP. POcr mutants that affect the viability of E. coli cells were highlighted; in red were 
POcr mutants that appeared to severely affect cell viability whereas in green are POcr 
mutants that induce the same effect but to a lesser extent. Lastly, in blue are POcr mutants 
that are inactive and are 2APR to 20µg/ml but are not resistant to 80µg/ml.   
The preliminary results provide an insight into the activity profile of each mutant.  However, 
the experiment was repeated by comparing the viable cell count, on each type of plate, using 








Figure 7.2: Three different phenotypes were induced by the 102 POcr mutants screened. 
The three phenotypes had been witnessed previously in chapter 3 upon assessment of the 
Ocr multimutants where the phenotypes were classified as expressing mutants that exhibited 
no activity (a), partial activity by inducing poor growth (b) or no growth(c). Viable counts were 
plated as 10-fold serial dilutions in an anticlockwise direction for the control and 2AP20 
plates and a clockwise direction for +IPTG and 2AP80 plates.  
 
The cell survival rate of E. coli NM1041 cells was measured in the presence of a POcr 
mutant protein and 2AP. The results in Figure 7.2 demonstrate the typical phenotypes that 
were displayed as a consequence. Figure 7.2 demonstrates that expression of the mutants in 
E. coli NM1041 cells, in the presence of 2AP produced one of three phenotypes;  a  2AP 
resistance of 20µg/ml and two phenotypes that displayed a reduction (Figure 7.2b) or 
inhibition of cell growth (figure 7.2c). Results from chapter 3 show that the latter two 
phenotypes are common among mutants possessing intermediate binding affinities to RM 




Figure 7.3: A scatter graph showing the relationship between the total numbers of mutations 
found on each mutant protein and the corresponding phenotype in the 2AP assay (from a 
total of 102 sequences). The sick phenotype and partially active phenotype demonstrated in 
figure 7.2 have been combined in this graph. For comparison, the active mutants from 
chapter 5 and 6 have been included. 
 
The relationship between the number of acidic residues in POcr and the induced phenotype 
is shown in Figure 7.3 above. A larger proportion of the partially active mutants contain a 
greater number of acidic residues; on average 9 acidic residues were present on partially 
active mutants compared to an average of 7 acidic residues on inactive mutant mutants.  
However, this does not explain why mutants that contain the same number of acidic residues 
as the active mutants, isolated in chapter 5, remain inactive. This observation suggests that 
either (i) the position of an acidic residue/the sequence context of acidic residues is 
important or (ii) the mutant mutants categorised as ‘partially active’ in fact display different 
activities that result in the same phenotype.  
7.4.1 Positional context of acidic residues 
To assess whether the positional context of acidic residues is important and to pinpoint 
exactly which positions are of greatest importance, further analysis was carried out on POcr 
mutants that were isolated from the library LibDg only. The reason why only LibDg POcr 
mutants were analysed was so that direct comparisons could be made with the active POcr 
mutants isolated from LibDg in chapter 5. Therefore the 2AP screen above showed that of 
the 26 POcr mutants from LibDg 16 were partially active and 10 were inactive. These were 
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compared with the additional four active POcr mutants that were characterised in chapters 5 
and 6.  
The importance of each acidic residue towards the activity of the mutant was assessed by 
calculating whether antirestriction activity increases if a particular position contains an acidic 
residue. In order to do this the likelihood of a residue being acidic at each position of interest 
was calculated for the whole population of 30 mutants as a percentage, and this was 
compared to the percentage likelihood that a position is acidic from POcr mutants inducing a 
particular phenotype. From this bar charts were produced for each phenotype; Active, 
Partially Active and Inactive. These charts present a positive and negative percentage for 
each position of interest on the primary protein structure of POcr; these percentages 
represent the probability that a residue is acidic (positive percentage) or neutral (negative 
percentage) among the active (A)/ partially active (PA)/ inactive (IN) mutants compared to 
the whole population. Therefore a positive percentage represents an increased probability 
that an acidic residue at the supposed position is important to the phenotype of interest 
whereas a negative percentage suggests that an acidic residue is not essential at this position 












Figure 7.4: Three graphs that compare the % likelihood that a target site is acidic for POcr 
mutants that induce phenotypes; a) active (green), b) partially active (red) and c) inactive 
(blue,) as characterised by the 2AP screening procedure. The probability is compared to the 
% likelihood that the same target site is acidic when selected at random from the total 
population of POcr mutants characterised from LibDg.  
 
The graphs show the importance of acidic residues at particular positions for POcr mutants 















































































































































































































































































































































































































































































































trends show that an increase in activity correlates with an increase in the importance of 
acidic residues, with many acidic residues becoming more prominent as activity increases.  
It was suspected that no acidic residue would be present in abundance among inactive POcr 
mutants, indeed this was the case for all the acidic residues with the exception of positions 
30, 32 and 33 (likely a result of the small sample size). This suggests that the presence of 
acidic residues on POcr mutants is not important for inactive POcr mutants. 
However, POcr mutants that induce partially active and fully active antirestriction properties 
have a number of acidic residues that appear to be important in producing functional protein. 
A large number of acidic residues are present at high levels on the active POcr mutants with 
several conserved acidic residues (100% acidic). These were previously highlighted in 
chapter 6 and include acidic residues E21, D52, D74 and D77 which are also conserved on 
the partially active POcr mutants. This suggests that the acidic residues at these positions are 
important for partially active and fully active POcr mutants. Not only this but that these 
acidic residues are important towards the structural integrity of the POcr protein, rather than 
its biological activity.   
A fourth graph was produced in figure 7.5 that investigates the importance of acidic residues 
present on active POcr mutants, compared to inactive and partially active POcr mutants. This 
would highlight all of the acidic residues that appear to be important in antirestriction 
activity as opposed to those residues that are structurally important and so are present in high 







Figure 7.5: A graph that compares the % likelihood that a target site is acidic for POcr 
mutants inducing an active phenotype, as characterised by the 2AP screening procedure, 
compared to the % probability that the target site is acidic if selected from the POcr mutants 
characterised from LibDg that induce an inactive or partially active phenotype.  
 
Figure 7.5 shows that the acidic residues 68, 88 and 99 are in high abundance on POcr 
mutants that possess an active phenotype. This suggests that these residues are essential 
components for the activity of the POcr mutants, given that there is a ~80% likelihood that 
these positions are acidic. 
Other residues that appear to have some importance include the midloop region (residues 60-
68) and the Helix D region (88-96). The likelihood that these residues are acidic among 
active POcr mutants is ~40%.  Notably this is in agreement with results from chapter 3 
which indicate that the loop 2 region and a region on Helix D (Ocr multimutant M4) were 
important for antimethylation and antirestriction activity respectively.  
Interestingly, residues from the 1oop 1 region (26-36), which were also highlighted as 
important in chapter 3, were not as highly represented in figure 7.5 above. This suggests that 
these residues could play a minor role in the activity of the POcr mutants. Alignment of the 
active POcr mutants in chapter 5 shows that specific residues in the loop1 region were not 
conserved and that a non-specific representation of acidic residues in the two loop regions 
was sufficient for activity rather than acidic residues at specific positions.  
In summary the analysis of the POcr mutants from LibDg highlighted the importance of an 
acidic residues position on the performance of POcr as an antirestriction protein. The results 
show that the following acidic residues E21, D43, D52, D74 and D77 could possibly be 






































































































































































a number of non-specific acidic residues in both loop regions on POcr can produce a fully 
functional antirestriction protein.   
The analysis so far implies that the presence of at least five acidic residues is essential in 
producing a partially active antirestriction protein. However, Figure 7.3 shows that inactive 
POcr mutants can contain as many as 16 acidic residues and partially active mutants can 
possess as few as 3 acidic residues. These results suggest that the partially active POcr 
phenotype, which observed a reduced cell growth in E. coli NM1041 cells, may in fact have 
very different properties. 
7.4.2 Investigating the partially active phenotype 
A number of intermediate and inactive POcr mutants were selected for further analysis. In 
total forty two sequences were selected from the initial study. These mutants had a range of 
3-15 acidic residues per mutant. Twenty of these POcr mutants were inactive, with a 2APR of 
20µg/ml and possessed 3 to 13 acidic residues. Twenty two mutants were partially active and 
contained between 5-15 acidic residues. These have been highlighted in Figure 7.6. 
 
Figure 7.6: The selection of mutants that were chosen to be carried forward for further 
analysis. The graph describes whether the POcr mutants screened were inactive or partially 
active and the number of acidic residues each mutant possessed. POcr mutants that were 
selected for further analysis are highlighted by a black border. 
 
Previous results in chapter 3 have shown that a number of the Ocr multimutants were 
partially active. Upon overexpression in E. coli, these mutants were detrimental to cell 
growth inducing a phenotype of m+/-r+/-. Upon further investigations these Ocr multimutants 
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were shown to be active from in vivo phage infection assays. If like, the Ocr multimutants, 
the POcr mutants exhibit the m+/-r+/- phenotype then they will also exhibit antirestriction and 
antimethylation activity when carrying out phage infection assays.  
The eop results of the phage titre were used to calculate an arbitrary unit of antirestriction 
and antimodification for each of the mutants, by determining the ratio of the eop value for 




















wtOcr 7500.00 625.00     
pTrc 1.00 1.00     










ED10 (3) 0.10 1.23  G2=8 (5) 0.75 2.76 
C8(4) 0.24 0.88  2.5 (5) 0.15 0.15 
D7(4) 0.12 0.83  1+2-8 (6) 0.90 1.17 
E2(5) 0.24 0.6  ED6 (6) 0.38 2.00 
ED9(5) 0.33 1.20  1+2-5 (7) 0.86 0.95 
A11(6) 19.50 1.00  3.29 (7) 0.30 1.56 
D5(6) 0.40 0.66  2mm (7) 0.25 2.70 
ED4(6) 0.15 1.19  2.1 (8) 0.50 1.17 
A10(7) 0.09 0.95  3.2 (8) 0.21 0.88 
D10(7) 0.28 0.60  2+1-9 (9) 3.90 1.33 
E5(8) 0.17 1.99  2+1-1 (9) 0.35 1.38 
ED3(8) 0.50 0.24  G2=7 (9) 0.90 1.50 
Dg10(8) 2.00 1.90  1+2-7 (9) 3.25  n/a 
ES5(8) 0.17 1.58  2+1-6 (10) 0.21  n/a 
ES4(9) 0.40 1.17  B7(10) 0.21 0.90 
B12(10) 1.17  n/a  2+1-10 (11) 0.05 0.58 
113-3(10) 0.67 0.50  B4(11) 0.38 4.38 
ES8(13) 0.38 0.39  Dg4 (12) 0.28 1.31 
Dg12(13) 0.15 3.79  2+1-8 (10) 0.60 0.88 
Dg2(13) 0.20 1.11  2.4 (13) 0.33 1.53 
    Dg3 (13) 0.33 1.07 
    Bx3.11 (15) 2785.71 5250.00 
Table 7.2: The results from the phage infection assay. The unmodified lambda phage was 
used to infect restriction proficient and restriction deficient cells that were transformed with 
the mutant of interest. The resulting phage titre and eop value were calculated and the 
antirestriction value determined. Phage plaques from the restriction proficient cells were 
subsequently used to make a phage stock which was further used to infect E. coli cells in the 
presence and absence of the HsdR subunit. The resulting phage titre and eop value 
calculated the antimodification value. The results were carried out with a negative and 
positive control; the empty vector pTrc99A and wtOcr protein, respectively. Therefore an 
antirestriction and antimodification value greater than 1 suggests some antirestriction and 
antimodification activity is present. Errors were calculated from deviation of repeats from a 
mean average and were approximately +/- 20%. 
 
Table 7.2 shows that each of the POcr mutants demonstrates no antirestriction or 
antimodification activity from the phage assay. The one exception was the POcr protein 
Bx3.11, which not only exhibits antirestriction and antimodification activity but this activity 
is similar to the activity of the wtOcr protein, (incidentally this mutant contains the largest 
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number of acidic residues of all the POcr mutants that were assessed). The remaining 21 
partially active POcr mutants possessed no apparent activity towards EcoKI, suggesting that 
these mutants may be toxic to the cell.   
7.4.3 Cell toxicity and the restriction pathway 
If the toxicity induced by the partially active POcr mutants is not dependent on its interaction 
with the Type I RM enzyme EcoKI, then the POcr mutants could reduce the growth of all E. 
coli cells.  Such toxicity can be a common problem in recombinant protein expression in E. 
coli cells.103  
To assess the toxicity of each POcr mutant in table 7.2, bacterial growth curves were 
measured for E. coli NM1041 and NM1261 cells strains (HsdR+/-) with the expression 
construct of each POcr mutant. The growth curves for each cell strain were carried out with 
and without induction of heterologous gene expression. OD600 measurements were carried 
out every 5mins, for a total of 500mins at 37°C, with shaking at 180 rpm between readings.  
 
Figure 7.7: Three graphs which demonstrate the three main phenotypes that were 
recognised from carrying out bacterial growth curves of each of the mutants in the presence 
and absence of the HsdR subunit from left to right.  The growth curves for the E. coli 
NM1261 cells were offset from t=0, OD600=0 for comparison.  
 
The bacterial growth curves in Figure 7.7 demonstrate the difference between E. coli cells 
expressing each of the POcr mutants in the presence and absence of the HsdR subunit. The 
two sets of graphs refer to the growth curves obtained for E. coli NM1041 cells (HsdR+) or 
E. coli NM1261 cells (HsdR-) in the presence/absence of IPTG. The effect induced by each 
of the partially active POcr mutants on the growth rate of E. coli NM1261/NM1041 cells, 
could be defined by three major characteristics as; N/N, Y/N and Y/Y (Figure 7.7).  
160 
 
1) N/N- E. coli NM1041 and NM1261 cells exhibited no changes in growth upon expression 
of the mutant 2.5.  
2) Y/N- the mutant 2.4 reduces cell growth when expressed in E. coli NM1041 cells which 
contain the RM system EcoKI. However, upon expression of the mutant in the absence of 
EcoKI (E. coli NM1261) cell growth is unaffected. This result suggests that the reduction in 
cell growth is a direct result of the restriction pathway and the presence of the mutant; 
implying that the enzyme and the mutant are interacting. 
3) Lastly the mutant 2+1-6 demonstrates a Y/Y growth effect. Therefore, the expression of 
the mutant reduces the cell viability of E. coli cells in the presence and absence of the HsdR 
subunit. Such growth curves show an extended lag period with a growth delay of ~400mins. 
This suggests that expression of these mutants will be toxic in all E. coli cells.  
Upon closer inspection of the partially active POcr mutants in figure 7.2, those mutants that 
induce a Y/N growth pattern generally possess ≥8 acidic residues with the exception of only 
one Y/N POcr protein which contains 6 acidic residues. However, those POcr mutants that 
induce a toxic effect (Y/Y) appear to possess a variable number of acidic residues that ranges 










Figure 7.8: The graph above depicts each of the partially active mutants examined in relation 
to the number of acidic residues each of the POcr mutants contain. The colours denote the 
growth profile that each of the mutants exhibited from the examples shown in figure 7.7. The 
graph show that is no obvious trend between the growth profile induced by the partially 
active mutants and the number of acidic residues they possess. 
 
The results have shown that the POcr mutants that were defined as partially active from the 
initial 2AP screen in figure 7.1, in fact comprised of POcr mutants that possessed different 
growth profiles, figure 7.8.Three new phenotypes were discovered; 
i) POcr mutants effected the growth of E. coli cells, in the presence of an EcoKI 
enzyme but displayed no antirestriction/antimethylation activity upon phage 
infection. 
ii) POcr mutants reduced/inhibited the growth of E. coli cells in the presence and 
absence of the EcoKI enzyme and so were toxic in all E. coli cells. 
iii) The POcr mutant Bx3.11, was toxic to all cells but shared the same phenotype as 
the partially active Ocr multimutants (demonstrating full antirestriction and 
antimethylation activity upon phage infection). 
7.4.4 Evidence of cell filamentation 
Previous results in chapter 3 showed that the partially active Ocr multimutants that reduce 
the growth rate of E. coli NM1041 (+HsdR) caused cells to filament as a result of inducing a 
m+/-r+/- phenotype. Although the POcr mutants do not display any antirestriction or 
antimethylation activity upon phage infection, a number of them do induce the same growth 
profile (Y/N) as the Ocr multimutants. Therefore evidence of cell filamentation confirms that 
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these POcr mutants do possess the same phenotype (m+/-r+/-) as the Ocr multimutants and 
hence possess a weak binding affinity towards EcoKI. Furthermore, cell morphology in the 
presence of POcr mutants that are toxic (Y/Y) were also assessed to see if the toxicity effect 
induced the bacterial SOS response/triggered cell filamentation.  
The expression of each POcr mutant was induced once an OD600 of 0.3 was achieved, after 
which a further 2 hours incubation was followed by cell fixation using methanol. The cells 
were subsequently examined under a light and fluorescent microscope, to observe the DAPI 
stained nucleoid. 
 
Figure 7.9: Microscopy images of E. coli NM1041 cells which have been induced to express 
mutants that exhibit the three different phenotypes that were expressed from the bacterial 
growth curves that are shown in Table 7.2.  The mutant 2.5 induces no change (N/N), 
whereas mutant 2.4 induces reduced viability in the presence of the HsdR subunit (Y/N) and 
the mutant 2+1-10 which induces a reduction in the growth of E. coli cells in the presence 
and absence of an RM system(Y/Y). 
 
The microscopy images in Figure 7.9 are examples of the morphology of E. coli NM1041 
cells, where POcr mutants have been expressed produce three different growth profiles that 
define the partially active POcr mutants; N/N, Y/N and Y/Y. These represent the three 
different growth behaviors that were outlined in Figure 7.7. The figure 7.9 shows that the 
expression of the inactive (N/N) POcr mutant M2.5 has no effect on the morphology of E. 
coli NM1041 cells this was the case for all of the POcr mutants that were inactive.  
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However M2.4 represents a POcr mutant that reduces the growth of E. coli NM1041 cells 
only (Y/N, THsdR phenotype). Here the cells are longer and there are signs of cell 
filamentation, this is reflected for each of the POcr mutants that effect growth in the presence 
of EcoKI. However, the extent and size of the filaments produced differed for each POcr 
mutant analysed, Table 7.3. 
Partially active 
Mutant Filaments Small?/Large? Toxic?/THsdR? 
1+2-8 YES S THsdR 
Dg10 YES L THsdR 
ED6 YES S THsdR 
                   2.4 YES S THsdR 
2+1-8 YES S THsdR 
Dg4 YES L T 
2+1-10 YES L T 
2+1-1 YES S T 
2.1 YES S T 
G2=7 YES S T 
G2=8 YES L T 
2+1-6 YES S T 
2mm YES L T 
Bx3/11 YES S T 
Table 7.3: The table describes the size of filaments for E. coli cells that filament when the 
gene of a partially active POcr mutants is expressed. The size of the filaments was 
designated as small (S) or large (L) relative to the filaments exhibited for 2.4 and 2+1-10 
respectively (figure 7.9). This was associated with the toxicity exhibited for each of the POcr 
mutants, where THsdR signifies cell toxicity in the presence of EcoKI whereas T was attributed 
to POcr mutants that appear to be toxic to all E. coli cells.  
 
 Lastly, the POcr mutant 2+1-10 which induced a Y/Y growth profile and is toxic to all E. 
coli cells  can also cause E. coli NM1041 cells to filament. Furthermore, cell filamentation 
was observed in E. coli NM1057 (HsdR-) cells. This shows that the toxic mutants induce cell 
filamentation and therefore appear to be initiating the bacterial SOS response. The 
production of filaments occurs as replication and growth of cells proceeds but the cells do 
not divide producing elongated filaments. Such behavior is typically caused by the induction 




Figure 7.10: Microscope images that were captured for mutants 2+1-10 and 2.1 that were 
expressed in E. coli NM1261 cells.  
 
The extent of filamentation as well as the size and shape of the filaments differs with the 
expression of each POcr mutant. No obvious trend can be identified which correlates cell 
filamentation to growth behavior. However, different types of filaments were demonstrated 
and suggest that the POcr mutants may be behaving differently or that the subtle differences 
in surface negative charge of the POcr mutants, has an effect on the extent of filamentation. 
In addition some of the cells possess circular areas of light phase at either end of each cell. 
These circular patches are indicative of inclusion bodies. Inclusion bodies occur when over 
expressed protein is unable to fold appropriately causing the protein to aggregate; insoluble 
protein is then encapsulated into inclusion bodies that are generally observed at the poles of 
the bacterial cell. 126,103 This suggests that a further distinction could be made on the 
solubility of the different POcr mutants and the effect this might have on the activity of the 
mutant and its phenotype. 
 
7.5 Discussion 
The POcr expression construct fails to produce protein in E. coli cells however, the 
introduction of 13 acidic residues causes the protein to express, be soluble and function as an 
antirestriction protein. This suggests that acidic residues play a role in each of these 
properties. The plasmid libraries that were produced in chapter 4 contained a variety of POcr 
mutants which covered a range of isoelectric points. Analysis of these POcr mutants could 
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highlight mutants that straddle each of these properties, by associating the introduction of 
acidic residues towards the ability of POcr to express, be soluble and function as an 
antirestriction protein. This should increase our understanding into the effect of the acidic 
residues towards the properties of the protein wtOcr.  
7.5.1 Global analysis of activity 
The POcr mutants of LibDg contained the largest number of mutations per POcr mutant 
ranging from 8-17 acidic residues. From this library four unique POcr mutants were selected 
containing full antirestriction and antimethylation properties (Chapters 5 and 6). However 
POcr mutants from this library also induced inactive and partially active mutants, 
presumably because the acidic residues of importance are absent from their sequence. 
Therefore the analysis of sequences from the library allowed direct comparisons between 
these POcr mutants, to highlight which acidic residues are important. Thereby producing a 
global map across the mutants surface, rating the importance and necessity of each acidic 
residue.  
Analysis of partially active POcr mutants indicated that the acidic residues E21, D52, D74, 
D77 and D63, were commonly present.  However, when considering what acidic residues are 
important for elevating partially active to fully active mutants, the residues of importance are 
located in the loop 2 region and an area located on Helix D of Ocr. Both of these regions 
were highlighted previously in chapter 3 as important for binding towards the MTase and 
nuclease respectively. However these residues are not conserved which suggests that these 
acidic residues can be interchangeable within this region. Instead conserved residues present 
on active and partially active POcr mutants refer to acidic residues that surround either the 
loop1 or loop2 region, suggesting that these residues could stabilise the loop regions and are 
structurally important. The importance of each acidic residue was rated by; 
1) The conservation of acidic residues in active and partially active mutants, indicating 
their structural and functional importance 
2) The acidic residues that are conserved in active POcr mutants, presumably important 
for biological function 
3) Groups of acidic residues that are consistently present in high abundance on active 
and partially active POcr mutants 
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4)  Acidic residues present on active POcr mutants in high abundance 
 
Figure 7.11: Mapping the importance of acidic residues on the structure of wtOcr. Each of 
the acidic residues was pooled into groups depending on the importance of the residue to 
the activity of Ocr, which was based on the global analysis results from figures 7.4 and 7.5.   
7.5.2 Partially active mutants 
2AP was used to assess a selection of POcr mutants from each of the libraries that were 
produced in chapter 4. POcr mutants (102) were screened and subsequently categorised as 
either inducing an inactive or partially active phenotype. The POcr mutants contained 2-16 
acidic residues producing a pI range of 10.0-3.9. Although the average number of acidic 
residues was 7 for inactive mutants and 9 for partially active, this marginal difference in the 
number of acidic residues highlights that positional context of the acidic residues is 
important. However, the global study carried out above does not consider why partially 
active mutants might contain as few as 5 acidic residues and inactive mutants as many as 13 
acidic residues. As a result 42 of POcr proteins that possessed a range of pI values and 
demonstrated inactive and partially active phenotypes were investigated further. 
An in vivo phage assay was performed the results showed that none of the mutants appeared 
to inhibit phage infection, no antirestriction or antimethylation behavior was detected. The 
Most Least 
Importance 
D43, E60, D68, E88, E99 
E21, D52, D77 
D30, D63, D74, D93, E96 
D26, D27, E65, E67 
Residues which are not important: 
D13, E17, D32, D33, D36, D93, E99, D100, E104, E107-8, E110-1, 
E113-4, D115, E116-7 
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Ocr multimutants in chapter 3, possessed a weak binding affinity with EcoKI but provide 
adequate antirestriction activity in the in vivo phage assay. The POcr mutants do not share 
this activity which suggests that the partially active phenotype could encompass mutants 
with different activities and behaviors.  
Indeed each of the partially active POcr mutants observed one of two growth patterns Y/N 
and Y/Y.  
Y/N- The POcr mutants reduced the growth rate of E. coli cells in the presence of the HsdR 
subunit only. No change in cell growth is observed in the absence of the HsdR subunit 
Y/Y- The presence of the POcr protein reduces the growth rate of E. coli cells in the 
presence or absence of the HsdR subunit    
This indicates that these POcr mutants are interacting with the restriction pathway and  
suggests that the POcr mutants are only partially inhibiting the activity of the M.EcoKI and 
EcoKI enzymes, causing the cell’s chromosomal DNA to become susceptible to the 
nuclease. This self-destructive phenomenon was confirmed by the appearance of DNA 
filaments which was a result of chromosomal DNA becoming susceptible to EcoKI. This 
phenomenon was also shown in chapter 3 for a number of the Ocr multimutants, although 
these mutants displayed antirestriction and antimethylation activity from phage in vivo 
experiments. This difference could be due to the instability of the POcr mutants due to the 
loss of ~60-86% of acidic residues.  
On the other hand, several partially active POcr mutants reduced the growth of cells in the 
presence and absence of the EcoKI enzyme. The toxicity affect is common in the 
overproduction of recombinant mutants but due to the nature of the protein considered, as a 
DNA mimic, if mutation has not disrupted the shape and fold of the protein, it could mean 
that the POcr mutants are interacting with other components of the cell. This is supported by 
evidence of cell filamentation observed on E. coli cells expressing the toxic POcr mutants. 
The filamentation suggests the initiation of the SOS response as a result of DNA damage, 
which could be a result of POcr mutants interacting with other DNA–binding proteins. 
Although less probable, two factors increase its likelihood; the known binding of the wtOcr 
protein with E. coli RNA polymerase and the fact that one of the toxic POcr mutants Bx3.11, 




7.5.3 The enigma that is Bx3.11 
The most curious phenotype induced by a POcr mutant was from the mutant: Bx3.11. POcr 
mutant Bx3.11 demonstrates full antirestriction and antimethylation activity akin to wtOcr 
from the in vivo phage assay, (incidentally the only POcr mutant to do so, with the exception 
of the active POcr mutants described in chapter 5 and 6). However, POcr protein Bx3,11 also 
induces a toxic effect in the presence and absence of EcoKI. Microscopy images of E. coli 
NM1041 cells expressing the Bx3.11 construct have shown that a number of filaments were 
present, although the total number and size of the filaments were smaller than those induced 
by other toxic mutants. Therefore although this mutant appears to demonstrate full activity in 
vivo towards phage DNA, the expression of the construct is toxic towards the bacterial cell. 
This could suggest that either the specificity of the mutant has decreased by interacting with 
other DNA binding proteins in the cell including EcoKI or that expression of the construct is 
unstable producing insoluble protein which is detrimental to the cell. The POcr mutant 
Bx3.11 contains the largest number of acidic residues of the POcr mutants analysed in this 
chapter, with a total number of 15 acidic residues. Therefore sequence alignment studies 
were carried between the active POcr mutants and the mutant Bx3.11 to ascertain why 














Figure 7.12: Alignment studies of each of the active mutants with the mutant Bx3-11. 
Highlighted in red are acidic residues that are present in the protein sequence and yellow 
signifies where the residues has not been mutated back to an acidic residues and therefore 
remains a neutral residues from the original POcr template. 
 
The alignment of the protein, Bx3.11, with each of the active POcr mutants shows no 
striking differences between the protein sequences. Closer inspection of the sequences shows 
that the active POcr protein M1.1 is nearly identical to the toxic POcr mutant Bx3.11. The 
exception is the absence of the acidic residue at E88 on the Bx3.11 mutant, incidentally this 
residue is conserved on all four active POcr mutants. This suggests that this acidic residue is 
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crucial for the activity of the POcr protein M1.1 and its absence causes the protein to become 
toxic to the cell, although seemingly does not prevent the activity of the protein in the phage 
assay. A closer inspection of the E88 acidic residue shows that it forms part of a hydrogen 
bond network with amine groups of the POcr polypeptide chain located on the loop 2 region. 
As such it is thought that this hydrogen bond network may stabilise the loop 2 region of the 
protein. The loop 2 region has been highlighted as an important interaction interface in 
previous chapters and this result consolidates this theory. Not only this, the EM model of the 
EcoKI:Ocr interaction also displays this region at the interface of the two proteins and 
therefore this result also adds merit to this structural model.  
 
 
Figure 7.13: The EM structure of the Mtase:Ocr interaction. The Ocr protein is highlighted in 
wheat and the MTase in green. The E88 residue located on Helix D has been highlighted in 
cyan and the bond lengths of its side chain with the amine groups of the main peptide chain 
of the loop 2 region have been displayed using sticks and black dotted lines. The bond 
lengths are all ~3Å in length therefore could be possible hydrogen bonds.   
 
It is thought that the neutralisation of the E88 residue may destabilise the loop 2 region 
therefore producing a much more flexible interaction site which can therefore target other 
DNA-binding proteins as well as EcoKI.   The specificity of the interaction between wtOcr 









protein. The changes introduced on the Bx3.11 mutant could change the shape of the 
interface, decreasing the specificity of the POcr protein to interact as a DNA mimic towards 
other DNA/protein interactions, of which many distort/bend DNA upon binding.   
 
To conclude, the analysis of many POcr mutants with differing pI values indicate the 
importance of acidic residues to the antirestriction activity of POcr. The acidic residues were 
ranked producing a map of POcr that highlighted which acidic residues were most important 
and possibly what role they might possess. In addition, POcr mutants originally characterised 
as partially active were revealed to induce several types of behavior; they either exhibited 
some antirestriction activity or were toxic in E. coli cells. Analysis could not relate particular 
acidic residues with either phenotype but the formation of filaments indicated that the toxic 
mutants may provide promiscuous binding activity that subsequently induces the SOS 
response. Finally the mutant Bx3.11 possess its own unique behavior, although it binds to the 
EcoKI enzyme according to the phage infection assays (table 7.2), it is also toxic to E. coli 
cells. Furthermore its protein sequence shows that it is identical to the active POcr protein 
M1.1, with the exception of E88Q which is thought to reduce the specificity of Bx3.11 














Chapter 8. Mapping charge-function 
relationships 
 
In this study so far, each chapter has investigated the charge to function relationships of the 
Ocr homodimer using several different strategies. 
The results from each of the chapters has built on understanding the character of the protein 
Ocr; which is essentially a robust protein with a large number of non-essential acidic 
residues. However certain sequences that appear to follow no apparent trend in pI or hotspot 
coverage can initiate deleterious effects in the host bacterial cell. Therefore this chapter shall 
focus on aggregating all of the results to compile a profile of Ocr going from an active 
protein to an inactive protein.  
In order to do this several aspects associated with the charge and activities of the protein 
were analysed: 
1. The relationship between the total number of acidic residues and the isoelectric point for 
all the POcr and Ocr mutants analysed. 
2. The importance of acidic residues residing in the loop regions compared to non loop 
regions for the activity of the Ocr/POcr mutants 
3. The relationship between activity and acidic residues that reside in the loop region, the pI 
and acidic residues important for the structural integrity of the protein.  
Finally this chapter will present overall thoughts about the study, further work that is 
required and overall conclusions. 
 
8.1 Charge, residues and activity 
The number of acidic residues present on a POcr mutant should relate to its pI value. The 
activity of the Ocr protein is dependent on its ability to mimic DNA; therefore a decrease in 
the number of acidic residues should lead to a loss of activity. Although this has been 
demonstrated previously in chapter 7, by analysing all of the mutants from chapters 3-7 the 
relationships between the active, partially active and inactive mutants can be mapped out in 




Figure 8.1: Mutants of POcr and Ocr that were studied in each of the chapter 3-7 have been 
analysed according to their theoretical pI number (calculated by Expasy pI calculator) and 
the number of acidic residues that the mutant contains. 102 mutants were analysed and 
have been plotted according to their activity as a result of the 2AP RA assay, where; black = 
mutants that demonstrated full 2AP resistance (80µg/ml) and named active; Red = mutants 
that demonstrate deleterious effects in the assay were named partially active; Blue = 
mutants that had a 2AP resistance of 20µg/ml and so were inactive. The transparent red box 
highlights all of the mutants that have a smaller pI value and a higher number of acidic 
residues then most positively charged active POcr mutant (M1.9) that functions like wtOcr.  
 
The Figure 8.1 above shows that the activity of the POcr/Ocr proteins increases with a 
reduction in pI and an increase in the number of acidic residues. Active mutants appear to 
have the largest number of acidic residues and the lowest isoelectric point; these have been 
highlighted in the red oblong in figure 8.1. However there are a number of inactive and 
partially active mutants which are also in this range, these mutants also possess a large 
number of acidic residues and low pI values but are not fully active antirestriction proteins. 
This highlights that the amount of charge on the surface of the protein is not the only factor 
that governs the activity of Ocr.  
The inactive mutants are distributed widely with a pI range of 4.0-10.0 with 0-13 acidic 
residues. This again demonstrates that pI and the sheer number of acidic residues present on 
an Ocr/POcr mutant does not allow it to function as an antirestriction protein.  
The distribution of the partially active mutants shows a pI range of 3.9-9.5 and a maximum 
































































the majority of partially active mutants are concentrated at a pI range of 4.0-6.0. Although 
the distribution of partially active mutants seems to span the pI range of POcr to Ocr, results 
in chapter 7 revealed that the partially active phenotype harbored several different 
phenotypes, figure 8.2. These included; POcr mutants that were toxic to all E. coli cells 
(yellow in figure 8.2) and those specifically toxic to cells with a Type I RM system (green in 
figure 8.2).  As a result the partially active mutants were re-categorised taking into account 
these two new phenotypes that were observed in chapter 7, Y/Y and Y/N respectively.  
 
Figure 8.2: Mutants of POcr and Ocr that were studied in each of the chapter 3-7 have been 
analysed according to their theoretical pI number (calculated by Expasy pI calculator) and 
the number of acidic residues that the mutant contains. 102 mutants were analysed and 
have been plotted according to their activity as a result of the 2AP RA assay, where; black = 
mutants that demonstrated full 2AP resistance (80µg/ml) and named active; red = mutants 
that demonstrate deleterious effects in the assay were named partially active; blue = mutants 
that had a 2AP resistance of 20µg/ml and so were inactive. In green and yellow are mutants 
that were examined in chapter 3 and 7 and revealed a number of partially active mutants; 
that were toxic in E. coli cells in the presence of the HsdR subunits (green) and other 
mutants that were toxic to all cells (yellow). 
 
The results showed no clear relationship between the pI value and the number of acidic 
residues on the degree of toxicity induced by the mutants. However, no toxic mutants 
possessed over 15 acidic residues and a pI value less than 4.5. Instead the partially active 
mutants that are above this threshold were toxic in the presence of the HsdR subunit only. 












































Type I RM systems producing an M+/-R+/- phenotype. The only toxic mutant that appeared to 
be in the same range as the active mutants was the POcr mutant Bx3.11. Analysis in chapter 
7 showed that this mutant is identical to the active POcr mutant M1.1 with the exception of 
the acidic residue E88, which has presumably lead to instability and/or  promiscuous activity 
with other DNA binding proteins.  
Analysis of the active mutants shows that a minimum of 38% of the acidic residues and a pI 
of 4.5 is all that is required to maintain full antirestriction and antimethylation activity. 
However there are exceptions, a number of inactive mutants and partially active mutants 
have the minimum requirements for activity but they do not retain or only partially retain the 
activity of the Ocr protein. Sequence alignment of these mutants shows that acidic residues 
are reduced in the loop1 or loop 2 regions. This confirms that the number of acidic residues 
and the pI are important however they are not the only parameters that govern the activity of 
the protein and the position of the acidic resides are also important. 
8.2 Loop region versus non-loop region 
The analysis above and the results in chapter 3 showed that the loop regions are important 
for the activity of the protein. Therefore the relationship between the activity of the proteins 
was analysed with the % of acidic residues that were present in Loop regions and non-Loop 
regions which were defined as; Loop Regions= Loop1 aa25-33, Loop2 aa58-77 and Non-




Figure 8.3: Mutants of POcr and Ocr that were studied in each of the chapter 3-7 have been 
analysed according to the percentage number of residues that were found in the loop 
regions (aa25-33 and aa58-77) and non loop regions (aa7-24, 34-44, 49-57 and 78-106). 
The same mutants that were assorted in figure 8.1 were used within the analysis and plotted 
according to their activity as a result of the 2AP RA assay, where; black = mutants that 
demonstrated full 2AP resistance (80µg/ml) and named active; Red = mutants that 
demonstrate deleterious effects in the assay were named partially active; Blue = mutants 
that had a 2AP resistance of 20µg/ml and so were inactive. The transparent red box 
highlights all of the mutants that have a greater ratio of loop: non loop acidic residues then 
most positively charged active POcr mutant (M1.9) that functions like wtOcr.  
 
It is apparent that the proportion of acidic residues in the loop region compared to the non-
loop region is important to the activity of the mutants. The results do not take account of 
acidic residues that reside on the tail region of POcr or Ocr mutants, as it was found that 
these residues are not important towards the antirestriction activity of the mutants. The 
results in Figure 8.3 above showed that the minimum requirement of acidic residues for an 
active mutant contained a ratio of 40%:35%, Loop: Non-loop; this can be reduced to 30% of 
the acidic residues in the non-loop region however this is counterbalanced by the enrichment 
of the loop region to ~60%.  
Although full activity was observed for POcr mutant M1.9, at a ratio of 40%:35% Loop: 
Non-Loop, a number of Ocr/POcr mutants, that have been highlighted by the red box in 
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Figure 8.3, possesses the minimum requirements for activity but do not retain full activity. 
These mutants will be looked at in more detail and compared to the active POcr mutant, 














s1.9 A 13 4.56 42 35 7 
C2 IN 13 4.75 44 39 4 
M12 PA (THsdR) 23 3.96 67 100 5 
M16 PA (T HsdR) 24 4.1 56 87 4 
Dg7 PA (THsdR) 12 4.63 44 35 5 
Dg11 PA (THsdR) 16 4.35 48 43 3 
2+1-8 PA (T) 11 4.72 51 35 2 
Table 8.1: POcr and Ocr multimutants that are either inactive or partially active and 
represented in the red box in figure 8.2 as retaining properties that exceeded the active 
mutant M1.9. The properties that were analysed in figure 8.1 and 8.2 have been compared 
the properties of the active mutant that contains the minimum number of protein that are 
required for full activity where A, IN and PA identify active, inactive and partially active 
phenotypes according to the 2AP assay and T represents mutants that induce a toxic effect 
with THsdR signifying mutants that induce a toxic effect only in the presence of the HsdR 
subunit.  
 
The table shows that each of the POcr mutants have similar properties and contain acidic 
residues that exceed the numbers found in the active mutant M1.9. However expression of 
these mutants induces a different phenotype in the 2AP assay. Phage infection showed that 
the mutants M1.9, M12 and M16 all exhibited full activity but, in vitro studies in chapter 3 
showed that the Ocr multimutants M12 and M16 possessed a weak binding affinity to 
M.EcoKI, whereas M1.9 was a tight binding enzyme. The mutant C2 was inactive from all 
the assays carried out and the mutant 2+1-8 was toxic to all E. coli cells. This leaves the 
mutants Dg7 and Dg11 which were deleterious in the presence of the HsdR subunit and 
inactive in the phage assay, it is thought that this phenotype is also a result of a weak binding 





2+1-8 MAMSNMTYNNVFDHAYQMLKQNIRYNDIRDTNNLHNAIHMAANNAVPHYYANIFSVMASE        
Dg7 MAMSNMTYNNVFNHAYQMLKENIRYDNIRNTNDLYNAIHMAADNAVPHYYADIFSVMASE      
Dg11 MAMSNMTYNNVFNHAYQMLKENIRYDDIRDTDNLHDAIHMAANNAVPHYYADIFSVMASQ        
C2 MAMSNMTYNNVFNHAYQMLKENIRYNDIRDTNNLHNAIHMAANNAVPHYYADIFSVMASE       
M12 MAMSNMTYNNVFDHAYEMLKENIRYDDIRDTDDLHDAIHMAADNAVPHYYADIFSVMASQ       
M16 MAMSNMTYNNVFNHAYQMLKQNIRYNNIRDTDDLHDAIHMAADNAVPHYYADIFSVMASQ      
M1.9  MAMSNMTYNNVFNHAYQMLKENIRYNDIRDTDDLHNAIHMAADNAVPHYYADIFSVMASE 
************:***:***:****::**:*::*::******:********:*******: 
2+1-8 GIDLQFQNSGLMPDTKDVIRILQARIYQQLTINLWEDAEDLLNQYLQQVQQYEQNEQ          
Dg7 GIDLQFQNSGLMPDTKDVIRILQARIYQQLTINLWQDAEDLLNQYLQQVQQYQQNQQ         
Dg11 GIDLQFQNSGLMPDTKDVIRILQARIYQQLTIDLWQNAQDLLNQYLEQVQQDAEDQQ           
C2 GIDLQFQNSGLMPNTKDVIRILQARIYQQLTIDLWEDAQNLLNQYLEQVQQYQENQE          
M12 GINLQFQNSGLMPDTKDVIRILQARIYEQLTIDLWEDAEDLLNEYLEEVEEYEENQE          
M16 GINLQFQNSGLMPDTKDVIRILQARIYEQLTIDLWEDAEDLLNEYLEEVEEYEENQE         
M1.9 GINLQFQDSGLMPDTKDVIRILQARIYEQLTIDLWQNAQNLLNQYLQQVQQYQENQQ 
   **:****:*****:*************:****:**::*::***:**::*::  :::: 
Figure 8.4: Sequence alignment (carried out by Clustal Omega software) of the mutants in 
table 8.1. Many of these mutants exhibit similar properties (i.e. pI, acidic residues in the loop 
region) as the active POcr mutant M1.9, however they do not induce full antirestriction 
activity. In blue is the neutral residue N52 that is conserved only on mutant 2+1-8 which is 
toxic. In green the acidic residue D68 that is conserved on the active mutant M1.9 only and 
in pink the neutral residue N74, conserved only on the inactive mutant C2. The acidic 
residues that are underlined in bold; D52, D74 and E88 show a triplet of residues that are 
only conserved on the mutants M12, M16 and M1.9.  
 
The alignment of the sequences does not show a clear pattern as to why each of the mutants 
are similar and yet display different antirestriction and antimodification activities. However a 
closer inspection of the sequences does reveal some subtle differences between each of the 
mutants. The only clear difference between the active mutant M1.9 and the other sequences 
is the absence of the acidic residue at D68 (highlighted in green). This suggests that this 
particular residue might be important to the activity of Ocr. In fact, this residue is conserved 
among each of the active POcr mutants. Each of the other mutants appear to be missing at 
least three of the conserved residues that were discovered in chapter 5 (E21, D43, D52, E60, 
D68, D77 and E88). Notably a number of these conserved residues are not present in either 
of the loop regions.  
However, comparisons between the inactive mutant C2 and each of the other mutants 
showed that C2 was the only mutant that did not possess an acidic residue at position 74. 
N74, highlighted in magenta, appears to be conserved only in the inactive C2 mutant. 
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Sequence alignment comparisons did not reveal any other clear differences between the 
inactive mutant C2 and the other mutants although the loop2 region contains only one acidic 
residue. This suggests that the absence of the acidic residue D74 and the absence of acidic 
residues in the loop 2 region are detrimental to the activity of the protein.  
The properties outlined in Table 8.1 for the inactive mutant C2 shows that it is similar to the 
mutant 2+1-8 which is toxic to all cells. These mutants possess the highest pI values of the 
mutants analysed and both contain a similar number of acidic residues in the Non-Loop 
region. Alignment of the toxic mutant 2+1-8 showed that the neutral residue N52 is 
exclusively conserved on 2+1-8, which implies that the absence of an acidic residue at this 
position seems to destabilise the protein. As a result this residue appears to be structurally 
important as its absence induces a toxic effect. Furthermore, the mutant 2+1-8 only contains 
2 of the seven acidic residues that were found to be conserved among each of the active 
mutants in chapter 6.  
The remaining mutants include Dg7 and Dg11, which exhibit partial activity in the 2AP plate 
assay but are inactive in the phage infection experiments, and the mutants M12 and M16, 
which are also partially active in the 2AP assay but active in the phage infection assay. It 
was more difficult to be able to define the residues responsible for each of the phenotypes 
exhibited as they closely resembled each other. However by looking at groups of residues, in 
particular at residues that were already highlighted as absent from the other phenotypes (i.e., 
D52 and D74), the acidic residues D52, D74 and E88 were seen to be conserved in the 
mutants M12 and M16. The mutants Dg7 and Dg11 also contain the acidic residues D52 and 
D74 but not the residue E88; this seems to have reduced the activity of these mutants in 
comparison to the mutants M12 and M16.  
Analysis of each of the sequences in Figure 8.4 can reveal differences which enables  
differentiation between the different phenotypes induced by the mutants. However the 
differences are hard to define without looking at each sequence carefully. This could be due 
to the small subset of potential POcr/Ocr multimutants that have been analysed. Perhaps with 
a larger number of POcr/Ocr proteins, the trends and relationships between activity and 





8.3 Structural residues versus loop region residues versus pI  
Overall the results above suggest that a number of specific acidic residues may contribute to 
more than just the electrostatic interactions of the Ocr protein towards Type I RM systems. 
The absence of acidic residues appears to affect the solubility of the mutants, for example, in 
chapter 7 the induction of some mutants led to the formation of inclusion bodies. 105 By 
aligning the sequences of Ocr/POcr mutants that are known to be soluble, the conservation of 
acidic residues should reveal residues important to the structure and stability of the Ocr 
protein.  
 
Figure 8.5: Sequence alignment (carried out by Clustal Omega software) of the soluble 
mutants from chapter 3 and chapter 6. Highlighted in red are all the acidic residues that have 
been reintroduced onto the mutants and in yellow are the remaining target sites where acidic 
residues are present in wtOcr from T7 bacteriophage.  Underlined are residues that are 
conserved or almost conserved in each of the mutants, it is possible that these mutants may 
be structurally important. O/P signifies the Ocr multimutant Ocr/POcr studied in chapter 3. 
 
The acidic residues that are almost completely conserved in the alignment study in Figure 
8.5 were; D43, D52, D74, D77 and E88. None of these residues are involved in the loop 
M2.1 MAMSNMTYNNVFNHAYQMLKENIRYNDIRDTNNLHNAIHMAADNAVPHYYADIFSVMASE      
M1.1  MAMSNMTYNNVFNHAYQMLKENIRYDNIRDTNDLHDAIHMAADNAVPHYYADIFSVMASE      
M1.9 MAMSNMTYNNVFNHAYQMLKENIRYNDIRDTDDLHNAIHMAADNAVPHYYADIFSVMASE      
M2.8 MAMSNMTYNNVFNHAYQMLKENIRYDDIRDTDDLHDAIHMAADNAVPHYYADIFSVMASE        
M1 MAMSNMTYNNVFNHAYQMLKQNIRYNNIRDTDDLHDAIHMAADNAVPHYYADIFSVMASE        
M2 MAMSNMTYNNVFDHAYEMLKENIRYNNIRNTNNLHNAIHMAADNAVPHYYADIFSVMASE        
M3 MAMSNMTYNNVFDHAYEMLKENIRYDDIRDTDDLHDAIHMAADNAVPHYYADIFSVMASE        
M4 MAMSNMTYNNVFDHAYEMLKENIRYDDIRDTDDLHDAIHMAADNAVPHYYADIFSVMASE        
M7 MAMSNMTYNNVFDHAYEMLKENIRYNNIRNTNNLHNAIHMAADNAVPHYYADIFSVMASE       
M11 MAMSNMTYNNVFDHAYEMLKENIRYNNIRNTNNLHNAIHMAADNAVPHYYADIFSVMASQ       
M16 MAMSNMTYNNVFNHAYQMLKQNIRYNNIRNTNNLHNAIHMAADNAVPHYYADIFSVMASQ        
O/P MAMSNMTYNNVFDHAYEMLKENIRYDDIRDTDDLHDAIHMAADNAVPHYYADIFSVMASE       
************:***:***:****::**:*::**:***********************  
M2.1 GIDLEFEDSGLMPDTKDVIRILQARIYEQLTIDLWENAQNLLNQYLQQVQQYQQNQQ          
M1.1 GIDLQFEDSGLMPNTKDVIRILQARIYEQLTIDLWQDAQNLLNQYLQQVQEYQQNQQ          
M1.9 GINLQFQDSGLMPDTKDVIRILQARIYEQLTIDLWQNAQNLLNQYLQQVQQYQENQQ          
M2.8 GIDLQFQDSGLMPDTKDVIRILQARIYEQLTINLWEDAEDLLNQYLQQVQEYQQNQQ           
M1 GIDLEFEDSGLMPDTKDVIRILQARIYEQLTIDLWEDAEDLLNEYLEEVEEYEEDEE            
M2  GIDLEFEDSGLMPDTKDVIRILQARIYEQLTIDLWEDAEDLLNEYLEEVEEYEEDEE           
M3  GINLQFQNSGLMPNTKDVIRILQARIYEQLTIDLWEDAEDLLNEYLEEVEEYEEDEE           
M4 GIDLEFEDSGLMPDTKDVIRILQARIYEQLTINLWQNAQNLLNEYLEEVEEYEEDEE            
M7 GIDLEFEDSGLMPDTKDVIRILQARIYEQLTINLWQNAQNLLNEYLEEVEEYEEDEE          
M11 GINLQFQNSGLMPDTKDVIRILQARIYEQLTIDLWEDAEDLLNEYLEEVEEYEEDEE          
M16 GINLQFQNSGLMPDTKDVIRILQARIYEQLTIDLWEDAEDLLNEYLEEVEEYEEDEE          




regions. As such these residues would not have been considered in the previous analysis in 
figure 8.3, which showed the relationship between loop and non-loop regions. However the 
fact that these acidic residues are conserved or almost conserved among soluble Ocr/POcr 
mutants implies their relevance to the structurally integrity of the Ocr protein. Furthermore, 
alignment of the mutants in figure 8.5 with Ocr proteins from other phage entities, shows 
that the residues D77 and E88 were conserved and the remaining target sites were either 
almost conserved (D43) or had conserved acidic residues, therefore either D or E residues at 
the following target sites; D/E52 and D/E74.   
Considering all of the findings so far, the relationship between negative charge and the 
function of the protein appears to follow three stages of development. Firstly an adequate 
number of acidic residues are required to produce a low pI value, secondly, the concentration 
of negative charge in the loop regions needs to be adequate and thirdly, the presence of 
acidic residues which appear to stabilise and allow the protein to fold adequately.  The 
following three factors were analysed; the number of acidic residues, the % number of 
residues that reside in the loop region and the % of residues present which are thought to be 









Figure 8.6: Mutants of POcr and Ocr that were studied in chapter 3-7 have been analysed 
according to the percentage number of residues that were found in the loop regions (aa25-
33 and aa58-77) and the theoretical isoelectric point (calculated on Expasy protein 
calculator) and structurally relevant residues (D43, D52, D74, D77 and E88) The same 
mutants that were assorted in figure 8.1 and figure 8.2 were used within the analysis and 
plotted according to their activity as a result of the 2AP RA assay, where; black = mutants 
that demonstrated full 2AP resistance (80µg/ml) and named active; Red = mutants that 
demonstrate deleterious effects in the assay were named partially active; Blue = mutants 
that had a 2AP resistance of 20µg/ml and so were inactive. 
 
From figure 8.6 it is clear that each of the active mutants possesses a low pI number, large % 
of acidic residues in the loop regions and most if not all of the structurally important residues 
are present. The graph does illustrate the importance of these three parameters for the active 
mutants and that the minimum requirements for an active mutant include; a pI value of 4.5, 
at least 40% of the acidic residues in the loop regions, and 4 out of 5 structurally-relevant 
acidic residues. Most importantly the properties of the inactive mutants appear to be 
consistently lower than the fully active mutants. In addition there were only a number of 
partially active mutants that had the same properties as the active mutants. These were the 
Ocr mutants, M12 andM16. However these mutants lacked a key feature, namely, 100% of 
the acidic residues in the midloop region were absent from both mutants. 
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The partially active and inactive mutants are distributed across a narrow plane of the 
potential sequence space provided by each of the parameters investigated. The partially 
active mutants appear to be concentrated between the two extremes of the graph; possessing 
a pI of 5-6, an average of 3 structural residues and between 20-30% of the acidic residues in 
the loop regions. 
Nevertheless, a number of exceptions do not appear to follow this general pattern, this could 
be because these mutants have not been fully characterised. In light of the results from 
chapter 7 a number of unclear phenotypes emerged that suggested that the partially active 
phenotype encompassed a multitude of activities which included, figure 8.7; toxic mutants 
(yellow), mutants that appear to be partially active but fail to prevent the restriction of phage 
DNA (magenta), partially active mutants which are toxic (brown) and partially active 
mutants (green), this would make the relationship between phenotype and charge more 








Figure 8.7: Mutants of POcr and Ocr that were studied in chapter 3-7 have been analysed 
according to the percentage number of residues that were found in the loop regions (aa25-
33 and aa58-77) and the theoretical isoelectric point (calculated on Expasy protein 
calculator) and structurally relevant residues (D43, D52, D74, D77 and E88) The figure is the 
same as figure 8.6 but the partially active mutants in red have been subdivided into; Yellow, 
mutants that are toxic to all E. coli cells; Green, mutants that exhibit the M+/-R+/- phenotype; 
Magenta, mutants that are partially active from the 2AP assay but are inactive from the 
phage assay and dark red, mutants that are partially active and toxic. Highlighted in red were 
the remaining partially active mutants of the 2AP assay that were not further characterised 
the other mutants exhibited in black and blue were as previously described; black = mutants 
that demonstrated full 2AP resistance (80µg/ml) and named active and Blue = mutants that 
had a 2AP resistance of 20µg/ml and so were inactive. 
 
The graph above tries to differentiate the partially active mutants further. No clear 
relationship can be resolved between the different phenotypes and the three properties that 
have been analysed in figure 8.6. However the results do show that those mutants that are 
partially active (green) possess a low pI value and a large number of structurally relevant 
acidic residues however, the number of acidic residues in either or both loop regions is 
diminished. These mutants express protein and even provide antirestriction activity towards 
phage, however, upon over expression these mutants, in the presence of EcoKI, produce 
toxic effects in E. coli.  The mutant Bx3.11 (dark red) induces the same behaviour, however, 
a reduction in the total number of acidic residues and the absence of the structurally relevant 
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E88 residue means that this protein is active for phage infection but toxic to E. coli. It is 
more difficult to distinguish between the toxic, inactive POcr mutants in yellow and the 
partially active mutants in magenta. Unlike the Y/N Ocr multimutants (green partially active 
mutants) these POcr mutants fail to inhibit the restriction of phage DNA.  
8.4 General discussion 
To summarise, the analysis carried out in this study has started to piece together the in vitro 
evolution of the Ocr protein. The results have shown that the location as well as the number 
of acidic residues present on the wtOcr protein is important for antirestriction activity. The 
acidic residues that reside on the loop regions of the protein appear to be particularly 
important in the electrostatic interaction of the protein with its binding partner, EcoKI (Type 
I RM systems). The results show that within these two loop regions, only a few acidic 
residues need to be present to elicit a fully functional response. Acidic residues within the 
loop regions that are conserved among the active POcr mutants only include E60 and D68 
which reside in loop2 and no residues were conserved in the loop 1 region.  
Mutations in Loop 1 in conjunction with either the Loop 2 region or a second region (M4) 
located on Helix D can completely abolish the activity of Ocr. The M4 region, aa93-100, has 
a similar effect to the Loop 1 region; results from chapter 3 suggest that the absence of acidic 
residues in this region itself had no effect on the antirestriction activity of Ocr, however, in 
combination with the neutralisation of either the Loop 1 or Loop2 region, activity was 
completely lost. Furthermore in vitro characterisation of M7 (neutralisation of both the 
Loop1 and M4 regions) showed that antirestriction activity was reduced however 
antimethylation activity was still fully functional. This was confirmed by the reduced 
antirestriction activity exhibited by the active POcr proteins, analysis showed that a 
maximum of only 20% of the acidic residues in the M4 region were present on each of the 
active POcr proteins. However, this had no noticeable effect on the activity of the POcr 
mutants in vivo and does not affect the binding interaction of the protein to the M.EcoKI 
enzyme. The differentiation in vitro between the antirestriction and antimethylation activity 
displayed for each of the active POcr proteins implies that there might be a secondary 
binding site located on the Ocr protein (at aa93-100), which binds to the HsdR subunit 
producing a more stable interaction.  
The selection of the minimum number of acidic residues that retained the full activity of the 
Ocr protein in chapter 5 demonstrated that a loss of over 60% of the acidic residues on the 
Ocr protein, had no effect on the activity of the protein. In addition truncations of the Ocr 
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protein showed that the loss of the negatively enriched C-terminal region (10 acidic residues) 
had no effect on activity. The C-terminal region contains over 40% of acidic residues on the 
Ocr protein.  
Sequence alignments studies of POcr mutants in chapter 7 revealed the importance of acidic 
residues towards the structural integrity of the protein. The most important finding in chapter 
7 was the observation of toxic POcr mutants. The most peculiar of these was Bx3.11 which 
is; fully active from phage infection assays, induces partial activity from the 2AP assay but 
was toxic to all E. coli cells. This demonstrated a new phenotype where the toxicity effect 
did not affect its antirestriction activity towards phage DNA. Sequence analysis reveals that 
the POcr mutant Bx3.11 has a protein sequence identical to the active POcr mutant M1.1, 
with the exception of the acidic residue E88 which is Q88 on Bx3-11. This shows that 
reducing the charge of one acidic residue has destabilised the protein, the absence of E88 
appears to disrupt a hydrogen bond network which stablises the loop 2 region. Evidence of 
filamentation suggests that this disruption has initiated the SOS response which could 
inadvertently be due to promiscuous activity of the mutant Bx3.11 with other DNA binding 
proteins. 103,102,128,129 Notably, in 1974 D.Ratner et al127, discovered that the Ocr protein had a 
strong interaction with E. coli RNA polymerase (RNAP). As a RNA binding protein it has 
many mechanistic similarities to EcoKI, both contain helicase domains and Mg2+ binding 
sites. However, studies need to be carried out to ascertain if the POcr proteins do indeed 
provide any promiscuous activity.     
Overall the results from chapter 7 highlighted that a number of acidic residues that were not 
located in the loop region were important for the structural integrity of the protein. This has 
been further recognised by the sequence alignment in figure 8.4 which indicated that the 
mutants D43, D52, D74, D77 and E88 were likely to be these structural residues.    
 
8.5 Overall conclusions and looking ahead 
To conclude, this study has shown that the number of acidic residues in the loop region, a 
low pI value and the number of structurally relevant proteins are important in producing an 
effective antirestriction protein. The investigations have shown that many of the acidic 
residues on the surface of Ocr appear to be redundant for the function of the protein. The 
conservation of over 60% of the acidic residues on Ocr proteins from different bacteriophage 
appear to have no obvious selective advantage, with the revelation that 13 out of a possible 
34 residues is the minimum number required to retain full activity of the protein Ocr.  
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Yet the Ocr proteins have evolved with many of these supposedly useless acidic residues 
conserved. Therefore it is likely that the Ocr protein has not evolved from a neutral protein 
scaffold and gradually selected for acidic residues but has evolved from a protein already 
enriched with a large number of acidic residues. The in vitro evolution of negative charge on 
the protein Ocr shows that the loss of charge in the loop regions induces a partially active 
mutant that is detrimental to E. coli in the presence of a Type I RM system. Furthermore, the 
acidic residues in the M4 region possibly form a secondary interaction hotspot specific to the 
restriction subunit. 
However further investigations need to be performed to assess the effect of charge on the 
solubility of the protein by carrying out expression trials and possibly by tagging the protein 
with a fluorescent tag and identifying the production of inclusion bodies. In addition the 
investigations carried out in this study only managed to elucidate four unique POcr mutants 
that were active and on the borderline of activity. Further screening of the library LibDg 
could hopefully reveal more active mutants; this would provide more information and a 
clearer link between activity and charge.  
In addition, further investigations on whether the residues within the loop regions are 
interchangeable with one another could be carried out using the active POcr mutants such as 
mutant M2.1. 
More long term studies would include identifying if the POcr mutants possess promiscuous 
interactions with other DNA binding proteins. This could be done by carrying out pull down 
assays from cell extracts or by attempting to purify the proteins. Due to their 
toxicity/solubility these mutants could be tagged to help purify the protein. Genetic knockout 
assays could be designed to pinpoint other interactions.   
Being able to understand how the charge of the protein can be used to change the selectivity 
of a protein like Ocr could lead to the production of tailor-made inhibitors for DNA 
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Figure A.8: Bacterial Growth Curves with the Ocr mutants expressed in E. coli, NM1041 
(clpXP-, r+m+) cells in the absence of 2AP. pTrc99A is the vector alone, all other data are for 
cells expressing Ocr wild-type (wt) or Ocr mutants. OD600 measurements were recorded 
every 15 min for 500 min. Errors are ±7% for triplicate measurements (error bars not shown 






Figure A.9: The ITC traces which follow the reaction between M.EcoKI with wtOcr (black) 
and wtOcr with buffer (20 mM HEPES, pH 8.0, 6 mM MgCl2, 7 mM 2-mercaptoethanol). The 
"Sample Cell" contained the M.EcoKI, while the "Syringe" contained wtOcr protein. The 




ArdA is an antirestriction protein and, like wtOcr, it functions as a competitive inhibitor of 
EcoKI by mimicking the shape and charge of B-form DNA. However, there are also many 
fundamental differences between the two antirestriction proteins; the ArdA protein is more 
elongated mimicking 42bp of dsDNA compared to Ocr which mimics 24bp dsDNA, the 
secondary structure fold of both proteins is also different, indicating that they belong to two 
separate protein families. Furthermore, the antirestriction proteins are located on different 
types of mobile genetic elements. Genes that code for the Ocr protein reside in lytic 
bacteriophage whereas the ArdA gene locus is highly dispersed among conjugative plasmids 
and transposons.  
Each of these mobile elements behaves differently upon infection; lytic bacteriophage dock 
onto the cell membrane of the bacterial cell and inject the phage genome into the cytoplasm. 
Upon replication of the virion, the phage initiates cell lysis and destroys the bacterial cell. 
Once destroyed the phage progeny are released and able to subsequently infect and replicate. 
However, conjugative plasmids are symbiotic in nature, consisting of circular dsDNA. These 
mobile genetic elements are transferred into bacterial cells by direct conjugational transfer.  
As a result the plasmid can replicate and produce proteins and genes that can be 















advantageous to the bacterial cell. The key difference between conjugative transposons and 
plasmids is that transposons tend to integrate into the chromosomal DNA, whereas plasmids 
remain separate from the host genome.  
Previous studies of ArdA proteins from different transposons and plasmids have shown that, 
unlike Ocr, the ArdA proteins can exhibit differential activity towards antirestriction and 
antimodification activity depending on the particular ArdA protein and the particular Type I 
RM system being targeted. Furthermore comparisons of the binding affinity of wtOcr from 
T7 bacteriophage and Orf18 ArdA from the transposon Tn916 shows the ArdA has a weaker 
interaction to EcoKI compared to wtOcr. In addition, ArdA proteins exist as a monomer and 
homodimer in solution, in fact the monomer is dominant at lower concentrations whereas the 
homodimer is prevalent at higher concentrations.  
During the development of the 2AP in vivo assay, a study to investigate the loss of negative 
surface charge upon the three domains that exist on the Orf18 ArdA protein was underway in 
the lab (by Dr GA Roberts). In a similar manner to the Ocr mutant investigation, several 
mutants were designed which targeted acidic residues residing on different regions (in this 
case the three different domains) of the Orf18 ArdA protein structure. These acidic residues 
were neutralised by substitutions of aspartic and glutamic acid to asparagine and glutamine 
respectively. In addition, a mutant which targeted the hydrophobic interactions of the dimer 
interface, with the aim of producing an ArdA monomer protein, was created. Although in 
vivo characterisation of the ArdA mutants was carried out by assessing the success of phage 
infection on restriction proficient and deficient cells, further in vitro characterisation could 
not be carried out on a number of the ArdA mutants. Attempts to purify the protein showed 
that there was variable expression between the mutants. In fact insufficient protein was 
expressed to be detected on a DEAE column making purification of these mutants difficult. 
Therefore the mutants were investigated with the 2AP RA assay. This provided the 
opportunity to test the assay on a set of mutants from a different antirestriction protein, 
assessing the flexibility and versatility of the assay. Also the study should hopefully allow us 
to gain a more detailed profile for the activity of the ArdA protein. 
ArdA multimutants 
The initial design and creation of the ArdA mutants including the subsequent in vitro 
characterisation of the mutants M5, M6, L127E were carried out by Dr G.A. Roberts and 





Figure A.10: The primary amino acid and DNA sequence of the Orf 18 ArdA wild type (wt) 
protein. Highlighted are the targets of mutagenesis, the acidic residues aspartic and glutamic 
acid were substituted with asparagines and glutamine respectively. Each color represents a 
different ArdA multimutant.  
In vivo restriction alleviation assay  
From Figure 3.2 in chapter 3, it was shown that like wtOcr, the presence of an active ArdA 
protein can rescue the cell viability of E. coli NM1041 exposed to 2AP by inhibiting the 
EcoKI enzyme.  
E. coli NM1041 cells were transformed with each of the ArdA mutants. The effect of 2AP 
on cell survival, in the presence of the ArdA mutants is shown in Figure 10.4. The RA assay 
was carried out with leaky expression (-IPTG) and over expression (+IPTG) to discern any 
differences in activity. RM enzymes are present in low concentrations in the cellular 
environment; this small amount of expression can be represented in the leaky expression of 
the mutants as well as reflecting the conditions used in the phage infection experiment.  
atggacgatatgcaagtctatattgcgaatttaggcaaatacaatgagggcgaattggtc 
 M  D  D  M  Q  V  Y  I  A  N  L  G  K  Y  N  E  G  E  L  V  
ggtgcgtggtttacctttcccattgactttgaggaagtcaaagagaaaatcggcttgaat 
 G  A  W  F  T  F  P  I  D  F  E  E  V  K  E  K  I  G  L  N  
gatgaatatgaggaatacgccattcatgactacgagttaccctttacggttgacgaatac 
 D  E  Y  E  E  Y  A  I  H  D  Y  E  L  P  F  T  V  D  E  Y  
acttccattggcgaactcaatcgactatgggaaatggtatcggaattacccgaagaatta 
 T  S  I  G  E  L  N  R  L  W  E  M  V  S  E  L  P  E  E  L  
caatcggagctatctgctctgctcactcatttttcaagcattgaagaactaagcgaacat 
 Q  S  E  L  S  A  L  L  T  H  F  S  S  I  E  E  L  S  E  H  
caagaggatattatcattcattccgattgtgatgatatgtatgacgtggcacgctactac 
 Q  E  D  I  I  I  H  S  D  C  D  D  M  Y  D  V  A  R  Y  Y  
attgaagaaacgggtgctttaggcgaagtaccagctagtcttcaaaactatattgattat 
 I  E  E  T  G  A  L  G  E  V  P  A  S  L  Q  N  Y  I  D  Y  
caagcctatggtcgggatttagacctttcaggaacgtttatctcaaccaatcatgggatt 
 Q  A  Y  G  R  D  L  D  L  S  G  T  F  I  S  T  N  H  G  I  
tttgaaatcgtctattaa 














Figure A.11: The RA assay measuring cell survival of E. coli NM1041 (clpXP−, r+m+) when 
transformed with various plasmids expressing Orf 18 ArdA or its mutant forms. The graph 
shows growth on LB-agar plates supplemented with antibiotics (cyan) only, and in the 
presence of antibiotics plus increasing concentrations of 2AP (20, 40 and 80 µg/ml are green, 
red, and magenta, respectively).  
 
In the absence of 2AP, the E. coli strain grew well for all of the ArdA mutants at 107 cells 
per ml. A loss in cell viability was observed for cells grown with the empty plasmid vector 
pTrc99A, at a concentration of 20µg/ml. This is consistent with observations from the Ocr 
experiments and represents the resistance conferred by an inactive antirestriction protein.  
Cells grown with each of the ArdA mutants possessed the same resistance to 2AP, each of 
the mutants lost cell viability at a 2AP concentration of 40µg/ml. However, wtArdA 
maintains 2AP resistance at a concentration of 80ug/ml. This suggests that all of the mutants 
provide some antirestriction activity, although this is reduced compared to wtArdA protein 






Figure A.12: The RA assay measuring cell survival of E. coli NM1041 (clpXP−, r+m+) when 
transformed with various plasmids expressing Orf18 or its mutant forms. The graph shows 
growth on LB-agar plates supplemented with antibiotics (cyan) only, antibiotics and IPTG 
(green) and, in the presence of antibiotics, IPTG plus increasing concentrations of 2AP (10, 
20, 40 and 80µg/ml are red, magenta and olive, respectively).  
 
The 2AP resistance exhibited by E. coli cells in the presence of pTrc99A vector or wtOrf18 
ArdA remained unchanged from the uninduced assay and E. coli cells overexpressing each 
mutant displayed a resistance that was no greater than 40µg/ml, confirming that none of the 
mutants functioned as a fully active antirestriction protein. However, E. coli NM1041 cells 
upon overexpression of the mutant Mut5/6 reduced 2AP resistance from a concentration of 
20µg/ml to 10µg/ml; this is the same resistance as the pTrc99A vector indicating that the 
mutant Mut5/6 is inactive. 
Upon induction by IPTG, cells grown with the mutants, Mut1, Mut2, Mut4, Mut6 and L127E 
showed toxic effects and loss of cell viability was observed for Mut1/2 at 10µg/ml, these 
mutants share the same phenotype witnessed by the Ocr mutants M12, M16, Ocr/POcr and 
M3. However the remaining ArdA mutants have shown new phenotypes.  
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The 2AP resistance experienced by the remaining mutants ranges from 20µg/ml to 80µg/ml. 
Cells in the presence of Mut3/4 lost viability at a concentration of 40µg/ml, whereas both 
Mut3 and Mut5 lost viability at 80µg/ml. The increased sensitivity of the RA assay and over 
expression of the mutants has allowed us to differentiate between the mutants by increasing 
the level of 2AP.  
Bacterial growth curves 
The RA assay shows an effective phenotype for each of the mutants, however, we do not 
know how the cell cultures are affected as a function of time. Bacterial growth curves of the 
ArdA mutants identified subtle differences in the growth rate of cells. The growth curves 
compared the growth rate of cells with and without induction of the protein. Bacterial growth 
curves of the E. coli NM1041 were also measured with increasing levels of 2AP by 
measuring the OD600 of the bacterial cultures every 5mins for a total of 900mins. 
	
Figure A.13: Cell growth with the ArdA, Orf18 mutants expressed in E. coli, NM1041 (clpXP−, 
r+m+) in the presence of antibiotics only (Km and Carb). It is clear that cells expressing 
different ArdA mutants showed the same growth rate. Growth behavior of the mutants was 
compared with wtOrf18 and the empty vector pTrc99A which represent an active and 
inactive anti-restriction protein respectively.  
 
Bacterial growth curves were recorded for E. coli NM1041 cells grown with each of the 
ArdA mutants. Under selective antibiotic markers only, each of the mutants induced 
conventional growth patterns, similar to E. coli NM1041 cells in the presence of pTrc99A or 
wtArdA (Figure A6). The bacterial growth curves of the ArdA mutants demonstrated a 
doubling time of ~101minutes, this doubling time is slightly faster than the doubling rate of 
E. coli NM1041 cells in the presence of wtOcr which was ~130mins. This suggests that 
unlike the Ocr mutants none of the ArdA mutants caused adverse growth patterns as a result 
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of leaky expression. This is verified by the uninduced RA assay carried out in Figure A.4, 











Figure A.14: Cell growth with the ArdA Orf18 mutants expressed in E. coli, NM1041 (clpXP−, 
r+m+) in the presence and absence of 2AP. It is clear that cells expressing different ArdA 
mutants showed varying  growth rates, some cultures were affected by; the expression of the 
mutant (+IPTG) or when exposed to increasing concentrations of 2AP. Growth behavior of 
the mutants were compared  with wtOrf18 and the empty vector pTrc99A which represent an 
active and inactive anti-restriction protein respectively. Graphs on the left show mutants 
which have retained some activity when exposed to increasingly toxic conditions whereas on 
the right are the mutants which have a sigmoidal curve which represents a loss of activity 
both types of graph include the growth curve of wtArdA for comparative analysis. OD600 
measurements were recorded every 5 min for 800 min. Errors are ±7% for triplicate 




Overall the growth of E. coli NM1041 in the presence of the ArdA mutants, displays growth 
curves which reflect the phenotypes produced from the RA plate assay. The exception is the 
growth profile of cells grown with mutants Mut3 and Mut5. Although the level of 2AP 
resistance is retained at a concentration of 80µg/ml from the results of the 2AP plate assay 
and bacterial growth curves, upon over expression with IPTG both mutants induce a slow 
growth rate but retain antirestriction activity. 
Microscopy 
The deleterious effect induced by particular ArdA mutants on cell growth has been witnessed 
previously by the Ocr mutants, M12, M16 and Ocr/pOcr in chapter 3. The severe reduction 
in cell growth was previously attributed to the production of DNA filaments. On the other 
hand, a number of the ArdA mutants confer different levels of 2AP resistance/antirestriction 
activity that have not been identified before.  
Therefore E. coli NM1041 cells expressing ArdA or its mutants were induced with IPTG, the 
cells were fixed with methanol and examined under a light microscope. Comparisons that 
showed that the majority of cells observed were a similar size regardless of the ArdA mutant 
present. However, cells grown with some of the ArdA mutants did produce a number of 
filaments although these were not as obvious as those induced by the Ocr mutants. To be 
able to discern whether the number of filaments is significant and can be attributed to the 
activity of the ArdA mutant, the cell length was measured for at least 400 cells that were 
selected at random. Each of these cells were categorised as either normal or as filaments. 
Conventionally cell length follows a normal distribution with the majority of cells inducing 
pTrc99A measuring ~2 microns, if the length of a cell was greater than 4 microns then it 
would be classified as a filament. The percentage frequency of filaments to normal cells is 





Figure A.15: Light Microscopy images of cell morphology of bacterial cultures of E. coli 
NM1041 (ClpXP-, M+R+) transformed with plasmids expressing wild-type Orf18, ArdA or its 
variants. Control cells were transformed with the vector pTrc99A.  
 
Figure A.16: Morphology types of E. coli NM1041 (m+r+, ClpXP−) cells, transformed and 
induced with wild-type Orf18 ArdA or the mutant derivatives. Filaments were assigned to 
cells which were twice the unit size of the pTrc99A cell without the introduction of ArdA Orf18 
or mutants thereof. The number at the top of each bar is equal to the total number of cells 
examined. 
 
Filaments are observed for several mutants, however the total percentage of filaments does 
not exceed 23%, except for the culture expressing the mutant L127E. Cell cultures 
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expressing pTrc99A, wtArdA and Mut5/6 possess minute numbers of filaments, < 2% of the 
total population. The mutants Mut1/2, Mut3, and Mut5 acquired filaments which contributed 
to ~10-20% of the population whereas, the mutants Mut1, Mut2, Mut4, Mut6 and L127E all 
contained the highest percentage of filaments ~20% relative to the population size. The 
increase in filamentation appears to correspond to a decrease in 2AP resistance, with the 
mutants Mut1, Mut2, Mut4, Mut6 and L127E producing highly deleterious effects, as shown 
by the results from the RA assay and the bacterial growth curves.  
Discussion 
Structure to function relationships 
The Orf18, ArdA monomer protein structure is made up of 3 domains. Each of the mutants 
targeted two negatively enriched clusters on each domain, producing Muts1-6. In addition 
combinations; Mut1/2, Mut3/4 and Mut5/6 which combine the two negatively enriched 







Figure A.17: The ArdA homodimer crystal structure, representing the three domains that 
produce the ArdA monomer structure, the table details which residues that belong to each of 
the domains. 
 
The ArdA mutants Mut1 and Mut2 are located in domain I which dominates the N- terminal 







assay. The toxic effect is a result of the restriction activity of the EcoKI complex being 
active, whereas modification has been inhibited, a so called M-R+ phenotype. The 
combination of both of the mutants to form the mutant Mut1/2, produces a 2AP resistance of 
up to 10µg/ml. This resistance is just slightly less than the 2AP resistance exhibited by the 
pTrc99A plasmid, producing an almost inactive ArdA mutant protein. This suggests that the 
ArdA protein might have additional binding sites with the HsdR subunits which do not 
include the core interaction of ArdA protein with the M.EcoKI enzyme.  
The core interaction of the ArdA protein with M.EcoKI includes the interaction of the HsdS 
subunit with the central region of the ArdA protein. In chapter 3 a similar, central region was 
highlighted as an important interaction between the HsdS subunit with the Ocr protein. The 
central region is dominated by the C-terminal domain III of the ArdA protein and the 
mutants Mut5 and Mut6 target this particular region of the ArdA structure. The mutant Mut6 
produced a deleterious effect similar to the Ocr mutant M12. In vitro studies showed that this 
deleterious effect correlates with mutants that possess weak antirestriction properties with a 
phenotype of M-/+R-/+.  
However the Mut5 protein is resistant to high concentrations of 2AP, its resistance is similar 
to wtArdA although the growth rate of the E. coli cells is reduced, which could suggest some 
deleterious effects, this was confirmed by the formation of filaments (10-20% of the total 
cell population). This suggests that its antirestriction activity is not as efficient as wtArdA. 
The combination of the two mutants to form the Mut5/6 protein produces a mutant that is 
completely inactive. The mutant Mut5/6 shares the same phenotype as the pTrc99A plasmid 
in the 2AP assay. However upon leaky expression the Mut5/6 protein demonstrates a greater 
2AP resistance compared to pTrc99A, as such the protein may possess some slight activity 
that remains undetectable once the mutant protein is over expressed. 
The last domain is domain 2 which lies between the C-terminal (domain 1) and N- terminal 
(domain III). Mut3 and Mut4 represent the mutations which target this region and the two 
mutants appear to display some 2AP resistance. The Mut3 protein displays the same change 
in growth rate that was demonstrated for the Mut5 protein, therefore, Mut3 is active but with 
reduced antirestriction activity whereas the mutant Mut4 appears to be deleterious. This 
implies that the mutations in Mut4 are more detrimental to the activity of the ArdA protein 
then those on Mut3. The inability to inhibit both the antirestriction and antimodification 
activity fully causes E. coli cells with the Mut4 protein to become susceptible to restriction 
by the EcoKI enzyme. The combination of the mutants in Mut3/4 reduces 2APR to 20µg/ml, 
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the resistance of E. coli cells in the absence of antirestriction proteins is 10µg/ml, and as 
such Mut3/4 exhibits limited antirestriction and antimodification activity.  
In summary, the mutants that target each domain can affect either the antirestriction or/and 
antimodification properties of wtArdA. A reduction in the number of acidic residues 
presented in domain I appear to reduce antirestriction activity to a greater extent. This 
suggests that the ArdA protein has multiple binding sites which are specific to the M.EcoKI 
and EcoKI complexes. This is reflected by the elongated nature of the ArdA protein. As a 
result, upon binding to the M.EcoKI core complex, domain I of the wtArdA homodimer 
flank either side of the complex whereas the wtOcr protein is completely engulfed by the 
enzyme.  
On the other hand residues that reside in domain III appear to be important to the interaction 
between the mutant and the MTase core and as a result mutants that target this domain 
demonstrate weak binding affecting both the antirestriction and antimodification activity of 
these mutants. Domain II has the same effect as domain III but to a lesser extent. 
Interestingly the mutants Mut3 and Mut5 which span domain II and domain III appear to 
have the least effect on the activity of the protein. Both of these mutants retain almost the 
same activity as the wtArdA protein.  
The mutant L127E which results in the ArdA monomer protein is deleterious similar to 
Mut1, Mut2, Mut4 and Mut6 and this suggests that, although the monomer protein has a 
weak binding affinity towards EcoKI enzyme, this is not sufficient and the wtArdA 







Figure A.18: Aligning both wtOcr and wtOrf18ArdA homodimer structures to dsDNA in a 
model of the interaction of wtOcr: M.EcoKI complex. The acidic residues of wtOcr and 
wtOrf18ArdA have been highlighted in red. Comparisons highlight the elongated form of the 
ArdA dimer which proceeds out of the M.EcoKI complex presumably revealing binding sites 
towards the HsdR subunits. However the wtOcr protein has been engulfed by the methylase 
core of the enzyme revealing very few sites of further interaction with the Endonuclease 
complex. Furthermore the wtOcr protein appears to have a more tight fit within the M.EcoKI 
compared to the wtArdA protein possibly justifying the smaller Kd value of it interaction.   
 
Comparing results 
Although the purification of the ArdA mutants was difficult the mutants Mut5, Mut6 and 
L127E were all successfully purified and characterised in vitro, by Dr GA Roberts and 
colleagues. In addition previous investigations measured the effect of phage infection on 
restriction proficient and restriction deficient cells in the presence of each of the mutants. 
Table A.1 compares the results obtained from the 2AP investigation presented in this chapter 












Plasmid Antirestriction Antimodification 
2AP (-
IPTG) 2AP (+IPTG) 
pTrc99A n/a 0.9 20 20 
wtOrf18 3.70E+03 122 80 <80 
Mut1 2.90E+03 1 40 T 
Mut2 2.80E+03 1.9 40 T 
Mut1/2 2.40E+03 1 40 10 
Mut3 2.90E+03 3.2 40 80 
Mut4 2.80E+03 1.5 40 T 
Mut3/4 4.00E+02 2 40 40 
Mut5 2.00E+02 1 40 80 
Mut6 2.80E+03 2.9 40 T 
Mut5/6 1.10E+01 1 40 20 
L127E 3.00E+03 1 40 T 
Table A.2: The table compares the results from the 2AP RA assay for each of the ArdA 
mutants with results from a previous in vivo phage infection experiment (kindly donated by 
Dr GA Roberts). The 2AP results present the 2AP resistance exhibited by each of the 
mutants with and without IPTG inducing agent. The values are the concentrations reached 
before cell death for cultures in the presence of each of the mutants. ‘T’ represents those 
mutants which were toxic to the cells, mutant which caused cell death in E. coli NM1041 
cells upon over expression. 
 
One defining difference between the ArdA proteins and wtOcr, is that ArdA proteins can 
display differential antirestriction and antimodification activity, these differences are 
dependent on the type of RM enzyme and the origin of the ArdA protein.70 The same 
differences in antirestriction and antimodification activity have been demonstrated by 
mutations to the Orf18 ArdA protein. 
Mut5 and Mut3/4 possessed high levels of 2APR for Mut5 this was similar to wtArdA and 
for Mut3/4 a 2APR of 40µg/ml was recorded. However bacterial growth curves showed a 
reduction in the total cell population for Mut5 which indicates that the antirestriction and 
antimodification activity of these mutants is reduced. The phage assays suggest that the 
antimodification activity of the protein has suffered more compared to antirestriction.   
Several ArdA mutants exhibit toxic effects towards E. coli NM1041 from the 2AP RA assay 
and this, together with the formation of cellular filaments, implies a phenotype that prevents 
methylation but not restriction M-R+. On the other hand, the results from the phage assay 





The low solubility of the ArdA mutants meant that only the mutants Mut5, Mut6 and L127E 
were successfully purified. Analysis of the mutants L127E and Mut5 revealed that these 
mutants existed as ArdA monomers in solution rather than homodimer proteins (personal 
communication by Dr GA Roberts). The Mut5 protein targets acidic residues near the dimer 
interface, it seems that this has inadvertently caused a change in the local folding pattern 
causing the Mut5 protein to exist as a monomer. However studies have shown that at high 
concentrations the equilibrium between the monomer and dimer unit shifts towards increased 
dimer (personal communication by Dr GA Roberts). This could affect the activity of these 
mutants at high and low concentrations. Therefore the phage results represent the activity of 
Mut5 and L127E at low concentrations as monomer units. The phage results show that the 
monomers are unable to inhibit methylation but do prevent restriction of the EcoKI RM 
enzyme. However upon over expression in the 2AP RA assay the mutants Mut5 and L127E 
could exist as a mixture of monomer and homodimer, as such the phenotype that these 
mutants express in E. coli NM1041 cells would differ compared to the phage assay. The 
mutant Mut5, at high concentrations, retains a 2APR that is almost the same as wtArdA but 
the slight decrease in activity seems to affect the rate of cell growth. In contrast the mutant 
L127E is deleterious, suggesting that methylation is inhibited but restriction is prevalent, and 
this phenotype is atypical of weak binding ArdA mutants to the M.EcoKI/EcoKI enzyme.   
Comparisons between the in vivo phage infection assay and the 2AP RA assays in Table A.1 
above showed that a multitude of phenotypes have been exhibited by the ArdA mutants. The 
diversity of the activity demonstrated is much greater than that exhibited by mutants of 
wtOcr, this shows that even though both of these antirestriction proteins essentially mimic 
dsDNA the subtleties in the difference of their design and fold means that changes to the 
ArdA protein are highly sensitive to the activity exhibited however, the wtOcr protein is very 




Figure A.19: The ArdA homodimer has been aligned to the dsDNA molecule within a model 
of the MEcoKI:DNA structure (pdb: 2Y7H). Each of the domains has been highlighted on the 
ArdA homodimer to highlight the possible location of each of these domains upon ArdA 
interaction with the M.EcoKI enzyme. Domain 3 is clearly seen to not be involved in the 
interaction of the ArdA protein to the methylase core of the enzyme. 
 
An overall summary suggests that the acidic residues in domain 1 appear to be important for 
antirestriction behavior of the protein, the central region domain 3 interacts with the 
M.EcoKI core inhibiting modification and domain 2 spans both regions. The acidic residues 
located on Mut1 and Mut2 both contribute to antirestriction activity of the ArdA protein. The 
residues from mutant Mut4 appear to have a greater effect on M.EcoKI and the residues on 
Mut3 appear to affect both antirestriction and antimodification activity equally. Finally, the 
acidic residues of the mutant Mut6 seem important in the binding of the protein to the 
M.EcoKI core, however, the acidic residues found on Mut5 appear to produce an ArdA 
monomer which either produces a dimer at high concentrations or the monomer is able to 
bind with a 2:1 or 1:1 stoichiometry with the EcoKI complex. 
 
